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1GENERAL INTRODUCTION AND AIMS OF THIS THESIS
Introduction
Parkinson’s Disease
Parkinson’s disease (PD) is a neurological disorder which was first described 
by James Parkinson in 1817. It is nowadays the second most common neuro-
degenerative disorder, coming second to Alzheimer disease only (de Lau and 
Breteler, 2006). Clinically, PD has traditionally been defined by the presence of 
cardinal motor signs: rest tremor, rigidity, bradykinesia and postural instability. The 
clinically based diagnosis of PD is typically made based upon the presence of 
these motor features, as well as the absence of atypical findings suggestive of an 
alternative diagnosis (the so-called ‘red flags’), plus a favorable response to 
levodopa (Samii et al., 2004). The diagnostic criteria most frequently used in clinical 
research are those of the UK Parkinson’s Disease Society Brain Bank (Gibb and 
Lees, 1988). Differentiating PD from other parkinsonian disorders such as progressive 
supranuclear palsy (PSP) or multiple system atrophy (MSA) can be challenging, 
particularly in the early course of the disease. Both standard neuro - imaging (Meijer 
et al., 2011) as well as advanced neuroimaging techniques (Brooks, 2010b, a) have 
been used to facilitate a more accurate early diagnosis of PD, but are currently not 
widely used in clinical practice (Brooks, 2010a).
The diagnosis PD is therefore made on clinical grounds, and ‘definite’ PD cannot be 
diagnosed during life but requires neuropathological confirmation. The pathological 
hallmarks of the disease include dopaminergic cell loss within the substantia nigra 
pars compacta and the presence of Lewy bodies (LBs) and Lewy neurites 
(collectively referred to as Lewy-related pathology) in vulnerable populations of 
neurons (Braak et al., 2003, Braak et al., 2004).
To investigate the neurobiological changes occurring in PD, research initially relied 
mainly on post-mortem material from PD patients (Bernheimer et al., 1973, Kish et 
al., 1988, Braak et al., 2003) and on animal models of PD (Langston et al., 1984). 
These studies have been valuable for defining the neuropathology of PD. However, 
post-mortem material is collected mostly from patients with advanced disease, 
where brain pathology is obscured by secondary changes and perhaps by 
age-related rather than PD-related changes. Moreover, pathological studies cannot 
address functional changes in the PD brain that occur prior to neuronal death. 
Furthermore, animal models are not able to fully capture all aspects of human PD, 
such as the changes within the cognitive domain (Di Monte, 2003). For example, 
the most commonly used animal model is based on chronic exposure to 1-methyl-
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compensatory mechanisms serving to delay or even reduce clinical symptoms 
(Bezard and Gross, 1998). In early stage PD, fMRI has provided evidence for such 
cerebral reorganization (Helmich, 2011). However, little is known about the premotor 
phase of parkinsonism in humans. The premotor phase of the disease has thus far 
mainly been studied in primates exposed to MPTP. In this model, low doses of 
MPTP were repeatedly administered over a time course of 1 month to cause 
progressive striatal dopaminergic denervation, but without causing clinically 
4-phenyl-1,2,5,6-tetrahydropyridine (MPTP), a neurotoxin that damages the nigrostriatal 
dopamine tract (Langston et al., 1984, Bloem et al., 1995, Bloem and Roos, 1995). 
While nigrostriatal degeneration in PD patients follows a gradual progression, such 
a time course is much more difficult to achieve using these MPTP injections in 
animals (Mounayar et al., 2007). 
In the last decades, development of brain imaging methods such as functional 
magnetic resonance imaging (fMRI; see BOX1) has enabled non-invasive assessments 
of brain activity in vivo. These neuroimaging tools can be used to investigate functional 
brain changes occurring in patients with clinically overt PD. Functional cerebral 
reorganization in such symptomatic phases of PD can take different forms. For 
example, it might be localized to specific brain regions, or involve system-level 
changes at the network level. Furthermore, functional reorganization in PD may 
have different behavioural consequences. That is, they could reflect pathological 
alterations that produce clinical or behavioural impairments, but could also represent 
Box 1.1   Functional magnetic resonance imaging (fMRI).
Functional magnetic resonance imaging (fMRI) is a method that uses MRI to 
investigate which areas of the brain are active during performance of a specific 
task (figure 1.1). It was developed in the early 1990s (Ogawa et al., 1990, 
Kwong et al., 1992) and since then has grown to become the dominant 
technique in cognitive neuroimaging. An advantage of fMRI is that it allows for 
noninvasive recording of brain signals, without for example the risks of 
exposure to radiation that is associated with some other neuroimaging 
techniques such as X-ray computed tomography scans. In addition, it allows 
for recording with a high spatial resolution of 3-6 mm. A disadvantage is that 
the temporal resolution is relatively low compared to techniques such as electro-
encephalography (EEG). This is related to the fact that fMRI does not measure 
neuronal activity directly. Rather it measures the changes in blood flow and 
blood oxygenation in the brain related to the neural activity in the brain. 
Functional MRI cannot detect absolute activity of brain regions, it can only 
detect differences in brain activity between different conditions. During the 
fMRI experiment, the subject is therefore asked to perform several tasks. Each 
of these conditions is repeated several times and separated by rest periods. It 
is important that the experimental and control conditions are as similar as 
possible. If the conditions differ in more than one way, there could be multiple 
explanations for the differences in cerebral activity.
Figure 1.1   
A. Photograph of a MRI scanner, the main magnetic field is 3 Tesla. Subjects lay 
supine in the scanner. Task stimuli are programmed on a computer in the control 
room, and presented onto the screen via a beamer. Subjects can respond in 
different ways (e.g. button press with hands or feet, or eye-movements with an 
eye-tracker). B. An image of the brain with areas of statistically significant areas 




1CHAPTER 1 GENERAL INTRODUCTION AND AIMS OF THIS THESIS
The genetics of parkinsonism
In the past decade, genetic studies in PD families from different geographical 
regions worldwide have confirmed the hypothesis that PD has a substantial genetic 
component. Since the first locus (PARK1; SNCA) (Polymeropoulos et al., 1996, 
Polymeropoulos et al., 1997) was described in 1996, a total of now 18 different loci 
has been identified through traditional cloning approaches, linkage studies or 
genome-wide association studies (Gasser et al., 1998, Leroy et al., 1998, Hicks et 
al., 2002, Pankratz et al., 2003, Strauss et al., 2005, Belin and Westerlund, 2008, 
Lautier et al., 2008, Di Fonzo et al., 2009, Paisan-Ruiz et al., 2009, Pankratz et al., 
2009, Satake et al., 2009, Simon-Sanchez et al., 2009, Hamza et al., 2010). 
Mutations in eight of the corresponding genes (SNCA, LRRK2, Parkin, DJ1, PINK1, 
ATP13A2, VPS35 and EIF4G1) have conclusively been demonstrated to cause 
monogenetic forms of parkinsonism (Lesage and Brice, 2009, Chartier-Harlin et al., 
2011, Vilarino-Guell et al., 2011). These rare genetic forms of PD show a substantial 
clinical phenotypic overlap with sporadic, non-genetic PD. Non-manifesting 
individuals who carry a single heterozygous mutation in the Parkin (PARK2) or 
PINK1 (PARK6) genes - both of which associated with recessively inherited PD in 
case of two pathogenic mutations - have attracted particular interest. In these 
individuals, positron emission tomography (PET) – that has been used to evaluate 
dopaminergic neurotransmission – has shown a mild presynaptic dopaminergic 
dysfunction despite absence of corresponding clinical manifestations (Hilker et al., 
2001, Khan et al., 2002a, Khan et al., 2002b). In addition, heterozygous mutation 
carriers have an increased risk to develop signs of PD throughout their life (Hedrich 
et al., 2002, Hedrich et al., 2006). Therefore, it has been argued that non-manifesting 
carriers of a single mutant allele in these two recessive PD genes provide a human 
model to study downstream changes within the cortico-basal ganglia-thalamo-
cortical circuitry in the context of a subclinical loss of dopamine-producing cells in 
the substantia nigra (van Eimeren and Siebner, 2006).  
In healthy subjects with or without such mutations that render them to be at risk for 
PD, it is now possible to study cerebral activity (using techniques such as fMRI) to 
identify primary, premotor functional changes. The identification of these (compensatory) 
mechanisms is important to expand our knowledge about the neurobiological 
mechanisms that are at play in this premotor phase of PD. In the future, this may 
lead to new therapies aimed at modulating functional reorganization in vivo, for 
example by tuning down pathological changes or by facilitating compensatory 
mechanisms using transcranial magnetic stimulation (TMS). For that purpose we 
also conducted studies, as outlined in the second part of this thesis, aimed to 
induce temporary inhibition of different cortical areas with TMS (see BOX2) to test 
discernable symptoms in these animals (Bezard et al., 2001). This “subacute” 
MPTP model revealed that progressive striatal dopamine depletion can trigger 
several compensatory mechanisms, both within and outside the basal ganglia 
(Bezard et al., 2003).
Other insights in the premotor phase from PD in humans come from epidemiologic 
studies, in particular retrospective case control series, and also large prospective 
cohort studies. These studies have suggested that certain non-motor manifestations, 
such as rapid eye movement sleep behavior disorder (Uchiyama et al., 1995, 
Schenck et al., 1996, Stiasny-Kolster et al., 2005), anxiety disorders (Shiba et al., 
2000, Weisskopf et al., 2003, Bower et al., 2010), hyposmia (Ponsen et al., 2004, 
Ponsen et al., 2009, Ponsen et al., 2010, Berendse et al., 2011), constipation (Abbott 
et al., 2001, Savica et al., 2009a) and anemia (Savica et al., 2009b), may precede 
the motor manifestations of PD by a long time. This indicates that there is a premotor 
period, which might be as long as 20 years before the onset of motor signs, 
although it remains very difficult to make reliable estimates about the duration of 
this premotor phase. (Note that it is presumably better to use the term premotor 
phase, rather than preclinical phase, because it can be argued that the presence of 
non-motor symptoms in the years before onset of motor symptoms is in fact already 
a clinical phase, even though it is currently not yet defined as such. In this thesis, 
we will consistently refer to this period as the premotor phase). It is conceivable that 
cerebral compensatory processes are at least partially responsible for the absence 
of the characteristic motor symptoms, despite the presence of PD-related pathology 
(as can be identified in vivo using nuclear imaging of the dopaminergic system in 
these individuals during the premotor phase). However, it remains unknown just 
how the human motor system adapts to this slowly progressive nigrostriatal 
dopaminergic denervation; one of the reasons is the fact that we have no reliable 
diagnostic test at hand that can be easily applied to the general population, in order 
to identify individuals that are in the premotor stage of PD. Fortunately, new 
opportunities to study the premotor phase of PD have arisen in the past decade, 
due to advances in the field of genetics. Specifically, as we will point out in more 
detail below, there are now possibilities to study asymptomatic carriers of mutations 
in different genes that have been shown to cause genetic forms of PD. 
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whether it is possible to capture cerebral reorganization by combining TMS and 
fMRI in healthy controls and PD patients. 
Box 1.2   Transcranial magnetic stimulation (TMS).
In 1985, Barker et al. (Barker et al., 1985) developed a method of external 
brain stimulation, namely transcranial magnetic stimulation (TMS). This is a 
noninvasive method to cause depolarization or hyperpolarization in the 
neurons of the brain. The scientific principle on which magnetic stimulation is 
based was discovered by Michael Faraday in 1831. He described the 
phenomenon of mutual induction, whereby current flows in a secondary circuit 
when it is brought near a current-carrying primary circuit. In 1896, D’Arsonval 
reported that flickers of light were seen by volunteers when their heads were 
placed in a time-varying magnetic field. In 1965, Blickford and Freming 
demonstrated muscular contractions in animals and humans after magnetic 
stimulation. Twenty years later, in 1985, Barker (figure 1.2) stimulated the 
human brain with a magnetic stimulator as it is being used nowadays.  For 
TMS, we use an electromagnetic coil that is held over the subject’s head. 
When current passes through the coil, it generates a magnetic field that can 
penetrate the subjects’ scalp and skull. By rapidly changing the magnetic 
field, weak electric currents can be induced in the nearby brain tissue (electro-
magnetic induction). This allows for triggering of brain activity with minimal 
discomfort. The effects of TMS can be divided into two types depending on 
the mode of stimulation. First, single or paired pulse TMS causes neurons in 
the cortex under the site of stimulation to depolarize and discharge an action 
potential. When TMS is applied over the primary motor cortex, it produces a 
response that can be seen directly, in the form of muscle twitches. The 
response results from the activation of corticospinal neurons in the motor 
cortex that project directly to the spinal cord and that are connected in the 
spinal cord with alpha motor neurons that activate the muscles. The motor 
response induced by TMS is called the motor-evoked potential (MEP; see 
figure 1.3) which can be recorded with electromyography. The amplitude of 
the MEP reveals the net excitability of the corticospinal system (Rothwell et al., 
1991). If used on the occipital cortex, ‘phosphenes’ (flashes of light) might be 
perceived by the subject. In most other areas of the cortex, the participant 
does not consciously experience any effect, but his or her behaviour may be 
slightly altered (e.g. slower reaction time on a cognitive task), or changes in 
brain activity may be detected using sensing equipment such as EEG 
(Pascual-Leone et al., 2002). Second, repetitive TMS (rTMS) produces 
longer-lasting effects that persist after of the actual stimulation has stopped. 
Box 1.2   Continued.
rTMS can increase or decrease the excitability of the corticospinal tract 
depending on the intensity of stimulation, coil orientation, and frequency. The 
mechanism of these effects is not clear, although it is widely believed to reflect 
changes in synaptic efficacy akin to long-term potentiation (LTP) and long-term 
depression (LTD) (Fitzgerald et al., 2006). In our studies, we used continuous 
Theta Burst Stimulation (cTBS; see figure 1.4) (Huang et al., 2005), a relatively 
new variant of conventional 1 Hz rTMS, to induce inhibitory cortical after-effects 
in the stimulated cortical areas in PD patients and healthy controls during 
different tasks.
Figure 1.2   
Anthony T. Barker (on the right) with the stimulator that was used to deliver TMS 
for the first time (Barker et al. 1985).
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may prevent or delay clinical manifestation. In addition to mutations causing monogenic 
forms of PD, common polymorphisms in genes that influence mono-aminergic 
signalling or synaptic plasticity may have modifying effects on distinct aspects of 
PD. I also discuss how functional and structural neuroimaging can be used to 
better characterize genotype-phenotype correlations. Furthermore, in chapter 3, I 
reviewed how fMRI can be used to identify compensatory mechanisms that help to 
prevent development of overt disease. 
In chapter 4, I used a combined neurogenetic-neuroimaging approach to examine 
the functional consequences of premotor dopaminergic nigrostriatal dysfunction in 
the human motor system. Specifically, I examined how a single heterozygous 
mutation in two genes associated with recessively inherited PD (Parkin and PINK1) 
alters the cortical control of sequential finger movements during fMRI. The most 
important question which I address is whether the observed cerebral reorganization 
reflects a “generic” or “gene-specific” compensatory mechanism to maintain motor 
function in the context of a mild dopaminergic deficit. For this purpose, we studied 
subjects with mutations in different PD genes and compared the nature of their 
adaptive plasticity. In chapter 5, I extended this work by examining premotor cerebral 
Outline of this thesis
The studies described in this thesis were aimed at providing insight into the 
functional and cerebral reorganization occurring in the premotor phase of PD. The 
results of these studies are described in two parts: the first part (chapters 2 to 5) 
covers fMRI studies to map premotor cerebral reorganization in non-manifesting 
mutation carriers of one of the PD genes, and the second part (chapters 6 and 7) 
focuses on TMS to induce cerebral reorganization in healthy controls and patients 
with clinically overt PD.  
In the next chapter, chapter 2, I reviewed how structural and functional neuroimaging 
of individuals carrying a mutation in one of the PD genes offers a unique new 
avenue to obtain insights into the pathophysiology of PD. In addition, neuroimaging 
of non-manifesting mutation carriers has emerged as a valuable tool to identify 
mechanisms involved in adaptive motor reorganization at the premotor phase that 
Figure 1.3   
The basic principle of TMS (adapted from Ridding and Rothwell, 2007). The current 
flowing briefly in the coil generates a changing magnetic field that induces an 
electric current in the tissue, in the opposite direction. When TMS is applied over 
the primary motor cortex, it produces a motor response that can be recorded 
with electromyography (see right panel).
Figure 1.4   
Continuous Theta Burst Stimulation (cTBS). This inhibitory rTMS stimulation protocol 
was introduced by Huang et al, 2005. In this protocol, 3 pulses of stimulation are 
given at 50 Hz, repeated every 200 ms. In the cTBS paradigm, a 40 s train of 
uninterrupted TBS is given (600 pulses).
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which causes dominantly inherited parkinsonism, again using fMRI (during a well-
established motor imagery task) but also using voxel based morphometry (VBM) to 
capture any volumetric adaptations in the premotor phase.
In the second part of this thesis, I used TMS to transiently disrupt neuronal 
processing in cortical areas, in order to test their functional relevance in healthy 
controls and PD patients. Specifically, I transiently inhibited the left dorsal premotor 
cortex (PMd) by using continuous theta burst stimulation (cTBS) in chapter 6. The 
conditioning effects of cTBS on preparatory brain activity were assessed with fMRI, 
while participants (healthy controls) lifted a light or heavy weight, to learn whether 
we can indeed induce behavioral changes with TMS and also to map and correlate 
these behavioral changes with fMRI. This led to the last study in PD patients, 
described in chapter 7, in which I transiently inhibited the left PMd and right 
extrastriate body area with cTBS in healthy controls and overt PD patients, in order 
to test the functional relevance of the compensatory activity in these areas in PD 
patients that was demonstrated previously (Helmich et al., 2007).
Finally, in chapter 8 I provide a summary and general discussion of my findings 
and sketch several future perspectives.
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CHAPTER 2 IMAGING THE IMPACT OF GENES ON PARKINSON’S DISEASE
Abstract 
Although Parkinson’s disease (PD) has traditionally been considered to be a 
non-genetic disorder, recent progress in the neurogenetics of PD provided 
converging evidence that genetic factors play a relevant role in the aetiology of PD. 
The strongest case for a genetic contribution to PD was made by the discovery of 
mutations in single genes that can cause autosomal dominant (SNCA and LRRK2 
gene) or recessive (Parkin, PINK1, DJ-1, and ATP13A2 gene) forms of PD. Here, we 
review how structural and functional neuroimaging of individuals carrying a mutation in 
one of the PD genes have offered a unique avenue to obtain new insights into the 
pathogenesis of PD. In symptomatic mutation carriers (i.e. those with overt disease), 
brain mapping can help to link the molecular pathogenesis of PD more directly with 
functional and structural changes in the intact human brain. In addition, neuro- 
imaging of presymptomatic (i.e. non-manifesting) mutation carriers has emerged 
as a valuable tool to identify mechanisms of adaptive motor reorganization at the 
preclinical stage that may prevent or delay clinical manifestation. In addition to 
mutations causing monogenic forms of PD, common polymorphisms in genes that 
influence mono-aminergic signalling or synaptic plasticity may have modifying 
effects on distinct aspects of PD. We also discuss how functional and structural 
neuroimaging can be used to better characterize these genotype-phenotype 
correlations.
Introduction
Parkinson’s disease (PD) is the second most common neurodegenerative disorder 
(de Lau and Breteler, 2006). The traditional view dictates that affected patients 
present with a variable combination of motor symptoms, including bradykinesia, 
rigidity, resting tremor and – in later stages of the disease – also with postural 
instability. However, it is becoming increasingly clear that these “traditional” motor 
impairments represent just the tip of the iceberg, and that these are typically 
accompanied (or indeed, even preceded) by a variety of non-motor symptoms, 
including hyposmia, cognitive decline, mood disorders, pain, autonomic dysfunction 
and sleep disorders (Langston, 2006). In this review, we will focus on the patho-
physiology of the motor impairments in PD, and how these are linked to the 
underlying genetic abnormalities that can be found in subgroups of patients 
with parkinsonism. We have limited ourselves to the motor manifestations of PD 
as they represent the best “accessible” outcome measures in imaging and genetic 
studies.
The motor impairments in PD result mainly from progressive neuronal loss of 
dopaminergic neurons in the substantia nigra pars compacta and can improve 
markedly with dopaminergic drugs (Gibb, 1991, Gibb and Lees, 1991, Damier et al., 
1999). Interestingly, the motor system has a substantial potential to cope with the 
slowly progressive degeneration of the nigrostriatal dopaminergic projections. 
Clinical symptoms only emerge when around 70-80% of nigrostriatal nerve terminals 
have undergone degeneration (Bernheimer et al., 1973). The logical implication is 
that for most patients, the neurodegenerative process has likely started well in 
advance of the first overt clinical motor symptoms, although the length of this pre-
symptomatic period remains unknown. Indeed, post-mortem histological examinations 
have identified individuals who show Lewy neurites and Lewy bodies (the histological 
hallmarks of PD) in various brainstem areas but who had never developed 
parkinsonism during life time (Braak et al., 2003, Braak et al., 2004).
It has been a widely held notion that PD is mainly caused by environmental factors, 
with genetic factors playing only a very minor role in the pathogenesis. This 
“environmental” theory was supported in particular by the identification of “selective” 
nigrostriatal neurotoxins such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 
which can cause parkinsonian symptoms with a remarkable resemblance to 
idiopathic PD in rodents, primates and even in humans (Langston et al., 1983, 
Bloem and Roos, 1995). However, the ideas about the aetiology of PD have changed 
considerably in the last decades. Advances in neurogenetics have provided strong 
evidence that what clinicians perceive as “idiopathic PD” can in fact be genetically 
determined. There are converging sources of supporting evidence (Martin et al., 
1973, Tanner et al., 1999, Warner and Schapira, 2003), but the case is certainly 
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identified that carry single allele triplications (initially assigned as PARK4) or 
duplications of the wild-type SNCA gene (Farrer, 2006). Penetrance has been 
described to be as low as 33% (Nishioka et al., 2006), which is highly relevant for 
this review as it implies that many carriers of a pathogenic genetic abnormality 
somehow “manage” to remain asymptomatic. Why a substantial proportion of 
carriers never goes on to develop overt parkinsonism remains unknown. Here 
neuroimaging may provide some of the answers and help to clarify the pathophys-
iological substrate for this variable penetrance. For many of the SNCA-linked cases, 
the severity of the phenotype appears to depend on gene dosage, and patients 
with SNCA duplications clinically resemble ‘idiopathic’ PD patients more than those 
with triplications, although the phenotypic spectrum can be remarkably broad 
(Fuchs et al., 2007). SNCA is abundantly expressed in the vertebrate nervous 
system, where it is believed to participate in the maturation of presynaptic vesicles 
and to function as a negative co-regulator of neurotransmitter release (Vekrellis et 
al., 2004). SNCA has a propensity to aggregate owing to its hydrophobic non-amy-
loid-beta domain. Intriguingly, oligomer-forming species of SNCA, along with 
truncated, oxidized and phosphorylated variants have been found in insoluble 
inclusions (‘Lewy bodies and Lewy neurites’) of the human brain including 
SNCA-linked cases (Spillantini et al., 1997). 
PARK8 (dominant): LRRK2 
The LRRK2 (leucine-rich repeat kinase 2) gene has been identified by two 
independent groups (Paisan-Ruiz et al., 2004, Zimprich et al., 2004) and is now 
recognized as the most common known cause of familial and sporadic 
parkinsonism. Mutations in the LRRK2 gene are mostly associated with late-onset, 
classical parkinsonism. LRRK2 is a large gene that consists of 51 exons encoding 
a 2527-amino acid protein named LRRK2 featuring several functional domains. To 
date, more than 50 variants have been reported in this gene. By far the most 
frequent and best studied mutation is the c.6055G>A (p.G2019S) substitution that 
accounts for ~1.5% of all index cases with late-onset, classical parkinsonism (Healy 
et al., 2008). As for PARK1, penetrance is incomplete and is age-dependent, 
reaching perhaps around 70% depending on the age of the mutation carrier. The 
high prevalence of pathogenic mutations in the LRRK2 gene also implies that there 
are many presymptomatic individuals, with the same implications for neuroimaging 
as for PARK1. There is a surprisingly high degree of neuropathological heterogeneity 
even in members of the same family carrying an identical mutation, ranging from 
Lewy body-positive parkinsonism, to diffuse Lewy body disease, to nigral 
degeneration without distinctive histopathology, and to progressive supranuclear 
palsy-like pathology (Wszolek et al., 2004). LRRK2 functions as a protein kinase, 
mutations of which alter its phosphorylation activity through a proposed gain-of-
strongest for monogenic forms of familial PD that are caused by mutations in 
specific genes (Gasser, 2007, Klein and Schlossmacher, 2007).
Although monogenic forms account for only a small fraction of PD patients (perhaps 
around 3 to 5% of all cases), they have considerably stimulated the field of PD 
research. For example, the cellular pathways that are affected by monogenic 
variants of PD have provided important clues regarding the molecular pathogenesis 
in typical sporadic PD (Gasser, 2007). In this review, we will focus on another 
important research area that greatly profited from the advances in PD genetics, 
namely the field of neuroimaging. Specifically, we evaluate the structural and 
functional brain mapping studies that have been performed in individuals carrying 
a mutation in a specific PD gene, and discuss how this “neurogenetics-neuroimaging 
approach” provides unique means to tap into important pathophysiological aspects 
of PD.
Monogenic forms of Parkinson’s disease
The genes and chromosomal loci linked to familial forms of PD have been 
designated as PARK1–13. These loci include six autosomal dominant (PARK1 (=4), 
3, 5, 8, 11 and 13), four recessive (PARK2, 6, 7, and 9), one X-linked (PARK12), and 
one form with an as yet unknown mode of transmission (PARK10). Mutations in the 
LRRK2, Parkin and PINK1 genes are the clinically most relevant types because they 
are relatively frequent and their clinical phenotype shows substantial overlap with 
that of sporadic (non-familial) PD. A detailed description of the genetics of PD is 
beyond the scope of this paper and has been covered in several recent reviews 
(Shadrina and Slominskii, 2006, Gasser, 2007, Klein and Lohmann-Hedrich, 2007, 
Klein et al., 2007, Klein and Schlossmacher, 2007, Tan and Skipper, 2007, Belin and 
Westerlund, 2008). Here we will rather focus on a short description of well-estab-
lished forms of genetic PD for which neuroimaging data have become available, i.e. 
PARK1(=4), PARK2, PARK6, PARK7 and PARK8. In the following sections, these 
monogenic forms of parkinsonism will be grouped according to their mode of 
inheritance. This is in agreement with functional findings that suggest a gain-of-
function mechanism for dominant and a loss-of-function mechanism for recessive 
forms. However, things appear to be more complex as penetrance (percentage of 
mutation carriers that actually develop the disease) is remarkably reduced in 
dominant forms. Conversely, a putative role of single heterozygous mutations as a 
susceptibility factor has been suggested in recessive forms (Klein et al., 2007). 
PARK1(=4) (dominant) 
In 1997, the alpha-synuclein (SNCA) gene was the first one to be unequivocally 
associated with familial parkinsonism (Polymeropoulos et al., 1997). In addition to 
the three point mutations, a number of families with parkinsonism have been 
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function mechanism (Lu and Tan, 2008). Unexpectedly, the expression rate of the 
LRRK2 gene (as compared, for example, to the Parkin or DJ-1 gene) in mammalian 
brain is low in the predominantly affected dopaminergic neurons of the human 
substantia nigra, whereas high expression rates of LRRK2 were found in striatal 
neurons that receive dopaminergic input (Galter et al., 2006). 
PARK2 (recessive): Parkin 
Overall, Parkin mutation carriers tend to have an earlier age at disease onset, a slower 
disease progression and often feature a better response to levodopa than patients 
without Parkin mutations (Lohmann et al., 2003), as do carriers of mutations in the 
PINK1 and DJ-1 genes (see below). Mutations in the Parkin gene (Kitada et al., 1998) 
represent the most common known factor responsible for early-onset parkinsonism 
(10–20%), and have been found across all tested ethnic groups (Hedrich et al., 2004). 
One might predict that this recessively inherited disorder should spare heterozygous 
mutation carriers; yet it appears that carrying a single mutant allele acts as a 
susceptibility factor, increasing the risk of developing overt parkinsonism at a later 
age (Klein et al., 2007). The obvious implication for this review on neuroimaging is 
that carriers of single heterozygous mutations may represent another model – 
complementary to the presymptomatic dominant mutation carriers – of presympto-
matic parkinsonism. Similar considerations apply to the other recessive forms of 
parkinsonism discussed below (PARK6 and PARK7). 
The gene product, called Parkin, is an E3-type ubiquitin ligase that is involved in the 
proteasomal degradation of target proteins (Shimura et al., 2000). The available E3 
activity of many (but not all) PD-linked mutants is disrupted in ex vivo experiments; 
others affect the solubility, localization and binding properties of Parkin. Indeed, 
reduced ubiquitin ligase activity may only be one of several pathogenetic mechanisms 
(Feany and Pallanck, 2003) as recent studies have delineated an essential role of 
Parkin in mitochondrial integrity (Deng et al., 2008). Only two of the six Parkin mutant 
PD brains that have come to autopsy showed typical Lewy bodies, while the other 
four did not (reviewed in Pramstaller Ann Neurol 2005 (Pramstaller et al., 2005)).
PARK6 (recessive): PINK1 
Two homozygous mutations in the PINK1 (PTEN-induced kinase 1) gene were 
initially described in three families with autosomal recessive, early-onset 
parkinsonism (Valente et al., 2004). The frequency of PINK1 mutations ranges from 
1–8% in patients of different ethnicities (often selected for their young age of onset 
and positive family history). Most of the currently described mutations are localized 
within the functional serine/threonine kinase domain of PINK1. Wild-type PINK1 
protein is localized inside mitochondria and has been demonstrated to have a pro-
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Mapping striatal dopaminergic neurotransmission
After mutations in specific genes that can cause familial forms of PD had been 
identified, an obvious question was whether these mutations would affect striatal 
dopaminergic neurotransmission in a similar fashion as in the common sporadic 
form of PD. Specifically, symptomatic mutation carriers were examined with radio- 
tracer imaging techniques such as Positron Emission Tomography (PET) or Single 
Photon Emission Computed Tomography (SPECT). Various techniques have been 
used for this purpose (see e.g. (Piccini, 2004, Nandhagopal et al., 2008)), aiming to 
test either presynaptic or postsynaptic aspects of nigrostriatal integrity (Table 2).
Symptomatic patients with the sporadic form of PD show a reduction in striatal [18F]
FDOPA uptake, as well as a marked reduction in striatal VMAT2 and DAT binding 
(Brooks, 2004, Shih et al., 2006a). Signal decreases in the striatum typically show 
a rostro-caudal gradient, the putamen being more affected than the caudate 
nucleus, and with a stronger dysfunction in the hemisphere contralateral to the 
clinically most affected side (Nandhagopal et al., 2008). Postsynaptically, 
early-stage PD patients may display an increase in striatal D2 receptor binding 
which normalizes with chronic dopaminergic replacement therapy (Piccini, 2004, 
Verstappen et al., 2007). 
Radiotracer imaging of manifesting mutation carriers
We will first discuss the radiotracer imaging studies done in subjects with clinically 
overt disease (symptomatic mutation carriers). Table 3 lists the published PET and 
SPECT studies of patients with monogenic forms of PD. All studies that have used 
[18F]FDOPA PET in symptomatic mutation carriers revealed a marked reduction of 
pre-synaptic [18F]FDOPA uptake, similar to age-matched patients with sporadic 
non-hereditary PD. The same pattern emerged with PET or SPECT of DAT, showing 
a consistent bilateral reduction in striatal DAT. Similar to sporadic PD, most studies 
also found a caudo-rostral gradient with a stronger impairment of pre-synaptic 
dopaminergic function in putamen compared to the caudate nucleus. However, in 
contrast to sporadic PD, the pre-synaptic changes in putaminal dopaminergic neu-
rotransmission tend to display a more symmetrical pattern in Parkin and PINK1 
mutation carriers, along with additional reductions in caudate and midbrain (Khan 
et al., 2002b, Scherfler et al., 2004, Varrone et al., 2004, Hu et al., 2006). Repeated 
[18F]FDOPA PET imaging revealed a slower progression rate in presynaptic 
dysfunction in manifesting parkin mutation carriers relative to patients with common 
sporadic PD (Khan et al., 2002a, Pellecchia et al., 2007), consistent with the clinical 
disease course which tends to be more benign in recessive parkinsonism.
Post-synaptic dopamine function was found to be normal with [11C] Raclopride PET 
in patients with mutations in the SNCA gene (PARK1, n=4), the PINK1 gene (PARK6, 
Omi/HtrA2 have a chaperone activity, suggesting that PINK1 might participate in 
the detoxification of proteins through these interactions (for review, see Plun-Favreau 
PNAS 2008 (Plun-Favreau and Hardy, 2008)). 
PARK7 (recessive): DJ-1
The DJ-1 gene (Bonifati et al., 2003) is associated with early-onset parkinsonism in 
about 1–2% of cases. The DJ-1 gene is ubiquitously expressed and was initially 
described in association with oncogenesis and male rat infertility. DJ-1 has been 
shown in mice to co-regulate the D2 dopamine receptor signalling (Goldberg et al., 
2005). The protein has also been found to confer chaperone-like activity, and 
several reports convincingly demonstrated that DJ-1 acts as an intracellular 
protector against oxidative stress (Dodson and Guo, 2007). Furthermore, 
mitochondrial localization of DJ-1 leads to enhanced neuroprotection (Junn et al., 
2009), implicating also this protein in mitochondrial function.
These forms of monogenic parkinsonism create a unique perspective for studies 
that use neuroimaging to understand the pathophysiology of parkinsonism. This is 
based on the following notions: i) Genetically defined parkinsonism represents a 
more homogeneous and etiologically defined entity as compared to ‘idiopathic’ 
PD. This homogeneity helps to reduce variability, which is one of the prime 
challenges in neuroimaging studies. ii) Neuroimaging yields important insights into 
the pathophysiology of the various genetic forms; conversely, specific features of 
genetic forms, such as pattern and type of neurodegeneration, areas of highest 
gene expression or protein function, may inform the choice of neuroimaging 
techniques and paradigms. iii) Neuroimaging studies of non-manifesting PD 
mutation carriers and of asymptomatic mutation carriers with only subtle motor 
signs suggestive of parkinsonism open up a window for the investigation of 
preclinical and very early disease phases in vivo, and for the possible identification 
of compensatory mechanisms that help to prevent development of overt disease. 
An additional advantage of truly non-manifesting carriers is that these subjects can 
be tested functionally (i.e. by asking them to perform a particular motor task in the 
scanner), without concerns that differences in performance (caused by disease 
signs) by themselves change cerebral activation and thereby obscure interpretation 
of the data. 
Here we review the synergistic applications of neuroimaging and genetics of PD. 
From a conceptual point of view, we will distinguish studies done in non-manifest-
ing carriers from those done in subjects with clinically overt disease. While we 
mainly focus on neuroimaging of monogenic forms of PD, we will also discuss how 
neuroimaging may help to assess the influence of common genetic variation/
polymorphisms on distinct aspects of PD. 
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were on long-term treatment with dopaminergic drugs (Khan et al., 2002b, Scherfler 
et al., 2004, Varrone et al., 2004, Hu et al., 2006). It is unclear if this finding is caused 
by the disease itself or by the medication. A recent [11C] Raclopride PET study 
showed an up-regulation of striatal D2-receptors in dopaminergic drug-naive 
patients with a parkin mutation, in a similar fashion as drug-naive patients with 
sporadic PD. Patients with sporadic PD show a normalisation of striatal [11C] 
Raclopride binding after long-term treatment with dopaminergic drugs. This makes 
it more likely that the decrease in striatal [11C] Raclopride binding in levodopa 
treated patients with a parkin mutation is caused by a greater susceptibility to the 
exposure to dopaminergic medication rather than primarily by the genetic defect 
itself, compared to patients with sporadic PD (Scherfler et al., 2006).
Taken together, the PET findings in patients with monogenic forms of PD confirm 
a substantial loss of presynaptic dopaminergic nigrostriatal afferents without 
accompanying post-synaptic neurodegeneration. Except for a few subtle differences 
and the decrease in striatal [11C] Raclopride binding in patients with a parkin 
mutation, which can possibly be explained by a higher susceptibility to dopaminergic 
medication, the alterations in striatal dopaminergic neurotransmission of monogenic 
forms of PD are indistinguishable from those of common sporadic PD. This shared 
neurochemical phenotype underscores the pathophysiological overlap between 
idiopathic PD and monogenic forms of parkinsonism. 
Radiotracer imaging of non-manifesting mutation carriers
This next section deals with the preclinical stages, as can be found in non-manifest-
ing mutation carriers. Only a few PET or SPECT studies have examined such non-
manifesting mutation carriers. Subtle but consistent pre-synaptic abnormalities in 
striatal dopaminergic neurotransmission were demonstrated in non-manifesting 
carriers of single heterozygous mutations in the parkin gene (PARK2) and PINK1 
gene (PARK6), as indexed by a mild decrease in striatal DAT binding (Pellecchia et 
al., 2007) or pre-synaptic [18F]FDOPA uptake (Hilker et al., 2001, Khan et al., 2002a, 
Khan et al., 2002b). In LRRK2 mutations (PARK8), PET imaging with multiple tracers 
showed reduced striatal DAT binding in two non-manifesting mutation carriers, 
while another two were initially normal but later developed a decrease in DAT 
binding after 4 years of follow-up (Adams et al., 2005). Notably, the reduction in 
striatal DAT binding occurred in the absence of any change in striatal [18F]FDOPA 
uptake, suggesting that mapping striatal DAT binding is more sensitive to a 
subclinical loss of nigrostriatal dopaminergic afferents than mapping regional [18F]
FDOPA uptake. Based on these findings and findings in previous studies (Lee et al., 
2000) it was argued that DAT down-regulation may constitute a compensatory 
mechanism to maintain normal AADC levels and that helps to delay the onset of 
parkinsonian symptoms. 
n=3) and LRRK2 gene (PARK8, n=2) (Samii et al., 1999, Adams et al., 2005, Kessler 
et al., 2005). A notable exception were levodopa treated patients with a Parkin 
mutation (PARK2), who showed a uniform decrease in striatal [11C] Raclopride 
binding indicating a symmetric postsynaptic alteration in striatal neurotransmission 
(Hilker et al., 2001). This finding was confirmed in a different group of patients who 
Table 2   Radiotracer imaging techniques that have been used to map  
the functional impact of monogenic forms of PD on dopaminergic 
neuro transmission.
Positron Emission Tomography (PET)
•  Presynaptic nigrostriatal integrity / Dopamine transporter ligands
º  [18F]-fluoro-L-dopa a
º  11C-dihydrotetrabenazine (DTBZ) b
º  [11C]-2-β-carbomethoxy-3-β-[4-fluorophenyl]tropane c
º  [11C]-d-threomethylphenidate c
º   [18F]-N-3-fluoropropyl-2-β-carboxymethoxy-3-β-(4-iodophenyl) nortropane 
([18F] FPCIT) c
•  Postsynaptic nigrostriatal integrity
º  [11C] raclopride d
Single Photon Emission Computed Tomography (SPECT)
•  Presynaptic nigrostriatal integrity / Dopamine transporter ligands
º  [123I]FP-CIT c
º   [2-[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo [3.2.1]oct-2-yl]methyl](2-mer-
captoethyl)amino]ethyl] amino]ethanethiolato-(3-)-N2,N2’,S2,S2’] oxo-[1R-(exo-
exo)]-[99mTc]technetium ([99mTc]TRODAT-1) c
•  Postsynaptic nigrostriatal integrity
º  [123I]-iodobenzamide (IBZM) d
a May underestimate the actual degree of dopaminergic denervation, particularly in early stages of 
PD (Lee et al., 2000).
b Reflects nerve terminal density by labeling the vesicular monoamine transporter type 2 (VMAT2), 
which is predominantly associated with striatal dopaminergic terminals. VMAT2 expression is 
relatively resistant to regulatory changes in response to denervation and pharmacotherapy.
c binds to pre-synaptical dopamine transporters (DAT) which mediate dopamine reuptake from the 
synaptic cleft into the dopaminergic terminal; may be influenced by pharmacotherapy or age.
d labels postsynaptic availability of striatal dopamine D2 receptors (Leenders, 2003, Shih et al., 
2006b). Note that [11C] raclopride competes with endogenous dopamine for in vivo binding to D2 
receptors, so it can be used for “activation studies” to document local alterations in synaptic DA 
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helps to compensate for the latent nigrostriatal dysfunction. The morphometric 
finding also has an important implication as the regional increase in grey matter 
volume needs to be taken into account when interpreting changes in striatal 
dopaminergic function as revealed by [18F]FDOPA PET. 
These findings raise an important further issue, namely whether the “compensatory” 
increase in striatal grey matter volume persists if a mutation becomes clinically 
symptomatic. A cross-sectional VBM study which included symptomatic carriers of 
a Parkin mutation and patients with idiopathic PD suggest that this “hypertrophy” 
can be maintained only partially in the symptomatic stage of PD. Regression 
analyses which tested for linear changes in striatal grey matter as a function of 
severity and duration of the disease revealed bilateral grey matter decreases in the 
basal ganglia in symptomatic Parkin mutation carriers, suggesting that the basal 
ganglia are subject to a progressive atrophy, which gradually increases with disease 
severity and duration. However, this question needs to be addressed prospectively 
by performing repeated structural MRI images in asymptomatic mutation carriers 
as they become symptomatic (Reetz et al., 2008a).
Another important application of structural MRI is to link specific features of the 
clinical phenotype to regional changes in brain structure. In a recent study, a 
morphometric MRI study searched for structural correlates of psychiatric symptoms 
in 14 manifesting carriers of a PINK1 mutation and 14 healthy controls without 
mutation (Reetz et al., 2008b). Mutations in the PINK1 gene can cause parkinsonism 
and are frequently associated with psychiatric symptoms that may even precede 
motor symptoms and signs (Hedrich et al., 2006, Steinlechner et al., 2007). This 
group of PINK1 mutation carriers presented with a variety of psychiatric disorders, 
including major depression without psychotic symptoms (N=5), schizophrenia-
spectrum disorders (N=4), panic disorder (N=2), adjustment disorder (N=2) and 
obsessive-compulsive personality disorder (N=2). Statistical comparison between 
all PINK1 mutation carriers and controls demonstrated a reduction in grey matter in 
the hippocampus and parahippocampus. Multiple regression analysis considering 
all psychiatric subscores simultaneously displayed degeneration patterns of 
different frontal and limbic structures.
Mapping the consequences of mutation in PD genes on brain 
function 
Another line of recent research addressed how a mutation in one of the PD genes 
might affect functional brain networks. A wide array of complementary brain 
mapping techniques are available for this purpose, including functional MRI (fMRI), 
event-related cortical potentials (ERPs), or transcranial magnetic stimulation (TMS). 
Functional MRI (fMRI) is probably the most commonly used imaging modality, and 
maps regional changes in the blood oxygen level dependent (BOLD) signal to 
An alteration in pre-synaptic dopaminergic function has not always been found in 
non-manifesting mutation carriers: a non-manifesting homozygous carrier of a 
mutation in the DJ1 gene (PARK7) showed reduced striatal DAT binding, but not 
her non-manifesting heterozygous brother (Hering et al., 2004). Moreover, three 
non-manifesting carriers of a mutation in the SNCA gene (PARK1) showed normal 
striatal DAT binding (Ahn et al., 2008). 
Conversely, postsynaptic dopaminergic function seems to be normal in non-mani-
festing carriers. No changes in postsynaptic D2 receptor binding were found in 
eight non-manifesting mutation carriers in the SNCA gene (PARK1, n=1, (Kruger et 
al., 2001)), Parkin gene (PARK2, n=5, (Hilker et al., 2001)) and PINK1 gene (PARK6, 
n=3, (Kessler et al., 2005)).
In summary, despite the observed inter-individual variability, the crucial implication 
here is that the presence of a mutation in one of the PD genes may lead – in at least 
some of the non-manifesting mutation carriers – to a deficit in presynaptic 
dopaminergic transmission, but without leading to the hypokinetic-rigid features 
characteristic of PD. This latent presynaptic dysfunction, which is presumably 
caused by a subclinical neurodegeneration of nigrostriatal dopaminergic afferents, 
could be a threshold issue – not enough dopamine was lost in these subjects to 
render them symptomatic – but could also point to the presence of adaptive 
plasticity, either in the dopaminergic system or elsewhere. The evidence so far 
point towards activation of adaptive presynaptic – but apparently not postsynaptic 
– mechanisms to compensate for the loss of dopamine in the striatum. 
Complementary neuroimaging techniques such as functional MRI can further 
tackle such issues, as we will address later
Structural magnetic resonance imaging
With the advent of voxel based morphometry (VBM), morphometric analysis of 
high-resolution MRI scans has emerged as an objective tool to screen for subtle 
changes in local brain structure in a wide range of normal and pathological 
conditions (Ashburner and Friston, 2000, Good et al., 2001). Non-manifesting 
heterozygous carriers of a Parkin or PINK1 mutation display a bilateral increase in 
grey matter volume in the posterior putamen and internal globus pallidus (Binkofski 
et al., 2007). This result was also obtained when performing a standard region-of-
interest analysis. Since most of the Parkin mutation carriers had previously been 
examined with [18F]FDOPA PET, it was possible to test whether regional changes in 
presynaptic dopaminergic function correlated with regional changes in grey matter 
as revealed by structural MRI. It turned out that regional increases in striatal grey 
matter volume showed an inverse linear relationship with regional decreases in [18F]
FDOPA uptake (Binkofski et al., 2007). It was proposed that this “morphometric 
fingerprint” in the dysfunctional striatum may reflect an adaptive mechanism that 
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with the left posterior putamen in Parkin mutation carriers relative to controls. 
Critically, these changes in task-related activity and coupling were only present if 
movements relied on internal cues. From these results it was inferred that in non-
manifesting Parkin mutation carriers, the latent nigrostriatal dysfunction triggered a 
compensatory reorganisation of striatocortical loops to maintain normal performance 
(Buhmann et al., 2005).
Following-up on the study by Buhmann et al (2005), a recent fMRI study examined 
how a heterozygous mutation in a gene linked to recessively inherited Parkinson s´ 
disease alters functional brain networks sub serving simple sequential movements. 
The study included non-manifesting individuals carrying a single mutant allele in 
the Parkin (n = 13) or PINK1 (n = 9) gene and two healthy control groups without 
mutation (van Nuenen et al., 2008). During fMRI, participants had to quickly perform 
a brief “chunk” of three movements, which were all determined by external cues. In 
Parkin or PINK1 mutation carriers, the simple motor sequence task consistently 
activated the rostral supplementary motor area (pre-SMA) and right rostral dorsal 
premotor cortex (PMd) which are specialized for the control of complex motor 
sequences. These premotor areas were not activated in control subjects without 
mutation. The additional recruitment of pre-SMA and rostral PMd was independent 
of the underlying genotype and occurred in the absence of any change in task 
performance. Taken together, the fMRI studies by Buhmann et al. (2005) and van 
Nuenen et al. (2008) consistently show that a preclinical dopaminergic deficit in the 
striatum alters cortical processing during motor tasks that rely on an intact function 
of the basal ganglia. The extra-recruitment of premotor areas seems to constitute a 
“generic” compensatory mechanism to maintain normal motor performance in the 
context of a latent nigrostriatal dopaminergic dysfunction. 
While these studies show that functional brain mapping provides a valuable tool of 
tracing adaptive changes in the motor system in non-manifesting mutation carriers, 
several issues remain to be addressed. It is likely that the latent dopaminergic 
dysfunction also results in compensatory changes in cortico-basal ganglia-thala-
mocortical loops that subserve more cognitive or limbic brain functions. Moreover, 
the latent dopaminergic deficit should also alter neuronal processing in the basal 
ganglia. A crucial question is how these adaptive changes dynamically develop 
during lifetime and which factors trigger a break-down of effective compensation. 
Future fMRI studies need to select appropriate experimental tasks and employ 
repeated fMRI measurements to tackle these issues.
Normal genetic variations in the general population
Given the multifactorial nature of PD, a likely scenario is that several genetic variants 
in the same or in different genes act together to confer susceptibility, although each 
variant alone is not pathogenic (Singh et al., 2008). In addition, many genetic 
assess the spatiotemporal pattern of brain activation during an experimental task 
(Logothetis, 2008).
In patients with idiopathic PD, fMRI and ERP recordings have been used extensively 
to examine how the neurodegenerative process affects the function in motor, 
cognitive and limbic territories of the cortico-basal ganglia thalamocortical loops 
and how these abnormalities can be normalized by therapeutic interventions (van 
Eimeren and Siebner, 2006). With respect to monogenic forms of PD, the question 
arises whether the genetic forms of PD are associated with similar or different 
patterns of functional reorganization as sporadic PD. It is also interesting to know 
whether the “functional phenotypes” as revealed by functional brain mapping differ 
in monogenetic forms of PD depending on the affected gene. Another open 
question is whether genetic forms of PD are associated with unique response 
profiles of functional brain networks to acute or long-term dopamine replacement 
therapy and other therapeutic interventions. These functional imaging studies are 
currently underway, but no results have been published yet.
Several PET studies have provided converging evidence for a latent presynaptic 
deficit of nigrostriatal dopaminergic neurotransmission in non-manifesting mutation 
carriers of mutations in the Parkin, PINK1 and LRRK2 gene (Table 3). Therefore, 
functional neuroimaging of non-manifesting mutation carriers opens up the unique 
opportunity to examine how the cortico-basal ganglia-thalamocortical loops cope 
with a latent nigrostriatal dysfunction. One intriguing question is whether adaptive 
functional changes remain confined to the basal ganglia or also involve the cortex. 
Another interesting question is whether functional changes in cortico-basal ganglia-
thalamocortical loops follows a stereotypical pattern across different experimental 
tasks or whether these changes differ depending on the cognitive processes that 
are required to perform a given experimental task.
In a first study, fMRI was employed to assess movement-related neuronal activity 
while 12 non-manifesting heterozygous carriers of a Parkin mutation and 12 healthy 
non-carriers performed visually paced thumb-to-finger opposition movements 
(Buhmann et al., 2005). In different blocks, participants had to select each movement 
themselves (i.e., internally cued movements) or movements were determined by the 
visual cue (i.e., externally cued movements). This task was chosen because patients 
with sporadic PD show under activity of the rostral supplementary motor area (SMA) 
and right dorsolateral prefrontal cortex during the internal selection but not externally 
determined finger movements (Playford et al., 1992).
The presence of a Parkin mutation did not affect task performance, but task related 
activation was significantly influenced by the genotype. Non-manifesting mutation 
carriers showed a stronger increase in movement-related activity with internally 
selected movements in the right rostral cingulate motor area and left dorsal 
premotor cortex. The rostral cingulate motor area also showed stronger coupling 
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CHAPTER 2 IMAGING THE IMPACT OF GENES ON PARKINSON’S DISEASE
A second fMRI experiment used a task which required shifts in attention to 
demonstrate an interactive effect between the COMT val(158)met polymorphism 
and dopaminergic medication (Bartres-Faz et al., 2007, Williams-Gray et al., 2007, 
Williams-Gray et al., 2008). This study included 29 medicated patients with early 
PD. Val/val homozygotic patients with high COMT activity used a typical strategy, 
displaying preferential shifts in attention within rather than between dimensions. In 
contrast, met/met homozygotes with low COMT activity failed to form such an 
“attentional set” along with a reduced activation of the frontoparietal attentional 
network. The functional effects of COMT genotype on attentional strategy and brain 
activation interacted with dopaminergic medication (Williams-Gray et al., 2008). 
The pattern of the genotype-phenotype interaction gave further support to the 
inverted U hypothesis relating dopamine levels to prefrontal function with optimal 
function at intermediate prefrontal dopamine levels (Goldman-Rakic et al., 2000).
The results by Williams-Gray et al. (2007, 2008) provide a proof-of-principle that 
neuroimaging of interactions between PD and common functional variants in genes 
associated with dopaminergic function provide new insights into the pathophysiol-
ogy and pharmacotherapy of PD. We anticipate that this approach will be extended 
to other functional polymorphisms that influence other neurotransmitter systems 
(e.g. serotonergic system) or synaptic plasticity. Polymorphisms in the serotonergic 
system might be of relevance to emotional processing and affective disorders in 
PD, while polymorphisms which influence synaptic plasticity might modulate the 
tendency to develop dyskinesias during chronic dopamine replacement therapy.
Conclusion 
The combined neurogenetics-neuroimaging approach has already started to yield 
results that shed new light on the pathophysiology of PD. Maybe the best example 
is the multimodal assessment of brain structure and function in non-manifesting 
carriers with a single mutant Parkin allele (Fig.1). Although the results need to be 
confirmed in larger cohorts of mutation carriers, the different imaging modalities 
provided important pieces to resolve the puzzle of preclinical reorganization of PD. 
Together these studies added weight to the hypothesis that the presence of a single 
mutant Parkin allele does affect nigrostriatal dopaminergic function which triggers 
adaptive changes in motor cortical areas (Fig.1). Similar multimodal studies are 
warranted in other monogenic forms of PD. One pertinent question is which neuro-
biological factors reduce the penetrance of mutations in the LRRK2 gene.
Another promising line of research is to evaluate the functional consequences of 
common genetic polymorphisms on brain function or response to treatment. The 
feasibility of this approach has been demonstrated for the (val(158)met) polymorphism 
variants may modify the penetrance or onset of PD or may only influence specific 
aspects of PD such as the response to medication or contributing to the phenotypical 
heterogeneity (e.g. expression of specific symptoms). This renders it difficult to 
identify genetic susceptibility factors, quantify their effect size, and disentangle the 
complex interactions among them (Klein and Lohmann-Hedrich, 2007).
In healthy individuals, a vast body of neuroimaging data has been accumulated that 
normal variations in a single gene can explain inter-individual differences in regional 
brain activation when subjects perform experimental tasks (Goldberg and Weinberger, 
2004, Mattay and Goldberg, 2004). For example, several single nucleotide poly -
morphisms (SNPs) in genes that regulate monoaminergic neurotransmission have 
been linked to distinct cognitive profiles, personality traits, and functional phenotypes 
as revealed by brain mapping (Volavka et al., 2004, Savitz et al., 2006).
Therefore, it can be assumed that common genetic variations may also influence 
cognitive functions, personality and brain network activity in patients with PD. It is 
likely though that these influences will differ from those found in the normal 
population because the neurodegenerative process may alter the susceptibility of 
functional brain networks to the functional consequences of a given polymorphism. 
Especially common polymorphisms that impact on dopaminergic signalling may 
exert disease-specific effects in patients with PD, for instance by influencing the 
functional brain response to dopaminergic therapy. In addition, the functional effects 
of common polymorphisms are likely to differ in motor, cognitive, and limbic cortico- 
striato-thalamo-cortical circuits given the rostro-caudal gradient of nigrostriatal 
neurodegeneration in PD.
Functional neuroimaging can be used to characterize gene-disease interactions 
between, on the one hand, PD and, on the other hand, common genetic poly- 
morphisms that influence dopaminergic neurotransmission (Bartres-Faz et al., 
2007, Williams-Gray et al., 2007, Williams-Gray et al., 2008). Two recent fMRI studies 
focused on a common functional polymorphism (val(158)met) within the catechol 
O-methyltransferase (COMT) gene which mainly impacts on prefrontal dopamine 
signalling (Weinberger et al., 2001). In a first fMRI experiment, patients with early 
sporadic PD who were homozygous for either valine (val) or methionine (met) were 
studied while they performed an executive task comprising both Tower of London 
(planning) and simple subtracting (“control”) problems during fMRI (Bartres-Faz et 
al., 2007, Williams-Gray et al., 2007, Williams-Gray et al., 2008). Response times for 
planning problems but not control problems were significantly longer in met/met 
relative to val/val homozygotes. Met/met patients with a low COMT activity showed 
a reduced BOLD signal increase within the frontoparietal network involved in 
planning as opposed to val/val patients with high COMT activity. This suggests that 
the COMT genotype modulates executive function in PD through a direct influence 
on frontoparietal activation (Williams-Gray et al., 2007). 
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in the COMT gene, and motivates further studies on the impact of other common 
genetic polymorphisms that modify monoaminergic neurotransmission or influence 
neuronal plasticity. It remains a challenge, however, how to deal with multiple poly- 
morhisms and their complex interactions with environmental factors (e.g. exposure 
to neurotoxins) and normal aging.
While previous studies have been cross-sectional, prospective longitudinal assessment 
of genotype-phenotype interactions are warranted to identify the role of genetic 
factors in various stages of PD. Neuroimaging will also play a role in the therapeutic 
application of genetics in PD. For instance, gene transfer therapy is currently considered 
as a new therapeutic option in PD (Kordower et al., 2006, Emborg et al., 2007, 
Feigin and Eidelberg, 2007, Kaplitt et al., 2007, Eberling et al., 2008, Marks et al., 
2008). Here neuroimaging techniques may be valuable to assess the consequences 
of these new interventional therapies on brain function (Feigin et al., 2007).
Acknowledgements
H.R. Siebner received grant support from BMBF (grant 01GO 0511). B. R. Bloem 
was supported by NWO (VIDI research grant #016.076.352). C. Klein receives 
grant support from the Volkswagen Foundation and the Hermann and Lilly Schilling 
Foundation. 
Figure 1   
Multimodal neuroimaging in non-manifesting carriers of a simple heterozygous 
mutation in the Parkin gene (1.) Transcranial sonography showed an abnormal 
signal increase in the SN. In some cases, hyperechogenicity was demonstrated 
even before there are changes in 18F-Dopa uptake on a PET scan. (Walter et al., 
2004). (2.) PET revealed a decrease in presynaptic [18F]FDOPA uptake in the 
striatum being most prominent in the dorsal putamen (Hilker et al., 2001). 
(3.) These changes in striatal dopaminergic neurotransmission were paralleled 
by an increase in grey matter volume in the posterior putamen as revealed by 
high-resolution structural MRI. This structural change showed a negative 
correlation with the reduction in putaminal 18F-Dopa uptake. (Binkofski et al., 
2007). (4. + 5.) In an fMRI study in which finger movements had to be internally 
selected, the presence of a single mutant Parkin allele was associated with 
stronger task related BOLD signal increases in the rCMA and PMd as opposed 
to controls without mutation (Buhmann et al., 2005).
Figure 1  Continued.  
Increased activity of the rCMA concurred with an increase in effective connectivity 
between the rCMA and the posterior striatum in the context of internal movement 
selection (Buhmann et al., 2005). (6.) A second fMRI study revealed a stronger 
activation of the pre-SMA and the right rostral PMd during a simple sequence of 
finger- to-thumb opposition movements (van Nuenen et al., 2008).
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LRRK2 Leucine Rich Repeat Kinase 2 
PINK1 PTEN-induced putative kinase 1 
OMIM Online Mendelian Inheritance in Man
PET  Positron Emission Tomography
SPECT Single Photon Emission Computed Tomography 
[18F]FDOPA  6-[18F]fluoro-L-3,4-dihydroxyphenylalanine
[123I]FP-CIT 123-Iodine-Fluorpropyl-Carbomethoxy-3-β-(4-Ioophenyl)-Tropane 
[99mTc]-TRODAT-1  [2-[[2-[[[3 - (4 -ch loropheny l ) -8 -methy l -8 -a zabicyc lo[3,2,1]oct-2-y l ]methy l ] 
(2-mercaptoethyl)amino]ethyl]amino]ethanethiolato(3-)-N2,N2’,S2,S2’]oxo-[1R-(exo-exo)]
[123I]-β-CIT [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane
DTBZ 11C-dihydrotetrabenazine  PET 
VMAT2 Vesicular Monoamine Transporter type2 
DAT  Dopamine Transporter 
IBZM  123I-iodobenzamide 
[11C]-MP 11C-d-threo-methylphenidate
GPi Globus Pallidus Internus
Put Putamen
MRI  Magnetic Resonance Imaging
fMRI Functional Magnetic Resonance Imaging
VBM Voxel-Based Morphometry
BOLD  Blood Oxygen Level Dependent
SMA  Supplementary Motor Area
PMd  Dorsal Premotor Cortex 
rCMA  Rostral Cingulate Motor Area
TCS Transcranial Sonography
GSTP1 Glutathione S-Transferase pi 1
DRD2 D2 Receptor Gene
COMT  Catechol O-Methyltransferase
ID Intradimensional 
ED  Extradimensional 
CNS  Central Nervous System
Val  Valine
Met  Methionine
AAS  Adeno-Associated Virus
PEG Polyethyleneglycol 
PIL  Polyethyleneglycolylated Immuno Liposome
(h)AADC  (human) Aromatic l-Amino-Acid Decarboxylase
ERPs  Event-Related Cortical Potentials
TMS  Transcranial Magnetic Stimulation
SNP  Single Nucleotide Polymorphism
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CHAPTER 3 MAPPING PRECLINICAL COMPENSATION IN PARKINSON'S DISEASE
Abstract 
Mutations in the Parkin (PARK2) and PINK1 gene (PARK 6) can cause recessively 
inherited Parkinson s´ disease (PD).  The presence of a single Parkin or PINK1 
mutation is associated with a dopaminergic nigrostriatal dysfunction and conveys 
an increased risk to develop PD throughout lifetime. Therefore neuroimaging of 
non-manifesting individuals with a mutant Parkin or PINK1 allele opens up a window 
for the investigation of preclinical and very early phases of PD in vivo. Here we 
review how functional magnetic resonance imaging (fMRI) can be used to identify 
compensatory mechanisms that help to prevent development of overt disease. In 
two separate experiments, Parkin mutation carriers displayed stronger activation of 
rostral supplementary motor area (SMA) and right dorsal premotor cortex (PMd) 
during a simple motor sequence task and anterior cingulate motor area and left 
rostral PMd during internal movement selection as opposed to externally cued 
movements. The additional recruitment of the rostral SMA and right rostral PMd 
during the finger sequence task was also observed in a separate group of non-
manifesting mutation carriers with a single heterozygous PINK1 mutation. Since 
mutation carriers were not impaired at performing the task, the additional 
recruitment of motor cortical areas indicates a compensatory mechanism that 
effectively counteracts the nigrostriatal dysfunction. These first results warrant 
further studies that use these imaging genomics approach to tap into preclinical 
compensation of PD. Extensions of this line of research involve fMRI paradigms 
probing non-motor brain functions. Additionally, the same fMRI paradigms should 
be applied to non-manifesting mutation carriers in genes linked to autosomal 
dominant PD. This will help to determine how “generically” the human brain 
compensates for a preclinical dopaminergic dysfunction.
Introduction
Several genes have been identified in which mutations can result in familial forms 
of Parkinson s´ disease (PD) (Gasser, 2007, Klein and Lohmann-Hedrich, 2007, 
Klein et al., 2007). The genes and chromosomal loci linked to familial forms of PD 
have been designated as PARK1–13. These loci include six autosomal dominant 
(PARK1(=4), 3, 5, 8, 11 and 13), four recessive (PARK2, 6, 7, and 9), one X-linked 
(PARK12) and one form with an as yet unknown mode of transmission (PARK10). 
Although monogenic forms account for less than 5% of all patients presenting with 
PD, they have considerably stimulated research on PD. The identification of the 
gene products of the PARK genes and research into the relevance of these proteins 
to cellular function have considerably advanced our understanding of the molecular 
mechanisms causing PD (Gasser, 2007). 
Recent research has also started to examine how the alterations at the cellular level 
induced by a mutation in a PARK gene impact on human brain function in vivo. This 
question can be addressed using functional magnetic resonance imaging (fMRI). 
Blood oxygen level-dependent (BOLD) fMRI is probably the most widely used 
functional neuroimaging technique. Regional changes in BOLD signal assay the 
spatiotemporal pattern of brain activation during an experimental task (Logothetis, 
2008). As such, fMRI offers a sensitive method of mapping the functional impact of 
inter-individual genetic variations on neuronal processing within distinct brain 
regions and circuits (Goldberg and Weinberger, 2004). In individuals who carry a 
PARK mutation, fMRI can be used to identify how a given mutation changes the 
spatiotemporal patterns of brain activity subserving a specific type of behaviour 
(van Eimeren and Siebner, 2006). The potential of fMRI goes beyond studies that 
solely rely on behavioural tests or clinical examination. The fMRI approach can be 
used to examine where in the brain, under which condition, and how a given PARK 
mutation alters neuronal processing in functional brain networks. Since genotype-
specific changes in regional neuronal activity can be demonstrated without any 
observable change in behaviour, the neuroimaging-based approach is also more 
sensitive to identify genotype-specific traits in the human brain (Hariri and 
Weinberger, 2003). In this review, we summarize our recent fMRI results obtained in 
non-manifesting heterozygous carriers of a Parkin (PARK2) or PINK1 (PARK 6) mutation. 
Single heterozygous mutation in the Parkin and PINK1 gene 
Mutations of the Parkin gene (PARK2) and PINK1 gene (PARK6) are among the 
most common monogenic causes of early-onset PD (Gasser, 2007). Although 
there might be some characteristic clinical features as a group, it is impossible to 
distinguish individual PD patients carrying homozygous or compound heterozygous 
mutations in the Parkin or PINK1 gene from individual sporadic PD cases without 
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for subclinical nigrostriatal degeneration. Our central hypothesis was that non-
manifesting carriers of a single mutant allele should reveal changes in task-related 
activation during motor tasks that reflect the latent nigrostriatal dysfunction and 
preclinical compensation. Before describing this in more detail, we would like to 
summarize some general considerations which guided the design of our fMRI 
experiments.
Motor symptoms represent the clinical hallmark of sporadic PD. This is because 
nigrostriatal dopaminergic degeneration is most prominent in the motor loops of 
the cortico-basal ganglia thalamo-cortical circuits, especially in the early stage of 
PD (Gibb, 1997, Blandini et al., 2000).  Therefore, we decided to use experimental 
tasks in our fMRI studies that primarily probed specific aspects of motor control. 
When choosing our experimental motor tasks, three selection criteria were applied. 
First, we chose motor tasks that probed different aspects of manual motor control. 
This enabled us to test whether the presence of a Parkin or PINK1 mutation triggers 
functional changes in distinct motor brain networks that depend on the context of 
manual motor control. Second, we opted for motor tasks which have been 
extensively studied in patients with overt PD since we wished to interpret our fMRI 
results as closely as possible in the pathophysiological context of PD. Third, we 
deliberately selected simple motor tasks that could be easily performed by each 
participant. This ensured that task performance was matched among groups with 
different genotypes excluding any confounding effect of altered task performance. 
It also maximized our chances to identify motor regions that were additionally 
recruited in mutation carriers by avoiding any ceiling effect in terms of task-related 
activation.  
fMRI of internal movement selection
Our first fMRI study included 12 non-manifesting carriers of a single heterozygous 
Parkin mutation and 12 healthy age-matched non-carriers (Buhmann et al., 2005). 
The experimental task required the selection of single thumb-to-finger opposition 
movements which were performed with the right hand.(Buhmann et al., 2005) The 
onset of each movement was visually paced at a low rate. The task consisted of 
separate blocks in which participants had to select each movement themselves 
(internally cued) or execute a movement as specified by the visual cue (externally 
cued; figure 1A). 
This type of task probes the function of motor areas involved in movement selection 
(Samuel et al., 1997, Sabatini et al., 2000), and has been applied to patients with 
symptomatic PD (Playford et al., 1992, Georgiou et al., 1994, Jahanshahi et al., 1995). 
In PD patients, behavioral and neuroimaging studies have provided consistent 
evidence that internally selected movements are particularly affected by the basal 
ganglia dysfunction and results in an underactivity of the rostral supplementary 
mutations (Albanese et al., 2005, Bonifati et al., 2005, Hedrich et al., 2006). For a 
detailed review of Parkin or PINK1 associated PD, we refer to two recent reviews 
(Gasser, 2007, Klein et al., 2007).  
Given the recessive mode of inheritance of Parkin and PINK1 associated PD, one 
might expect that family members carrying only a single mutant allele should be 
spared. Recent research, however, suggests that a single mutant allele may also 
predispose to PD, although with a later onset and a much lower penetrance (Klein 
et al., 2007). Moreover, adult non-manifesting carriers of a single mutant Parkin or 
PINK1 allele showed a mild reduction of presynaptic 18F-Dopa uptake in the striatum 
(Hilker et al., 2001, Khan et al., 2005). The reduced striatal 18F-Dopa uptake indicates 
a subclinical nigrostriatal dopaminergic degeneration and confirms that a single 
mutant allele increases the susceptibility to late-onset PD. A single heterozygous 
mutation in the Parkin or PINK1 gene also alters the structure of the basal ganglia: 
Adult non-manifesting mutation carriers show a relative increase in grey matter 
volume of the posterior putamen and globus pallidus (Binkofski et al., 2007). In 
addition, transcranial ultrasound revealed hyperechogenicity of the substantia 
nigra (SN) in non-manifesting heterozygous Parkin mutation carriers, just as in 
patients with sporadic PD where SN hyperechogenecity is present in 90% of cases 
(Walter et al., 2004). 
In sporadic PD, it is assumed that the neurodegenerative process starts at least 
several years before affected individuals become symptomatic, although estimates 
of the preclinical period remain difficult (Braak et al., 2003). Importantly, the 
presence of such a preclinical period suggests that the human motor system has a 
substantial potential to compensate for the slowly progressive nigrostriatal 
dopaminergic denervation (Forno, 1969, Fearnley and Lees, 1991, Koller, 1992). 
However, the mechanisms that mediate functional compensation and delay the 
onset of overt PD are difficult to study in sporadic cases because a reliable method 
to identify individuals at risk for developing sporadic PD is not yet available. In this 
context, non-manifesting individuals carrying a single heterozygous mutation in the 
Parkin or PINK1 gene represent a rare but unique opportunity to study the preclinical 
pathophysiology of PD, because the mutation conveys an increased risk for PD and 
is associated with a latent nigrostriatal dysfunction. An additional advantage is that 
presymptomatic mutation carriers are not impaired at performing specific motor 
tasks, allowing for assessment of task-related cerebral activations without the 
confounding influence of differences in behavioural performance (a factor that 
complicates the interpretation of such studies in patients with overt disease).
Methodological considerations
In the following sections, we summarize the results of two recent fMRI studies that 
were conducted to tap into disease-specific mechanisms that might compensate 
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mutation carriers, the right rostral cingulate motor area (rCMA) and left dorsal premotor 
cortex (PMd) showed a stronger increase in movement-related activity when 
movements had to be internally selected relative to externally instructed movements. 
The rCMA also showed stronger coupling with the dopamine-deficient left posterior 
putamen in Parkin mutation carriers. Again, these changes in task-related coupling 
were only present if movements relied on internal cues. These alterations in 
task-related activation suggest that in non-manifesting Parkin mutation carriers, the 
latent nigrostriatal dysfunction triggers a compensatory recruitment of cortical 
motor areas along with a change in inter-regional connectivity to maintain normal 
performance (Buhmann et al., 2005). 
motor area (SMA) and right dorsolateral prefrontal cortex with internal movement 
selection (Playford et al., 1992, Georgiou et al., 1994, Jahanshahi et al., 1995).
While there were no differences in task performance between non-manifesting 
carriers of a Parkin mutation and controls without Parkin mutation, fMRI showed a 
significant influence of the genotype on task-related motor activity. In non-manifesting 
Figure 1   Summary of the experimental motor tasks.
Both fMRI experiments used a block design. A single fMRI run consisted of ten 
alternating blocks without movements (REST) or sequential movements (TASK). 
Each block lasted for 24 s. Panel A Motor task contrasting external and 
internal movement selection (Buhmann et al., 2005): A two-dimensional 
drawing of the palm of the right hand was continuously presented in the centre 
of the visual field throughout the fMRI session. During the REST periods, the line 
drawing of the hand was continuously presented but without dots. Participants 
were instructed to remain still and fixate the hand with their eyes. During the 
TASK periods (INT or EXT), participants performed a thumb-to-finger opposition 
movement at a frequency of 0.33 Hz. At the onset of each INT movement trial, all 
fingers were labeled with a red dot on a two-dimensional drawing of the palm of 
the right hand. Subjects had to select one of the four fingers for the thumb-to-
finger movement in each trial. At the onset of each EXT movement trial, the 
index, middle, ring or little finger was labeled with a red dot on a two-dimension-
al drawing of the palm of the right hand. The position of the red dot specified the 
the finger that had to be touched. There were 10 blocks of TASK (5 INT and 5 
EXT) and 10 blocks of REST.
Figure 1   Continued.
Panel B (van Nuenen et al., 2009a): A two-dimensional drawing of the palm of 
the right hand was continuously presented in the centre of the visual field 
throughout the fMRI session. During the REST periods, the line drawing of the 
hand was continuously presented but without dots. Participants were instructed 
to remain still and fixate the hand with their eyes. During each block of TASK, 
participants performed three motor sequences. Each sequence consisted of 
three thumb-to-finger opposition movements. At the onset of each movement 
trial, the index, middle, ring or little finger was labeled with a red dot on a two-
dimensional drawing of the palm of the right hand. The position and order of the 
red dot specified the motor sequence that had to be performed within a given 
trial. Participants sequentially tapped with the tip of their right thumb onto the tip 
of the indicated fingers after the instruction cue had disappeared from the 
screen. Participants were asked to move at a convenient speed and to perform 
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denervation that is present in individuals with a Parkin or PINK1 mutation is indeed 
functionally relevant. It appears to affect those aspects of motor control that rely on 
intact basal ganglia function such as internal movement selection or sequencing of 
movements. At least for relatively simple motor tasks, this dysfunction remains 
subclinical because additional motor areas are recruited during task performance. 
In other words, the motor system works harder to effectively compensate for the 
basal ganglia dysfunction. Compensatory recruitment involves motor cortical areas 
within the pre-existing network, and thus, the spatial pattern of increased cortical 
activity critically depends on the motor networks that subserve the experimental 
task. For instance, performing simple sequential movements led to increased 
activation in areas which are critical to the control of complex motor sequences in 
healthy subjects (Sadato et al., 1997, Boecker et al., 1998). 
We used the psycho-physiological interactions (PPI) method described by Friston 
et al (Friston et al., 1997) to further characterize the compensatory role of rSMA and 
right PMd. Defining the rSMA and right PMd as region of interest, the PPI revealed 
no effect of the genotype on task-dependent changes in functional coupling 
between the overactive regions and other motor brain regions. The implication is 
that the overactive premotor regions were able to draw on a normal pattern of 
connectivity. A second more speculative interpretation would be that no increase in 
functional coupling was needed to ensure a normal level of performance. An 
increase in coupling might be engaged if the task would require the performance of 
more complex motor sequences. 
Overactivity of pre-SMA and rostral PMd was equally present in PINK1 and Parkin 
mutation carriers. Since the compensatory recruitment of pre-SMA and rostral PMd 
was independent of the underlying genotype, we argue that the observed activation 
constitutes a “generic” compensatory mechanism to maintain normal sequencing 
of movements in the context of a mild dopaminergic deficit. However, PINK1 
mutation carriers showed an additional mainly left-hemispheric recruitment of 
frontoparietal areas that was not present in Parkin mutation carriers. It is unclear 
whether this reflects a true genotype-specific pattern of functional adaptation in the 
frontoparietal cortex. Alternatively, non-manifesting PINK1 mutation carriers might 
have a stronger functional impairment of the motor system, calling on additional 
frontoparietal loops during task performance. Another caveat is that all these 
results were obtained from members of two families, so there may be observations 
which are family-specific. Whatever the cause of the difference in the compensatory 
recruitment of cortical motor areas, it underscores the capacity of human 
sensorimotor networks to flexibly adapt to a nigrostriatal dysfunction.
fMRI of sequential finger movements
While our first study identified changes in neuronal activity depending on the mode 
of movement selection in non-manifesting carriers of a single mutant Parkin allele 
(Buhmann et al., 2005), two important questions were not addressed. Since only 
carriers with a Parkin mutation were studied, it remained unclear whether the enhanced 
recruitment of frontal motor areas constitutes a compensatory mechanism specific 
to mutations in the Parkin gene or reflects a “generic” response pattern that can be 
triggered by any mutation affecting nigrostriatal dopaminergic function. Another 
open question was whether motor compensation always recruits the same premotor 
regions across a range of different motor tasks. Alternatively, functional compensation 
might be more flexible recruiting different sets of premotor areas depending on the 
specific task demands. 
To address these issues, the second fMRI study (van Nuenen et al., 2009b) included 
non-manifesting carriers of a mutation in either the PINK1 or Parkin gene. Given the 
closely related dysfunctional effects of both proteins (Clark et al., 2006, Park et al., 
2006, Yang et al., 2006, Exner et al., 2007, Kim et al., 2008), our prediction was that 
the functional phenotype at a brain network level would be identical for both groups. 
We also modified the motor task which now required participants to generate 
sequential rather than single finger movements (figure 1B). Movement sequences 
were simple and consisted of three thumb-to-finger opposition movements. Visual 
cues instructed participants which sequence to perform on each trial. We chose 
this simple motor sequence task for two reasons. First, sequential finger movements 
have been widely used to study motor control in idiopathic PD (Samuel et al., 1997, 
Catalan et al., 1999, Carbon and Eidelberg, 2006) showing compensatory 
overactivity in the PMd and intraparietal sulcus. Second, neuroimaging studies in 
healthy individuals have identified frontal motor areas which subserve complex as 
opposed to simple movements. In healthy subjects, the rostral part of the 
supplementary motor area (referred to as pre-SMA) and the rostrodorsal portion of 
the right PMd (Sadato et al., 1997, Boecker et al., 1998) show a linear increase in 
regional activity with increasing complexity of the motor sequence. Therefore we 
were able to make specific predictions regarding the regional pattern of compensatory 
activation. We expected that the latent dopaminergic dysfunction in non-manifest-
ing carriers of a Parkin or PINK1 mutation will call on a compensatory overactivity in 
the pre-SMA and right PMd during the simple sequential finger movement task. 
As in our first fMRI study on movement selection (Buhmann et al., 2005), mutation 
carriers and controls without mutation performed the task equally well. Non- 
manifesting Parkin or PINK1 mutation carriers consistently activated the pre-SMA 
and right rostral PMd when they made simple sequential finger movements. These 
areas were not activated in the control groups without mutation. Taken together, the 
two fMRI experiments indicate that the otherwise preclinical nigrostriatal dopaminergic 
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PD: 20.9 ± 13.8; sporadic PD: 22.8 ± 12.8). All groups demonstrated that internal 
selection led to a stronger activation of a well described network of mesial and 
lateral frontal areas (pre-SMA, PMd and prefrontal cortex). Even with a very liberal 
Impact of task performance 
In the fMRI experiment on sequential finger movements, participants were instructed 
to perform the sequential finger movement as fast as possible, but also as 
accurately as possible. This resulted in a considerable inter-individual variation of 
mean movement time, presumably because participants adopted different 
strategies when performing the task. To examine whether genotype-driven changes 
in motor activity in the presence of a Parkin or PINK1 interacted with the speed of 
task performance, we divided both mutation carriers and non-mutation carriers into 
fast and slow performers. Median movement time was approximately 1500 ms. 
Therefore, all participants with a mean movement time more than 1500 ms were 
defined as “slow performers”, while participants who had a mean movement time 
less than 1500 ms were considered “fast performers”. This resulted in four groups: 
fast mutation carriers (fast Mut+), slow mutation carriers (slow Mut+), fast non- 
mutation carriers (fast Mut-), slow non-mutation carriers (slow Mut-). Overactivity in 
the rSMA and right PMd was independent of the speed of performance (Figure 2). 
Fast mutation carriers showed increased activation of the left primary motor hand 
area (M1-Hand) relative to fast non-mutation carriers, whereas slow mutation 
carriers showed stronger activity of the left putamen compared with slow 
non-mutation carriers (Fig.1). The activity profile showed an increased activity in all 
groups during the task except in fast non-mutation carriers in the left M1-Hand. In 
the left caudal putamen, slow mutation carriers showed more activity relative to the 
other three groups during the sequential task. These preliminary results indicate 
that the way participants perform the task does influence the effects of the genotype 
on movement-related activity. This issue needs to be taken into account in future 
studies on preclinical motor reorganization in non-manifesting carriers of a PARK 
mutation.
Dopaminergic therapy in Parkin-associated PD
We described compensational mechanisms in Parkin and PINK1 mutation carriers. 
But what happens when those mechanisms give way and formerly non-manifesting 
Parkin mutation carriers now become symptomatic? Patients with Parkin-associat-
ed PD often show a stable long-term response to dopaminergic therapy without 
developing motor fluctuations (Lohmann et al., 2003). Therefore, we reasoned that 
one may find differences in motor activation when comparing Parkin-associated 
and sporadic PD on dopaminergic medication. In an unpublished study, we tested 
this hypothesis using fMRI in nine medicated patients with Parkin-associated, 
eleven with sporadic PD, and ten healthy controls while they performed externally 
specified or internally selected finger movements. Both patient groups had similar 
disease duration, levodopa equivalent dose, and total motor scores of the United 
Parkinson’s Disease Rating Scale off dopaminergic medication (Parkin-associated 
Figure 2   Regional increases in task-related BOLD signal changes in  
non-manifesting carriers of a Parkin or PINK1 mutation. Statistical 
parametric maps.
Sagittal, coronal, and axial slices highlighting those voxels in the left primary motor 
cortex, adjacent PMd and the right pre-SMA that showed a relative increase in 
BOLD signal during the sequential finger movements in the fast mutation carriers 
relative to the fast controls (upper row in A) and in the left caudal putamen and 
right pre-SMA that showed a relative increase in BOLD signal during the sequential 
finger movements in the slow mutation carriers relative to slow controls (lower 
row in A). All the statistical parametric maps are superimposed on to a T2- 
weighted structural MRI template provided by MRIcro (http://www.sph.sc.edu/
comd/rorden/mricro.html). The voxels of the activation maps are colour-coded 
according to their Z-values. For illustrative purposes, the maps are thresholded 
at an uncorrected p-value of p < 0.01. Parameter estimates of task-related BOLD 
signal changes. The column plots (B) give the mean Beta-values (as estimated 
by the general linear model) for the task-related change in BOLD signal during 
the sequential finger movement task for each of the four groups (blue columns 
= mutation carriers; yellow columns = non- mutation carriers). The Beta values 
are given in arbitrary units (A.U.) and refer to the voxel showing a peak difference 
between mutation carriers and non-carriers. Error bars equal the 95% confidence 
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cortical areas that show compensatory activity. This would allow estimating the 
functional relevance of these areas for the maintenance of a motor function. Due to 
its excellent temporal resolution, EEG and MEG can identify compensatory changes 
in the time course of task related motor activity.
We anticipate that multimodal functional brain mapping will also be of great value 
in mapping preclinical reorganization of functional brain networks in individuals 
with a mutation in other PARK genes that lead to autosomal dominant PD (e.g. 
mutations in the LRRK2 gene). This would help to clarify whether or not the brain 
can “generically” compensate for preclinical dopaminergic dysfunction, in the 
context of a different genetic background. Another target for functional neuroimaging 
is to address how the latent nigrostriatal dysfunction in non-manifesting PARK 
mutation carriers triggers compensatory responses in cognitive and limbic brain 
networks. Finally, longitudinal fMRI studies need to clarify whether the compensatory 
mechanisms as identified with fMRI persist, increase or attenuate in mutation 
carriers who ultimately develop PD. A recent PET activation study of patients with 
sporadic PD suggests that compensatory extra-recruitment of frontal motor areas 
persists at least in the early stage of the disease (Mentis et al., 2003). 
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statistical threshold, patients with Parkin-associated PD, sporadic PD, and healthy 
controls showed no difference in this task-related activation pattern. Previous studies 
using the same type of task consistently showed hypoactivation of this network in 
non-medicated sporadic PD patients (Jenkins et al., 1992, Haslinger et al., 2001, 
Buhmann et al., 2004). Therefore, this finding may suggest that dopaminergic 
treatment is equally effective in normalizing deficient activation in Parkin-associated 
and sporadic PD. Although our sample size was too small to allow generalization, 
these preliminary findings suggest a substantial pathophysiological overlap 
between Parkin-associated and sporadic PD. Future studies on patients on and off 
medication will have to elucidate if and how brain activation patterns differ between 
Parkin-associated and sporadic PD when dopamine is not leveled up by medication.
Methodological considerations
While our results are encouraging, there are a few methodological issues that 
require some discussion. At a group level, asymptomatic PINK1 and Parkin mutation 
carriers display a latent dopaminergic depletion and have an increased risk of 
developing PD. However, there is currently no data on the natural course of potential 
clinical manifestations resulting from a heterozygous mutation in asymptomatic 
individuals; in fact, only some of them may actually develop PD during their lifetime. 
Another shortcoming is that the carriers of the PINK1 (Family W) and Parkin (Family 
LA) mutation were all members of a large kindred. Therefore the results need to be 
replicated in a more heterogeneous sample of mutation carriers from different 
families. It would also be interesting to conduct a pharmacological fMRI study 
to examine whether the compensatory recruitment of motor brain regions can 
be readily reversed by a small dosage of levodopa. Another open question is 
how relevant the compensatory recruitment of the motor areas actually is to task 
performance.
Conclusions and outlook
Our recent fMRI studies in non-manifesting carriers of a single heterozygous 
mutation carriers of PINK1 or Parkin highlights the potential of a combined neuroge-
netic-neuroimaging approach to unravel the intrinsic potential of the human brain to 
compensate for a latent nigrostriatal dysfunction. Future extensions of this approach 
may employ other brain mapping techniques such as transcranial magnetic 
stimulation (TMS), electroencephalography (EEG) or magneto-encephalography 
(MEG). So far, TMS has only been used to assess excitability changes in 
sensorimotor circuits (Baumer et al., 2007). In the context of functional reorganization, 
TMS may also be used to transiently disrupt task-related processing in motor 
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Abstract  
Background: To use a combined neurogenetic-neuroimaging approach to examine 
the functional consequences of preclinical dopaminergic nigrostriatal dysfunction 
in the human motor system. Specifically, we examined how a single heterozygous 
mutation in different genes associated with recessively inherited Parkinson’s 
disease alters the cortical control of sequential finger movements. 
Methods: Adult non-manifesting individuals carrying a single heterozygous Parkin 
(n=13) or PINK1 (n=9) mutation and 23 healthy controls without these mutations 
were studied with functional magnetic resonance imaging (fMRI). During fMRI, 
participants performed simple sequences of three thumb-to-finger opposition 
movements with their right dominant hand. Since heterozygous Parkin and PINK1 
mutations cause a latent dopaminergic nigrostriatal dysfunction, we predicted a 
compensatory recruitment of those rostral premotor areas that are normally 
implicated in the control of complex motor sequences. We expected this overactivity 
to be independent of the underlying genotype. 
Results: Task performance was comparable for all groups. The performance of a 
simple motor sequence task consistently activated the rostral supplementary motor 
area (pre-SMA) and right rostral dorsal premotor cortex (PMd) in mutation carriers 
but not in healthy controls. Task related activation of these premotor areas was 
similar in carriers of a Parkin or PINK1 mutation. 
Conclusion: Mutations in different genes linked to recessively inherited Parkinson s´ 
disease are associated with an additional recruitment of pre-SMA and rostral PMd 
during a simple motor sequence task. These premotor areas were recruited 
independently of the underlying genotype. The observed activation most likely 
reflects a “generic” compensatory mechanism to maintain motor function in the 
context of a mild dopaminergic deficit.
Introduction
Several genes have been identified that can lead to Parkinson’s disease (PD), 
including four recessively inherited forms caused by mutations in the Parkin 
(PARK2), DJ-1 (PARK7), PINK1 (PARK6), and the ATP13A2 (PARK9) gene (Kitada et 
al., 1998, Bonifati et al., 2003, Valente et al., 2004). These familial forms of PD show 
a substantial clinical overlap with sporadic PD. Non-manifesting individuals who 
carry a single heterozygous mutation in the Parkin and PINK1 gene associated with 
recessively inherited PD have attracted particular interest (Klein et al., 2007). 
Positron emission tomography (PET) of dopaminergic neurotransmission showed 
that these individuals have a mild presynaptic dopaminergic dysfunction in the 
striatum (Hilker et al., 2001, Khan et al., 2002a, Khan et al., 2002b, Khan et al., 
2005). Therefore, non-manifesting carriers of a single mutant allele provide a unique 
model to study how a subclinical loss of dopamine-producing cells in the substantia 
nigra on the human motor system (van Eimeren and Siebner, 2006).
In a recent functional magnetic resonance imaging (fMRI) study we provided 
evidence for a compensatory redistribution of neuronal activity within the motor 
system in non-manifesting carriers of a heterozygous mutation in the Parkin gene. 
With internally cued movements, mutation carriers displayed a stronger activation 
of the right rostral cingulate motor area and left dorsal premotor cortex (PMd) 
compared to externally cued movements (Buhmann et al., 2005). They also showed 
stronger functional coupling between the rostral cingulate motor area and posterior 
putamen in the context of internal movement selection. Because mutation and 
non-mutation carriers performed the task equally well, these activity changes were 
interpreted as adaptive redistribution of neuronal activity in rostral motor cortical 
areas which helps to maintain motor function in the context of a latent nigrostriatal 
dysfunction (Buhmann et al., 2005).
The present experiment extended our previous fMRI study in two directions. First, 
we used a different experimental task which required participants to quickly perform 
a brief “chunk” of three movements. In our previous fMRI study, the experimental 
task required the selection of single movements. The onset of each movement was 
externally paced at a low rate and consecutive movements were separated by 
periods of rest. By using a “real” motor sequence task, we examined how a hetero- 
zygous mutation in a gene linked to recessively inherited Parkinson s´ disease 
impacts on functional brain networks subserving sequential movements. We 
hypothesized that the regional expression of functional changes in motor cortical 
areas critically depends on the particular function probed by the experimental task. 
Therefore, the adaptive redistribution of cortical activity within pre-existing motor 
networks was expected to be different for the motor sequence task as opposed to 
the previously used movement selection task. Specifically, we predicted that 
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sequential finger movements with their right dominant hand. Each sequence 
consisted of three thumb-to-finger opposition movements instructed by external 
visual cues. Participants produced three different motor sequences in 
pseudorandom order. The details of the experimental task are given in Fig. 1a. 
Before fMRI, participants were familiarized with the task and practiced the respective 
finger sequences for approximately five minutes. 
By choosing a short sequence, we kept the task simple favouring automatic 
performance without a high level of monitoring. The use of longer sequences would 
have increased the load on working memory, possibly forcing subjects to divide the 
sequence into separate ”chunks” (Kennerley et al., 2004). We randomly presented 
three sequences rather than repeating the same sequence during a given block. 
This forced the participants to continuously switch between different motor repre-
sentations of simple overlearned sequences. 
Our decision to select sequential finger movements as experimental task was 
based on two considerations: First, sequential finger movements have been 
extensively studied in PD, providing evidence for compensatory overactivity in the 
PMd and intraparietal sulcus in PD during sequential movements (Samuel et al., 
1997, Catalan et al., 1999, Carbon and Eidelberg, 2006). Second, healthy controls 
show a linear increase in activity with sequence complexity in the rostral part of the 
supplementary motor area (referred to as pre-SMA) and the rostrodorsal portion of 
the right PMd (Sadato et al., 1997, Boecker et al., 1998). Therefore, we hypothesized 
that the latent dopaminergic dysfunction in presymptomatic carriers of a Parkin or 
PINK1 mutation results in a compensatory recruitment of the pre-SMA and right 
PMd to maintain motor performance within a normal range. 
Participants performed 30 consecutive sequences per fMRI session. To assess 
performance during fMRI, we taped aluminium foil to the tips of the thumb and the 
fingers of the right hand. When the thumb and finger tips contacted each other, an 
electrical circuit was closed which was specific to a given finger. For each trial, we 
recorded the time during which the tip of the thumb had contact with the index, 
middle, ring or little finger. This enabled us to calculate the time that elapsed 
between the first and last finger-to-thumb contact of the motor sequence, referred 
to as Tap1-Tap3 interval.  To assess the stability of motor performance, we calculated 
the mean Tap1-Tap3 interval for ten consecutive trials during the fMRI session. 
MRI data acquisition. Whole-brain MRI was performed on a 1.5 T Magnetom 
Symphony scanner (Siemens, Erlangen, Germany) equipped with a standard head 
coil. We used a T2*-weighted gradient-echo echoplanar sequence (TR = 3000 ms, 
TE = 40 ms, flip angle = 90°, matrix 64 x 64 voxels, field of view = 256 x 256 mm², 
30 axial slices, slice thickness: 4mm) to map task-related changes in the blood 
oxygen level dependent (BOLD) signal. 160 brain volumes were acquired per 
mutation carriers would show a compensatory recruitment of rostral premotor 
areas that are specialized for the control of complex motor sequences. 
Second, we included non-manifesting individuals carrying a single mutant allele in 
the Parkin or PINK1 gene. This enabled us to test whether the adaptive redistribution 
of neuronal activity in motor brain regions is specifically linked to mutations in a 
specific gene associated with recessively inherited Parkinson s´ disease. Given the 
closely related dysfunctional effects of mutations in both proteins in a drosophila 
model (Clark et al., 2006, Park et al., 2006), our prediction was that the functional 
phenotype at a brain network level would be similar for both groups.
Materials and Methods
Participants. We studied thirteen subjects (mean age 38.9±5.8 years, 7 men) 
carrying a single heterozygous mutation in the Parkin gene, either a deletion of 
exon 7 (n=7) or a single base-pair deletion in exon 9 (c.del1072T) (n=6) (Pramstaller 
et al., 2002). Nine other subjects (mean age 41.9±5.7 years, 7 men) carried a 
heterozygous c.1366C>T nonsense mutation of the PINK1 gene.(Hedrich et al., 
2006) Three of the Parkin (Pramstaller et al., 2002, Pramstaller et al., 2005) and five 
of the PINK1 (Hedrich et al., 2006, Hiller et al., 2007) mutation carriers had minor 
motor signs upon careful clinical examination, but were not aware of the motor 
signs and motor signs did not interfere with their daily activities. None of these 
subjects had a UPDRS score of more than 4 or met the international accepted 
diagnostic criteria of probable PD. Nine of the heterozygous carriers of a Parkin 
mutation had previously undergone 18F-DOPA PET showing a presynaptic 
dopaminergic deficit in the striatum (Hilker et al., 2001).  
We also studied two groups of healthy age-matched controls: 13 volunteers (mean 
age 38.7±5.5 years, 7 men) who served as controls for the non-manifesting Parkin 
mutation carriers and 10 volunteers (mean age 40.0 ± 5.9 years, 7 men) formed the 
control group for the non-manifesting PINK1 mutation carriers. Controls were 
recruited from a departmental register of volunteers and did not have mutations in 
Parkin or PINK1. 
Participants had no history of a previous neuropsychiatric disease nor had they 
previously received dopaminergic or other anti-parkinsonian drug treatment. All 
participants were consistent right-handers according to the Edinburgh handedness 
inventory (Oldfield, 1971). Written informed consent was obtained prior to the study. 
The experimental procedures had the approval of the local ethics committee. 
Experimental design. The fMRI experiment consisted of 10 alternating blocks of 
REST and TASK. During the TASK periods, participants repeatedly performed 
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the within-subject factor TIME (three levels: trial 1 to 10, trial 11-20, and trial 21-30) 
and between-groups factor GROUP (4 levels: non-manifesting PINK1 or Parkin 
mutation carriers and their respective control groups without mutation). The Green-
house-Geisser method was used to correct for non-sphericity if appropriate. 
Depending on a significant F-value, post-hoc t-tests were performed. Data are 
given as mean and onefold standard deviation. A p-value of <0.05 was considered 
significant.
The fMRI data were processed and analysed using statistical parametric mapping 
(SPM) software (SPM2; Wellcome Trust Centre for Neuroimaging, London, UK; 
http://www.fil.ion.ucl.ac.uk/spm). The first two scans of each session were discarded 
session. We also obtained a whole-brain structural MRI dataset using a three-di-
mensional T1-weighted FLASH sequence (TR = 15 ms, TE = 5 ms, 192 axial slices, 
voxel size = 1 x 1 x 1 mm³, axial field of view = 256 x 256 mm²).
Data analysis. Using the mean Tap1-Tap3 interval as dependent variable, we 
performed a two-factorial repeated-measures analysis of variance (ANOVA) with 
Figure 1   A. Experimental design.
The fMRI session consisted of ten alternating periods without movements (REST) 
or sequential movements. (TASK). Each block lasted for 24 s. There were 10 
blocks of TASK and 10 blocks of REST. A two-dimensional drawing of the palm 
of the right hand was continuously presented in the centre of the visual field 
throughout the fMRI session. During the REST periods, the line drawing of the 
hand was continuously presented but without dots. Participants were instructed 
to remain still and fixate the hand with their eyes. During each block of TASK, 
participants performed three motor sequences. Each sequence consisted of 
three thumb-to-finger opposition movements. At the onset of each movement 
trial, the index, middle, ring or little finger was labelled with a red dot on a two-
dimensional drawing of the palm of the right hand. The position and order of the 
red dot specified the motor sequence that had to be performed within a given 
trial. When the instruction cue disappeared from the screen, participants 
sequentially tapped with the tip of their right thumb onto the tip of the indicated 
fingers. They were asked to move at a convenient speed and to perform the task 
as accurately as possible. 
Figure 1   B. Main effect of the motor task.
The axial slices show the motor regions that showed a task-related increase in 
BOLD signal during the sequential finger movement task. The statistical 
parametric maps are superimposed on to a T2-weighted structural MRI template 
provided by MRIcro (http://www.sph.sc.edu/comd/rorden/mricro.html). The 
voxels of the activation maps are colour-coded according to their Z-values and 
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Results
Behaviour. All participants found the thumb-to-finger opposition tasks easy to 
perform. The maximum error rate was two sequential errors per session. ANOVA 
revealed no difference in mean Tap1-Tap3 interval among groups (p>0.5). The 
mean Tap1-Tap3 interval was 1.44±0.18s among individuals carrying a Parkin 
mutation and 1.45±0.08s among controls without mutation. The mean Tap1-Tap3 
interval was 1.40± 0.11s in individuals with a PINK1 mutation and 1.36±0.08s in the 
corresponding controls. 
Functional MRI. Epoch related analysis identified a bilateral set of sensorimotor 
areas where the BOLD signal increased when participants performed the finger 
sequence task (Fig. 1b and supplementary tables 1-3). Mutation carriers showed 
increased activation in right rostral PMd and the pre-SMA compared to controls 
(Fig. 2, Table 1). The overactivity in these rostral premotor areas was independent 
of the genotype (Fig. 2, Table 1). The pre-SMA and rostral PMd showed the most 
prominent increase in task related activation as compared to any other area in the 
brain. No additional activations emerged in any other brain area, even when we 
lowered the statistical threshold to an uncorrected P-value of 0.01 (extent threshold: 
20 voxels).  Mutation carriers showed no differences in task related deactivations 
relative to healthy controls. 
Relative to the corresponding control group, Parkin mutation carriers displayed an 
increased activation in the pre-SMA as well as a trend towards a stronger activation 
in the right rostral PMd. Likewise, PINK1 mutation carriers showed a bilateral 
overactivity in the pre-SMA which extended to the adjacent PMd. Controls without 
mutation showed no task-related regional increases in BOLD signal relative to the 
mutation carriers. The putamen showed a consistent task-related activation in all 
four groups. No between-group differences in task related activity were detected in 
the VOIs covering the right and left putamen.
There were also differences in task-related BOLD signal changes between the two 
groups of mutation carriers. The left and right PMd as well as the anterior and 
medial portion of the left intraparietal sulcus displayed a stronger activation in 
PINK1 mutation carriers relative to Parkin mutation carriers (Fig. 3, Table 2). 
Additional trends towards an increased activation were observed in the right medial 
intraparietal sulcus, the anterior cingulate cortex, and left primary motor cortex. 
There was no relative increase in BOLD signal with sequential finger movements in 
Parkin as opposed to PINK1 mutation carriers.
to allow for steady-state magnetization. The remaining images were realigned to 
the first image and spatially normalized to MNI stereotactic space using a standard 
EPI template as implemented in SPM2.  The normalized images were spatially 
smoothed with a Gaussian kernel of 9 mm at full-width half-maximum.
At the individual level, task-related changes in BOLD-signal were estimated at each 
voxel by modelling the time course of alternating blocks as delta functions 
convolved with a hemodynamic response function (HRF). Based on this model we 
computed a t-statistic for each voxel that tested for regional increases in BOLD 
signal during the finger sequence task. The result of the t-statistics was used to 
generate a SPM of task-related increases in BOLD signal. 
The contrast images obtained in each subject were entered into a two-sample t-test 
for between-groups comparisons to test for between-group differences in brain 
activations between mutation carriers and their respective control groups without 
mutation. The individual motor UPDRS scores were included in the analysis as 
covariate of no interest.  The resulting t-values were corrected for multiple 
comparisons at voxel level, using the false discovery rate (FDR) correction method. 
Significance level was set at a corrected p-value of p<0.05. Any task-related BOLD 
signal change that reached an uncorrected p-value of 0.001 but failed to survive 
FDR correction is descriptively reported as statistical trend.
We defined the pre-SMA, PMd  and intraparietal sulcus of both hemispheres as 
volumes of interest (VOI). The selection of cortical VOIs was based on previous 
neuroimaging studies. On the one hand, the pre-SMA and right PMd are increasingly 
active with the complexity of sequential finger movements in healthy individuals 
(Sadato et al., 1997, Boecker et al., 1998). On the other hand, patients with PD show 
bilateral increases in activity in PMd and intraparietal sulcus during sequential 
movements (Samuel et al., 1997, Catalan et al., 1999, Carbon and Eidelberg, 2006). 
Therefore, non-manifesting mutation carriers should show an additional recruitment 
of the pre-SMA, PMd and intraparietal sulcus during the finger sequence task. At 
the subcortical level, ROIs were placed in the posterior part of the putamen 
bilaterally. The putaminal ROIs were motivated by our recent morphometric study in 
which in a nearly identical group asymptomatic mutation carriers showed a 
putaminal increase in grey matter on T1-weighted structural MRIs (Weihofen et al., 
2008). 
Each VOI was covered by a sphere. The diameter of the sphere was 27 mm which 
was threefold the FWHM used for Gaussian filtering. The spheres were centred on 
the peak increase in BOLD signal for the main effect of task. For these pre-defined 
VOIs, correction for multiple comparisons only considered voxels within the sphere. 
Outside the VOIs, all results were corrected across the whole brain. 
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Figure 2   Regional increases in task-related BOLD signal changes in non-
manifesting carriers of a Parkin or PINK1 mutation. 
(A). Statistical parametric maps. Sagittal, coronal, and axial slices highlighting 
those voxels in the pre-SMA and adjacent PMd that showed a relative increase 
in BOLD signal during the sequential finger movement task in mutation carriers 
relative to controls without a mutation. The statistical parametric maps are 
superimposed on to a T2-weighted structural MRI template provided by MRIcro 
(http://www.sph.sc.edu/comd/rorden/ mricro.html). The voxels of the activation 
maps are colour-coded according to their Z-values. For illustrative purposes, the 
maps are thresholded at an uncorrected p-value of p<0.01. 
Figure 1   Continued. (B) Parameter estimates of task-rleated BOLD signal 
changes in the right and left pre-SMA and right dorsomedial PMd.
The column plots give the mean Beta-values (as estimated by the general linear 
model) for the task-related change in BOLD signal during the sequential finger 
movement task for each of the four groups (red columns = mutation carriers; yellow 
columns = non-mutation carriers). The Beta values are given in arbitrary units 
(A.U.) and refer to the voxel showing a peak difference between mutation carriers 
and non-carriers. Error bars equal the 95% confidence interval of the mean.
A
B
Table 1   Differences in task-related BOLD signal changes between mutation 
carriers of a Parkin or PINK1 mutation and healthy controls without 
mutation.
Region Side MNI coordinates (mm) Z-score P-value 
(SVC)
x y z
Parkin and PINK1 mutation carriers > controls without mutation
Rostral SMA R 10 2 58 4.29 0.007
L -10 4 58 3.44 0.016
Rostral PMd R 20 6 64 4.31 0.005
Rostral SMA R 6 8 62 4.31 0.018
Rostral PMd R 22 10 60 2.62 >0.05
PINK1 mutation carriers > controls without mutation
Rostral SMA R 18 4 66 4.28 0.014
L -12 4 58 3.45 0.028
Rostral PMd R 18 4 66 4.28 0.011
Areas showing a relative increase in BOLD signal during the sequential finger movement in non-
manifesting carriers. Differences in BOLD signal are characterized by their regional maxima (Z-score, 
P-value and x, y, z coordinates in MNI space). P-values are corrected for the number of voxels within 
the pre-defined spherical volumes of interest (for details see methods section). R = right; L = left; SVC 
= small volume correction; PMD = dorsal premotor cortex; SMA = supplementary motor area. 
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activation of the pre-SMA during sequential movements was attributed to the 
formation of and switch between visuo-motor associations rather than the control 
of the movements per se (Sakai et al., 1999, Rushworth et al., 2002). In the presence 
of a mutant Parkin or PINK1 allele, the “extra-recruitment” of the pre-SMA and 
adjacent PMd most likely reflects an adaptive mechanism by which the motor 
system counteracts the pre-existing latent nigrostriatal dysfunction (Hilker et al., 
2001, Khan et al., 2002a, Khan et al., 2005).
Mutation carriers and controls showed equal performance when performing the 
simple motor sequence task. We propose that the mechanism by which mutation 
carriers maintain a normal level of performance is to recruit additional premotor 
regions that are specialized for handling complex sequential movements. We argue 
that the subclinical nigrostriatal neurotransmission in non-manifesting mutation 
carriers produced a dysfunction of the cortico-basal ganglia-thalamo-cortical 
motor loops involved in the control of overlearned motor sequences. This latent 
dysfunction rendered the simple sequence task more demanding in terms of 
Discussion
When non-manifesting heterozygous carriers of a Parkin or PINK1 mutation perform 
a simple motor sequence task, they recruit the pre-SMA and right rostral PMd 
which are not utilized by healthy controls without mutation. This finding extends our 
recent morphometric MRI study showing an increase in grey matter volume in the 
basal ganglia in a comparable group of non-manifesting carriers of a Parkin or 
PINK1 mutation (Binkofski et al., 2007). Together, the functional and structural MRI 
data suggest that mutations in the Parkin and PINK1 gene produce a very similar 
functional and structural endophenotype. This implies that single heterozygous 
mutations in these two genes have a similar impact on the human motor system.
Converging evidence from neuroimaging and transcranial magnetic stimulation 
(TMS) show that in healthy individuals, the pre-SMA mainly contributes to motor 
sequence control in non-routine situations. Accordingly, functional neuroimaging 
demonstrated an activation of the pre-SMA and rostral right PMd with new or 
complex motor sequences but not with sequences that were highly overlearned or 
easy to perform (Sadato et al., 1997, Boecker et al., 1998, Sakai et al., 1999). The 
Table 2   Differences in task-related BOLD signal changes between carriers of 
a single mutant PINK1 or Parkin allele.
Region Side MNI coordinates (mm) Z-score P-value 
(SVC)
x y z
Parkin mutation carriers > PINK1 mutation carriers
No voxel in the brain
PINK1 mutation carriers > Parkin mutation carriers
PMd L -20 -12 68 4.67 0.002
PMd R 20 0 62 3.87 0.048
Caudal CMA L -6 -2 42 3.49 >0.05
lateral M1Hand L -40 -6 52 3.38 >0.05
anterior IPS L -36 -42 52 4.40 0.004
medial IPS L -18 -70 56 3.13 0.016
medial IPS R 18 -64 50 3.01 >0.05
Areas showing a relative differences in task-related BOLD signal changes between the two groups of 
non-manifesting mutation carriers. Differences in BOLD signal are characterized by their regional 
maxima (Z-score, P-value and x, y, z coordinates in MNI space). P-values are corrected for the number 
of voxels within the pre-defined spherical volumes of interest (for details see methods section). R = 
right; L = left; SVC = small volume correction; PMD = dorsal premotor cortex; CMA = cingulate motor 
area; M1HAND = primary motor hand area; IPS = intraparietal sulcus). 
Figure 3   Relative increases in task-related BOLD signal changes in  
non-manifesting carriers of a PINK1 mutation compared with non-
manifesting carriers of a Parkin mutation. 
Axial slices showing voxels in dorsal frontoparietal cortex with significant 
increase in BOLD signal during the sequential finger movement task in PINK1 
mutation carriers relative to Parkin mutation carriers. The statistical parametric 
maps are superimposed on to a T2-weighted structural MRI images provided by 
MRIcro (http://www.sph.sc.edu/comd/rorden/mricro.html). The voxels of the 
activation maps are colour-coded according to their Z-values. For illustrative 
purposes, the maps are thresholded at an uncorrected p-value of p<0.01.  
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that are normally further address this important question specialized for learning 
more difficult sequences. Additional fMRI studies on high-risk populations as well 
as cross-sectional studies on drug-naïve patients with newly diagnosed sporadic 
or monogenic PD are needed to. 
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neuronal motor control and specifically called on the “support” of rostromedial 
premotor cortex to maintain task performance.(Isoda and Hikosaka, 2007) Because 
the pre-SMA and rostromedial PMd are reciprocally connected with prefrontal 
areas (Luppino et al., 1993, Lu et al., 1994) and receive inputs from the “non-motor” 
(associative) territories of the cerebellum and basal ganglia (Akkal et al., 2007), the 
increased activation of the pre-SMA and rostral PMd might be driven by a 
compensatory increase in neuronal input from connected prefrontal or subcortical 
areas during the task.
The adaptive recruitment of cortical premotor areas was restricted to the pre-SMA 
and the dorsomedial part of right rostral PMd.  In a previous fMRI study, we also 
found an increase in rostral motor areas in non-manifesting carriers of a Parkin 
mutation, but the spatial pattern of increased activity was different from the one 
found in the present study. When participants selected a finger movement with their 
right hand based on internal cues, individuals with a mutant Parkin allele showed a 
stronger activation of the rostral cingulate motor area and the ventrolateral part of 
left rostral PMd but not in rostral SMA and right rostromedial PMd (Buhmann et al., 
2005). These findings lend support to the notion that a latent nigrostriatal 
dopaminergic dysfunction gives rise to variable patterns of activity changes in 
rostral premotor regions which critically depend on the specific motor functions 
probed by the experimental task. The observation that the compensatory 
recruitment of cortical motor areas is task-specific underscores the capacity of 
human sensorimotor networks to flexibly adapt to a regional dysfunction (Lee et al., 
2003).
We also identified some differences between carriers of mutations in the Parkin or 
PINK1 gene. PINK1 mutation carriers, we observed an additional mainly left-hemi-
spheric recruitment of frontoparietal areas, including distinct areas in left caudal 
PMd and intraparietal sulcus. It is unclear whether this reflects a true genotype-
specific pattern of functional adaptation if the frontoparietal cortex. One possibility 
is that non-manifesting PINK1 mutation carriers have a stronger functional 
impairment of the motor system, requiring recruitment of additional frontoparietal 
loops. Future studies could resolve this issue by correlating adaptive redistribution 
of cortical activity to the depth of the nigrostriatal dopaminergic deficit, for example 
using nuclear imaging.
An intriguing question is whether these increases in task-related activity persist, 
increase or attenuate in mutation carriers who ultimately develop PD. A recent H2
15O 
PET study provided some evidence that the extra-recruiment of frontal motor areas 
still represents an effective mechanism of compensation in the early stage of 
sporadic PD (Mentis et al., 2003). In that study, PD patients achieved equal 
performance with healthy controls when learning short motor sequences. In patients, 
equal performance was associated with the additional recruitment of cortical areas 
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Supplementary table 1
Region Side MNI coordinates (mm) Z-score P-value 
x y z
Main effect of task in controls
M1 HAND L -48 -34 40    6.47 <0.001
S1 HAND L -35 -45 55 6.60 <0.001
R 48 -32 50 7.62 <0.001
PMd R 32 -4 54 6.94 <0.001
L -28 -5 52 6.51 <0.001
PMv L -54 4 32 6.84 <0.001
L -45 0 35 6.71 <0.001
aIPS L -48 -34 40 6.47 <0.001
R 40 -42 54 7.34 <0.001
SMA R 2 4 60 6.54 <0.001
L -8 -2 66 6.23 <0.001
CMA R 6 10 52 6.45 <0.001
Putamen L -24 2 5 5.22 <0.001
R 20 10 2 5.14 <0.001
Thalamus L -14 -14 -4 6.74 <0.001
R 10 -16 6 6.00 <0.001
Cerebellum L -36 -56 -34 7.15 <0.001
R 32 -52 -32 6.95 <0.001
R 22 -55 -30 6.75 <0.001
MNI stereotactic coordinates of local maxima of motor regions showing main effect of task in control 
subject without mutation in the Parkin or PINK1 gene. For large clusters spanning several anatomical 
regions more than one maximum is given. The intensity threshold was set at P < 0.05 (FWE corrected). 
M1: primary motor cortex; PMv: ventral premotor cortex; PMd: dorsal premotor cortex; SMA: 
supplementary motor area;  aIPS: anterior Intraparietal sulcus; CMA: cingulate motor area.
Supplementary table 2
Region Side MNI coordinates (mm) Z-score P-value 
x y Z
Main effect of task in carriers of a Parkin mutation
M1 HAND L -34 40 48 5.67 <0.001
S1 HAND L -46 -32 44 6.26 <0.001
R 52 -28 42 5.67 <0.001
PMd L -38 -10 54 5.31 <0.001
R 22 2 64 6.58 <0.001
PMv L -58 8 16 6.37 <0.001
R 56 10 20 5.47 <0.001
L -30 -45 44 5.67 0.002
R 50 -22 30 6.21 0.023
SMA R 14 4 54 6.18 <0.001
R 12 0 52 6.16 <0.001
R 18 2 48 5.69 <0.001
L -22 -6 4 5.16 <0.001
R 38 -52 -30 5.18 <0.001
R 8 -52 -16 5.96 0.002
R 24 -52 -24 5.66 0.005
L -32 -58 -20 5.16 0.026
MNI stereotactic coordinates of local maxima of motor regions showing main effect of task in carriers 
of a single mutant Parkin allele. For large clusters covering several anatomical regions more than one 
regional maximum is given. The intensity threshold was set at P < 0.05 (FWE corrected). M1: primary 
motor cortex; PMv: ventral premotor cortex; PMd: dorsal premotor cortex; aIPS: anterior Intraparietal 
sulcus; SMA: supplementary motor area; SMG: supramarginal gyrus; CMA: Cingulate motor area.
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CHAPTER 5 COMPENSATION IN LRRK2-PARKINSONISM
Abstract 
Compensatory cerebral mechanisms can delay motor symptom onset in Parkinson’s 
disease. We aim to characterize those compensatory mechanisms, as well as early 
disease-related changes, by quantifying movement-related cerebral function in 
subjects at significantly increased risk to develop Parkinson’s disease, namely 
carriers of a leucine-rich repeat kinase 2-G2019S mutation associated with 
dominantly inherited parkinsonism. Functional magnetic resonance imaging was 
used to examine cerebral activity evoked during internal selection of motor repre-
sentations, a core motor deficit in clinically overt Parkinson’s disease. Thirty nine 
healthy first degree relatives of Ashkenazi Jewish Parkinson’s disease patients that 
carry the leucine-rich repeat kinase 2-G2019S mutation participated in this study. 
Twenty one carriers of the leucine-rich repeat kinase 2-G2019S mutation and 18 
non-carriers of this mutation were engaged in a motor imagery task (laterality 
judgments of left or right hands) known to be sensitive to motor control parameters. 
Behavioural performance of both groups was matched. Mutation carriers and 
non-carriers were equally sensitive to the extent and biomechanical constraints of 
the imagined movements in relation to the current posture of the participants’ 
hands. Cerebral activity differed between groups, such that leucine-rich repeat 
kinase 2-G2019S carriers had reduced imagery-related activity in the right caudate 
nucleus and increased activity in the right dorsal premotor cortex. More severe 
striatal impairment was associated with stronger effective connectivity between the 
right dorsal premotor cortex and the right extrastriate body area. These findings 
suggest that altered movement-related activity in the caudate nuclei of leucine-rich 
repeat kinase 2-G2019S carriers might remain behaviorally latent by virtue of 
cortical compensatory mechanisms involving long-range connectivity between the 
dorsal premotor cortex and posterior sensory regions. These functional cerebral 
changes open the possibility to use a prospective study to test their relevance as 
early markers of Parkinson’s disease.
Introduction
Clinical symptoms of Parkinson’s disease (PD) emerge when cerebral degenerative 
processes overcome compensatory mechanisms. Both phenomena start several 
years before clinical onset of PD (Palop et al., 2006), but their exact cerebral 
correlates at the system level are unknown. Experimentally induced dopaminergic 
depletion in animals treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
(MPTP) provides a controlled window into the presymptomatic period of induced 
parkinsonism. These studies revealed sensory-driven compensatory mechanisms 
in cortico-thalamo-cortical circuits (Bezard et al., 2003, Escola et al., 2003, 
Pessiglione et al., 2003), but it remains unclear to what extent these animal models 
can be generalized to human PD. More recently, neuroimaging studies in non-man-
ifesting carriers of mutations known to cause monogenetic forms of PD, like Parkin 
(PARK2) or PINK1 (PARK6) mutations (Broussolle et al., 2000, Hilker et al., 2001, 
Khan et al., 2002a, Khan et al., 2002b, Walter et al., 2004, Buhmann et al., 2005, 
Khan et al., 2005b, Baumer et al., 2007, Binkofski et al., 2007, Hagenah et al., 2007, 
Schweitzer et al., 2007, Hagenah et al., 2008, van Nuenen et al., 2009a, van Nuenen 
et al., 2009b, Reetz et al., 2010, Saunders-Pullman et al., 2010), have been used to 
map cerebral changes occurring before the clinical onset of PD (Farrer, 2006). 
Non-manifesting carriers of these mutations showed structural and functional 
alterations similar to those observed in idiopathic PD, e.g. nigrostriatal and premotor 
dysfunctions. However, it remains unclear whether the recessive genetic markers 
studied so far are representatives of classic PD phenotypes, particularly for 
heterozygous carriers of mutations in recessive genes. For example, neuropatho-
logical examination of PD patients with homozygous and compound heterozygous 
Parkin mutations have demonstrated absence of Lewy bodies, questioning whether 
the pathophysiological mechanism in Parkin-related PD might be different from 
idiopathic PD (Poulopoulos et al., 2012). Also, there is imaging evidence to suggest 
that different genetic mutations lead to different cerebral phenotypes: non-mani-
festing Parkin, PINK1 and ATP13A2 mutation carriers have increased grey matter 
volume in the putamen, whereas leucine-rich repeat kinase 2 (LRRK2) carriers have 
increased grey matter volume in the right caudate nucleus (Reetz et al., 2010). 
Here we study carriers of the LRRK2 mutation, the most frequent genetic cause of 
PD worldwide (Farrer, 2006). This dominantly inherited risk factor might be 
associated with changes in brain activity reflecting pathological and compensatory 
mechanisms of PD before symptoms become clinically evident. We characterize 
functional and structural markers of cortical changes associated with the LRRK2 
G2019S mutation, comparing asymptomatic LRRK2 carriers with non-mutation 
carriers. We assess a core deficit of PD: the internal selection of motor representations 
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assay ID C_63498123_10 in the StepOnePlus Real-Time PCR System (Applied 
Biosystems). The participants did not know their genotype status.  
Exclusion criteria were: clinical diagnosis of PD according to the Queen Square 
Brain Bank Criteria (Gibb and Lees, 1988), other neurological diseases (such as 
severe head trauma, stroke or history of psychiatric disease treated with 
neuroleptics), general exclusion criteria for MRI scanning (such as claustrophobia, 
pace-maker, and implanted metal parts), and failure to perform the motor imagery 
task during a training session outside the scanner (error rate >90%), or inside the 
scanner (error rate >30%). We also excluded subjects with severe head movements 
(Euclidean distance >4.0 mm). During data collection both examiners and 
participants were blinded for the mutation status.
Motor Imagery Experiment 
We used line drawings of left and right hands, with either the back or palm of the 
hand in view (figure 1). The left and right hand drawings were identical mirror 
images. The hand drawing could be rotated in either a counter-clockwise  or a 
clockwise  orientation. For both orientations, four different rotations (45°, 75°, 105° 
and 135°) were used; this yielded eight different rotations. These stimuli were 
presented through a PC running Presentation software (Neurobehavioural systems, 
Albany, USA). Images were projected via an LCD projector (NEC, VT660K) onto a 
screen positioned in front of the subjects’ forehead and viewed through a tilted 
mirror. Responses were gathered with an MRI-compatible response box (HH-1 × 
4L, Current Designs) and saved on a log-file for further analysis. Prior to entering 
the fMRI, all participants underwent a preparatory session during which adequate 
performance of the task was assured. Inside the scanner, participants were asked 
to report whether the drawing of the hand on display represented a left or a right 
hand (regardless of its rotation) by pressing one of the buttons that were located 
underneath their left and right big toes. During scanning, reaction times and error 
rates were measured for subsequent behavioral analysis. The imaging session 
consisted of 32 task blocks (duration 60 s per block) intermixed with 30 baseline 
periods (duration 10 s). Each block consisted of 12 trials, which started with a 
fixation cross, displayed for a variable interval (0.5–1.5 s), followed by the 
presentation of a drawing of a hand. When a response was provided, the stimulus 
was replaced by the fixation cross for a jittered period of 1.5-2.5 s and then a 
subsequent drawing was shown. Subjects did not receive feedback. Rotation and 
laterality of the hand drawings were randomized from trial to trial. On the basis of 
previous studies (Helmich et al., 2007), the RT cut-off was set at 5.0 s. In total, 
subjects performed 384 trials. During the experiment, the posture of the patients’ 
left and right hand was manipulated. At the beginning of each block, a text instructed 
(Brown and Marsden, 1988, Helmich et al., 2009). To identify these markers, we use 
a validated motor imagery task in which subjects are asked to make laterality 
judgments (left or right) of hand pictures (de Lange et al., 2005, Helmich et al., 2009), 
while measuring behavioral performance (reaction times) and cerebral activity (using 
fMRI). Previous studies have shown that subjects solve this task by mentally moving 
their own hand from its current position into the stimulus orientation for comparison 
(Parsons, 1987, de Lange et al., 2008a). This task allows subjects to internally select 
which hand is going to be mentally moved, according to hand- specific biomechanical 
constraints and the subjects’ own hand posture (de Lange et al., 2006). The validity 
of this task has been demonstrated both in healthy subjects (Shenton et al., 2004, de 
Lange et al., 2006) and in PD patients (Dominey et al., 1995, Helmich et al., 2007, 
Helmich et al., 2011). The known pathophysiology of LRRK2 suggests that latent 
dopaminergic deficits in LRRK2 mutation carriers might result in impaired activity in 
the striatum (Galter et al., 2006, Lin et al., 2011). We also predict that, similar to what 
has been observed in idiopathic PD patients (Helmich et al., 2007, van Nuenen et al., 
2012), increased connectivity between posterior sensory areas and the cortical motor 
system might compensate for those striatal deficits.  
Methods
We included 62 first-degree asymptomatic first-degree relatives of Ashkenazi 
patients with Parkinson’s disease who are carriers of the G2019S mutation in the 
LRRK2 gene (age 47.2±9.7 years, mean±S.D.; 28 men). Given the dominant 
inheritance of this mutation, approximately 50% of the subjects also have the 
mutation and are at higher risk to develop PD. All subjects were native Hebrew 
speakers and provided written informed consent after receiving full explanation on 
the nature of the study. The study was approved by the Tel Aviv Sourasky Medical 
Center Institutional Review Boards. Before scanning, subjects underwent a 
complete neurological examination, including the Unified Parkinson’s Disease 
Rating Scale (UPDRS). 
Genomic DNA was isolated from peripheral blood using standard protocols or from 
saliva according to manufacturer’s instructions (Oragene, Ottawa, Canada). To 
detect the 6055G_A (G2019S) mutation (rs34637584)  in LRRK2 exon 41, we 
amplified a 171 bp fragment with the following primers: forward 5’ CCTGTG-
CATTTTCTGGCAGATA 3’ and reverse 5’ CCTCTGATGTTTTTATCCCCATTC 3’ as 
previously described (Orr-Urtreger et al., 2007). PCR fragments were sequenced 
using the BigDye Terminator Chemistry (Applied Biosystems, Foster City, CA) and 
analyzed using an automated ABI Prism 3130xl Genetic Analyzer (Applied 
Biosystems). In addition LRRK2 G2019S mutation was also detected using TaqMan 
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the effects of biomechanical constraints and body posture on behavioral 
performance. The term “biomechanical constraints” (BMC) refers to the reaction 
time difference in mentally rotating a hand towards a lateral, as compared to a 
medial orientation with respect to the body axis. Lateral and medial orientations 
were coded as follows: counter-clockwise rotations (-135°, -105°, -75°, -45°) were 
averaged and recoded as a lateral orientation for left hands and a medial orientation 
for right hands; clockwise rotations (45°, 75°, 105°, 135°) were averaged and 
recoded as a medial orientation for left hands and a lateral orientation for right 
hands. The term “hand posture” refers to the posture of the participants’ hand 
(pronated or supinated) with respect to the posture of the hand drawing (irrespective 
of medio-lateral rotation). Trials were coded as matching (MATCH) or non-matching 
(NONMATCH) with respect to the subjects’ own hand posture. Thus, we tested the 
effects of factors HAND (2 levels: LEFT or RIGHT), BMC (2 levels: MEDIAL or 
LATERAL), hand posture (2 levels: MATCH or NONMATCH) and GROUP (2 levels: 
non-mutation carriers or nonmanifesting LRRK2-carriers) by means of repeated 
measures ANOVA on RTs collected during scanning. The Greenhouse–Geisser 
method was used to correct for non-sphericity. Alpha-level was set at p = 0.05. 
Functional MRI image acquisition and preprocessing
Imaging was performed on a GE 3T Signa HDxt scanner with a resonant gradient 
echoplanar imaging system. All images were acquired using a standard 8-channel 
head coil. Each subject received an anatomical scan using spoiled gradient 
(3D-SPGR) echo sequence with field of view (FOV) 250×250 mm; matrix size 
256×256; voxel size 0.98×0.98×1; Repetition Time (TR) 9; Echo Time (TE) 3.6 ms 
and functional scans (64x64, FOV 20, 35 slices, 3.5 thickness, no gap, TR 2200, 
REP 57). Functional data were pre-processed and analyzed with SPM5 (Statistical 
Parametric Mapping, http://www.fil.ion.ucl.ac.uk/spm). First, functional EPI images 
were spatially realigned using a least squares approach and a six parameter (rigid 
body) spatial transformation (Friston et al., 1995). Subsequently, the time-series of 
each voxel was realigned temporally to acquisition of the first slice (slice time 
correction). Anatomical images were spatially co-registered to the mean of the 
functional images (Ashburner and Friston, 1997) and segmented using a unified 
segmentation approach. The resulting transformation matrix was then used to 
normalize the anatomical and functional images. The normalized functional images 
were re-sampled at an isotropic voxel size of 2 mm and smoothed with an isotropic 
8 mm full-width-at-half-maximum (FWHM) Gaussian kernel.
Analysis of task-related effects
First-level analysis: The pre-processed fMRI time series were analyzed at the first 
level using an event-related approach in the context of the general linear model 
the patients to position their hands in one of four postures: (1) both palms up; (2) 
the left palm up, right palm down; (3) the left palm down, the right palm up; (4) both 
palms down. The period during which the text was displayed and the instruction for 
postural adjustment took place (duration 5 s) was followed by a baseline period 
during which a fixation cross was displayed on the screen. Each posture change 
was followed by a block of 12 trials. During the whole experiment, the patients were 
lying supine in the scanner, facing the bore of the magnet, unable to see their 
hands. Before the start of the scanning session, participants were trained until they 
could perform the task. 
Behavioral analysis
First, we analyzed the influence of the factors ROTATION (8 levels: -135°, -105°, -75°, 
-45°, 45°, 75°, 105° and 135°), HAND (2 levels: LEFT or RIGHT) and GROUP (2 levels: 
Non-mutation carriers or nonmanifesting LRRK2-carriers) by means of repeated 
measures ANOVA on reaction times collected during scanning. Second, we tested 
Figure 1   Task setup. 
An illustrative subset of the stimuli used in the motor imagery task (here shown 
only for the backs of right hands, across different orientations). Following the 
presentation of the drawing of a hand, subjects had to report whether the 
stimulus was a left or a right hand, irrespective of its rotation. The stimulus could 
be orientated either laterally (upper row) or medially (lower row) with respect to 
the body midline.  
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isolated two maxima along the precentral gyrus: left PMd [-26 -2 +52], right PMd 
[+34 -4 +48]; see Table 2. Then we tested for group differences in a sphere of 10 
mm around these functionally-defined PMd coordinates. Second, we focused on 
the right Extrastiate Body Area (EBA;MNI coordinates [46, -78, 6]), because this 
region showed increased motor imagery-related activity in symptomatic PD in a 
previous study (Helmich et al., 2007). Thus, we tested for group differences in a 
sphere of 10 mm around these coordinates, defined on the basis of an independent 
study (Helmich et al., 2007). Third, we searched for between-groups differences in 
the anatomically defined bilateral putamen and caudate nucleus (as obtained from 
the Anatomic Automatic Labeling atlas, AAL) (Tzourio-Mazoyer et al., 2002). 
Effective connectivity analysis
Having identified increased motor imagery-related activity in the right PMd of 
LRRK2 carriers, we next hypothesized a change in connectivity between this 
premotor region and other brain regions involved in compensatory processes in PD 
during motor imagery. More specifically, based on the previous finding of increased 
connectivity between PMd and EBA in symptomatic PD (Helmich et al., 2007), we 
hypothesized that LRRK2 carriers may also have increased connectivity between 
the PMd and the EBA during motor imagery. Since PMd activity was dependent on 
the length of the imagined movement (factor ROTATION), we hypothesized that 
altered connectivity of the PMd should also increase with increasing rotation.
For connectivity analyses, we employed the psychophysiological interaction (PPI) 
method (Friston et al., 1997). A PPI analysis makes inferences about regionally 
specified responses caused by the interaction between a psychological factor and 
a physiological activity in a specified index area. The analysis was constructed to 
test for differences in the regression slope of the activity in all remaining brain areas 
on the activity in the index area (e.g. right PMd), depending on the degree of rotation 
(45°, 75°, 105° and 135°). The index area was defined by the first eigentime series of 
all voxels within a 6 mm radius sphere centered on the regional maximum in the 
right PMd that showed a relative increase in BOLD signal during mental rotation of 
hands with increasing degree of rotation (45°> 75°> 105° > 135°; p<0.05 
uncorrected). In four non-mutation carriers and five LRRK2 carriers, no significant 
voxels were found for that contrast in the PMd, so their data could not be included 
in the analysis. First, we performed a PPI analysis for each subject at the first level. 
Then, we entered the individual PPI contrast images in a two-sample t-test at the 
second level (random effects analysis). Based on our a priori hypothesis, we 
considered only those voxels in our region of interest (right EBA). 
(GLM). This model considered the biomechanical constraints (factor BMC, 2 levels: 
MEDIAL, LATERAL), hand posture (factor POSTURE, 2 levels: MATCH, NONMATCH), 
laterality (factor HAND, 2 levels: RIGHT, LEFT) and ROTATION (4 levels: 45°, 75°, 
105° and 135°). The effect of stimulus ROTATION on cerebral activity was separately 
modeled for each condition using a linear basis function (parametric modulation 
with four levels corresponding to 45°, 75°, 105° and 135°). In addition, our first-level 
model included separate regressors of no interest: one regressor modeling 
incorrect and miss trials, two regressors describing the signal intensity averaged 
on each scan over the segmented white matter and over a blank portion of the MR 
images (out of brain signal), and regressors describing head motion [linear, 
quadratic and cubic effects of the six movement parameters belonging to each 
volume and also first derivative of each of those regressors, to control for spin-history 
effects (Lund et al., 2005)]. Parameter estimates for all regressors were obtained by 
maximum-likelihood estimation, while using a temporal high-pass filter (cut-off 128 s), 
and modeling temporal autocorrelation as a first-order auto-regressive process.  
Random effects analysis: We tested two different imagery-related effects over the 
whole sample of subjects. First, we tested for rotation-related effects, entering the 
relative contrast image for each subject into a within-subjects one-sample t-test. 
Second, we tested for orientation-related effects, entering the relative contrast 
images (BMC difficult, BMC easy) for each subject into a within-subjects paired 
t-test. Crucially, we then compared rotation- and orientation-related effects between 
the two groups, performing two-sample t-tests on the relevant contrast images 
from each subject. Although gender and age distribution were not significantly 
different between groups, we added this information as a covariate to the second 
level analysis, to account for possible gender- and/or age-related cerebral 
differences during motor imagery.
Statistical interference
Statistical inference (p<0.05) was performed at the cluster-level, correcting for 
multiple comparisons over the search volume (i.e. whole brain). Clusters were 
initially defined by using a voxel-level intensity threshold of p<0.001 uncorrected. 
We also performed region of interest (ROI) analyses, using a voxel-level statistical 
threshold of p<0.01, family-wise error (FWE) corrected for multiple comparisons 
over the search volume (i.e. the ROI). There were seven regions of interest. First we 
searched for differential imagery-related activity in the PMd, because this region is 
known to be specifically involved in motor imagery of hand movements (de Lange 
et al., 2006, Helmich et al., 2007). We localized the left and right PMd by testing for 
rotation-related activity across the whole group (i.e. in both carriers and non-mutation 
carriers), correcting for multiple comparisons across the whole brain. This analysis 
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for limited training in this study is that these participants performed an extensive 
battery of tasks (Pen and paper questionnaires: Montreal Cognitive Assesment 
(MoCa), University of Pennsylvania Smell Identification Test (UPSIT), State-Trait 
Anxiety Inventory (STAI), Blessed Dementia Scale (BDS), Trial Making Test (TMT), 
The Unified Parkinson’s Disease Rating Scale (UPDRS), Catergory Verbal Fluency 
Test, The Scale for Outcomes in Parkinson’s disease for Autonomic Symptoms 
(SCOPA-AUT), Digit Span Test, The Stroop color-word test, Finger tapping. 
Computerized test: Neurotrax - a computerized cognitive program (Thaler et al., 
2012). Motor test: Gait performance across 4 different walking velocities. In the MR 
scanner, the following tasks and imaging procedures were acquired: Motor imagery 
task (fMRI, reported in this manuscript), DTI scan, Resting state (fMRI), Observation 
of 2 movie clips (fMRI), Stroop task (fMRI), n-back task (fMRI), Domino task (fMRI), 
Structural scan (data used in this manuscript)) lasting over three hours. 
One subject was excluded because of claustrophobia, three subjects were 
excluded because of technical problems and five subjects were excluded because 
of movement artifacts. One subject had a mutation in the glucocerebrosidase gene 
(GBA), and was excluded because we were specifically interested in LRRK2 
mutation carriers because they have an increased risk for developing PD. GBA may 
or may not influence the risk for developing PD. To keep our comparison between 
LRRK2 carriers and non-carriers as clean as possible, we decided to exclude the 
subject with both LRRK2 and GBA mutation. Of the remaining 39 subjects, the 
LRRK2 G2019S mutation screening revealed a mutation in 21 participants (54%; 11 
men; 48 ± 9 years (mean ± S.D.)) and no LRRK2 G2019S mutation in 18 participants 
(46%; 8 men; 45 ± 9 years). There were no significant baseline differences between 
the two groups (Table 1).
Voxel-based morphometry 
We considered the possibility that between-groups differences in functional activity 
could reflect between-groups anatomical differences. Therefore we performed a 
voxel-based morphometry (VBM) analysis. VBM analyses were done in SPM8. We 
segmented the anatomical MRI scan of each subject into gray matter, white matter, 
cerebrospinal fluid, and extra-cerebral compartments (e.g. out-of-brain, skull, skin). 
We used the DARTEL toolbox (Ashburner, 2007) as implemented in SPM8 to create 
a study-specific anatomical template and register all individual gray matter images 
to this template. All images were subsequently normalized to MNI space, while 
correcting for volume changes induced by normalization. Last, we smoothed all 
gray matter images using a kernel of 10 mm FWHM, and we performed a regression 
analysis on these smoothed images to test for differences in gray matter between 
the two groups (non-mutation carriers and nonmanifesting LRRK2-carriers). We 
also included age, gender, as well as total gray matter as covariates, since these 
factors have been shown to have a great impact on gray matter volume (Good et 
al., 2001).  To maximize the power of the VBM analysis, we also included the 
subjects who were not able to adequately perform the fMRI motor imagery task. 
Therefore the VBM analysis included in total 28 non-mutation carriers and 34 
nonmanifesting LRRK2-carriers.  Besides whole-brain analysis, we focused the 
inferences on a set of ROIs based on previous VBM studies on nonmanifesting 
PARK-gene carriers(Binkofski et al., 2007, Reetz et al., 2010). We used an automated 
parcellation method [AAL atlas, (Tzourio-Mazoyer et al., 2002)] as implemented in 
the WFU-Pickatlas SPM8 toolbox (Maldjian et al., 2003), to generate anatomical 




Of the 62 included candidates, 34 (55%) had the G2019S LRRK2 mutation. Thirteen 
subjects had an error rate higher than 30% and were excluded from further analysis. 
It remains unclear why these participants had a poor task performance, but it 
seems unlikely to be related to their genetic status and any ongoing cerebral 
alteration. First, although a larger number of mutation carriers (eight) were excluded 
than non-mutation carriers (five), the proportion of excluded subjects is similar 
across the two groups (X2=2, p = 0.157). Second, previous work (Helmich et al., 
2007, van Nuenen et al., 2012) clearly indicates that even patients at quite advanced 
stages of PD (mean H&Y 2.1 and 1.4 respectively; range 1-3) can effectively perform 
the imagery task used in this study. However, in the above mentioned studies, 
participants and patients were trained before scanning to perform with an error rate 
< 10%, whereas in this study participants had a much shorter training. The reason 






Number (n) 18 21
Age (y) 44.7 ± 9.0 47.6 ± 9.1 0.23
gender (%men) 44.4 57.1
Handedness 17 RH / 1 LH 20 RH / 1 LH
UPDRS III 1.8 ± 1.3 1.9 ± 1.7 0.96
Baseline characteristics of subjects included in the fMRI experiment.
RH = right handedness/ LH = left handedness; UPDRS = Unified Parkinson’s Disease Rating Scale; 
Values indicate mean ± S.D.
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activity during increasing stimulus rotation in LRRK2 carriers compared to non- 
mutation carriers (MNI coordinates [34 -12 +46]; z = 3.24; p = 0.040 corrected; 
Figure 2A).
Behavioural results
The mean error rate was comparable between groups (non-mutation carriers: 10 ± 
2%; LRRK2 carriers: 10 ± 2%; t(37)= -0.123, p = 0.913; mean ± S.E.M.) as were the 
mean reaction times (non-mutation carriers: 1418 ± 86 ms.; LRRK2 carriers: 1443 
± 96 ms.; t(37) = -0.192, p = 0.849). The reaction times increased with increasing 
rotation of the hand drawing (main effect of ROTATION: F(3,46)=53.15; p<0.001). 
This effect was not influenced by the mutation carrier status (ROTATION x GROUP 
interaction: F(7,59)=1.93; p=0.124), or by the hand used to perform motor imagery 
(HAND X ROTATION x GROUP interaction: F(7,64)=0.56; p=0.683; See Fig 2). 
We then tested for the effects of stimulus orientation (biomechanical complexity, 
BMC: difficult or easy) and the effect of the subjects’ own body posture (matching 
or non-matching with respect to the stimulus) on reaction times. Reaction times 
were longer for stimuli in a biomechanically difficult than easy orientation 
(F(1,17)=62.21; p<0.001), and they were longer for stimuli that did not match the 
posture of the subjects’ own hand (POSTURE: F(1,17)=15.99; p=0.001). The 
subjects were faster when the stimuli were right hands (HAND: F(1,17)=9.35; 
p=0.007), and the behavioral slowing induced by the biomechanical complexity of 
the stimulus was larger for right than for left hands (HAND X BMC: F(1,17)=6.25; 
p=0.023). Importantly,  there were no significant interactions with the factor GROUP 
(all p>0.2). These results strongly suggest that both groups used first-person motor 
imagery to solve the task (i.e. they mentally rotated their own hands, taking into 
account their current posture and biomechanical constraints of the imagined 
movements), rather than visual imagery. Having used a task that LRRK2 carriers 
can solve as well as non-mutation carriers, it becomes meaningful to compare 




First, we identified regions where activity increased with increasing stimulus 
rotation. We found a bilateral parieto-premotor network, confirming its involvement 
in mental rotation of hands (table 2) (Johnson et al., 2002, de Lange et al., 2006, 
Helmich et al., 2007). Second, we tested for differential rotation-related changes in 
cerebral activity between LRRK2 carriers and non-mutation carriers (GROUP X 
ROTATION interaction). The head of the left caudate showed increased activity 
during increasing stimulus rotation in non-mutation carriers compared to LRRK2 
carriers (MNI coordinates [-16 -2 +20]; z = 4.36; p = 0.006 corrected), and we 
observed a trend for the same effect in head of the right caudate (MNI coordinates 
[+18 +2 +18]; z = 3.66; p = 0.063 corrected). The right PMd showed increased 
Figure 2   Behavioural performance. 
Reaction times (mean±S.E.M.) as a function of hand (left hand, in dark grey, or 
right hand, in light grey) and stimulus rotation (-135° to 135° from upright hand 
orientation; see figure 1) in the two groups of participants.  
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Biomechanical constraints and posture
As described above, reaction times were longer when the imagery task involved 
laterally-oriented hands. Cerebral activity following the same pattern was found in 
the bilateral insula, posterior parietal cortex, and middle occipital gyrus (table 3). 
There were no between-group differences in cerebral activity related to bio- 
mechanical complexity. At the conservative statistical threshold used in this study, 
we did not find significant posture-related cerebral activity, and no posture-related 
differences between groups. 
  
Effective connectivity
From the contrasts mentioned above, it emerged that the right PMd was more 
active during increasing stimulus orientation in LRRK2 carriers than non-mutation 
carriers. Building on recent observations in symptomatic PD patients, obtained 
during performance of the same task used in this study, we hypothesized that the 
increased PMd activity might relate to increased connectivity with the EBA (Helmich 
et al., 2007). We tested this hypothesis with PPI, a tool designed to assess changes 
in effective connectivity between cerebral regions (Friston et al., 1997). Using the 
right PMd as the seed region and the right EBA as the target region, we found that 
functional connectivity between these regions increased with stimulus rotation in 
LRRK2 carriers but not in non-mutation carriers (effect of GROUP: MNI coordinates 
[+40 -78 +4]; t = 3.71; p = 0.032 corrected; figure 3B). In a whole brain analysis 
without the right EBA as a target region, no brain area reached significance (p<0.05, 
corrected). Next, we reasoned that if this increased connectivity compensates for 
latent dopaminergic dysfunction in the striatum, then connectivity should increase 
as task-related activity in the right caudate decreases. To test this, we correlated 
task-related activity in the right caudate (beta values at [+18 +2 +18] from rotation-
related contrast image) with PMd-EBA connectivity (beta values at [+40 -78 +4] 
from PPI contrast image) separately for LRRK2 carriers and non-mutation carriers. 
In LRRK2 carriers, reduced activity in the right caudate predicted increased 
PMd-EBA connectivity (r = -0.580; p = 0.018). There was no significant correlation 
for the non-mutation carriers (r = 0.101; p = 0.731; Figure 3C).
Voxel-based morphometry
There were no significant differences in gray matter volume between groups, even 
when lowering the statistical threshold to a lenient threshold of p<0.01 uncorrected, 
and even when restricting our search to the striatum or to brain areas showing 
differential imagery-related activity. This indicates that the fMRI findings we report 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3   Cerebral effects. 
A: Between-groups differences in imagery-related brain activity. Anatomical 
distribution of voxels that showed a differential change in BOLD signal as a function 
of stimulus rotation (i.e. imagery-related) between non-mutation carriers (NMC) and 
non-manifesting LRRK2 mutation carriers (MC). On the left, axial slice showing 
reduced imagery-related BOLD signal in the caudate nuclei; On the right, axial slice 
showing increased imagery-related BOLD signal in the dorsal premotor cortex (PMd). 
Statistical parametric maps (SPMs) of imagery-related between-groups differences 
(Z-scores, in red-yellow) superimposed onto a T2-weighted structural MRI template (in 
grey). For illustrative purposes, SPMs are thresholded at an uncorrected p value of 
p<0.01 with a cluster extent threshold of > 50. B: Between-groups differences in 
imagery-related effective connectivity. The coronal slice on the right describes the 
anatomical distribution of voxels in the extrastriate body area (EBA) with differential 
increase in imagery-related coupling with the right PMd (left axial slice) between 
non-mutation carriers and non-manifesting LRRK2 mutation carriers. The SPM(Z) of 
between-groups differences  in PMd-EBA imagery-related connectivity (in red-yellow) 
is superimposed onto a T2-weighted structural MRI template (in grey). C: Between- 
groups differences in the relation between imagery-related activity in the right 
caudate and PMd-EBA connectivity. Scatterplot of parameter estimates (ß-values) 
of imagery-related activity in the right caudate (x = 18, y = 2, z = 18) against coupling 
strength between the right PMd (x =  34, y = -12, z = 46) and the right EBA (x = 40, 
y = -78, z = 4) for non-mutation carriers (left panel) and for non-manifesting LRRK2 
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in symptomatic PD patients, namely earlier and stronger alterations of the putamen 
than the caudate nucleus (Kish et al., 1988). However, if non-manifesting LRRK2 
carriers have a similar upregulation of the nigro-striatal dopamine system as 
observed in non-manifesting MPTP-treated monkeys (Mounayar et al., 2007), then 
dopamine levels of non-manifesting LRRK2 carriers could be normalized in the 
putamen, but overdosed in the relatively less depleted caudate. Given the restricted 
physiological range of dopaminergic modulation (Goldman-Rakic et al., 2000), an 
excess of dopamine in the caudate could lead to increased lability of the motor 
representations relevant for the imagery task (Cools and D’Esposito, 2011). The 
reduced caudate contributions observed in non-manifesting LRRK2 mutation 
carriers could then reflect a reduced ability of this striatal structure to support tem-
porally-sustained movement representations as required by the current motor 
imagery task. Given the known involvement of the head of the caudate in executive 
functions (Alexander et al., 1986, Marklund et al., 2009), the present finding would 
predict that LRRK2 carriers are characterized by cognitive alterations early in the 
disease, although this effect might be also driven by non-dopaminergic alterations 
(Alcalay et al., 2012).
A compensatory role for the dorsal premotor cortex? 
Non-manifesting LRRK2 mutation carriers and non-mutation carriers solved the 
motor imagery task equally well, but the former group had stronger activity in the 
right PMd. This effect is clearly located within the probabilistic cytoarchitectonic 
borders of Brodmann area 6 (Eickhoff et al., 2005), and more precisely within the 
dorsal premotor cortex (Mayka et al., 2006; Tomassini et al., 2007). On the basis of 
the guidelines offered by Picard & Strick (Picard and Strick, 2001), we infer that the 
current effect is located in the caudal sector of the dorsal premotor cortex, being 
about 8 mm anterior to the primary motor cortex (as inferred on the basis of Mayka 
et al, Neuroimage 2006). This portion of the dorsal premotor cortex is typically 
associated with movement-related phenomena (Picard and Strick, 2001). In 
contrast, the local maximum reflecting imagery-related activity in both mutation 
and non-mutation carriers (Table 2) is about 16 mm anterior to the primary motor 
cortex, most likely in the prePMd according to Picard and Strick (Picard and Strick, 
2001). 
Increases in PMd activity have been observed in non-manifesting Parkin and PINK1 
mutation carriers (Buhmann et al., 2005, van Nuenen et al., 2009b), and idiopathic 
PD patients also show increased PMd activity (Sabatini et al., 2000, Wu and Hallett, 
2005). Since different tasks, disease states, and mutation types appear to lead to 
increased PMd activity, it might be argued that the PMd effect reported in this study 
is quite un-specific, and that the human motor system deals with the consequences 
of different mutations by using a single mechanism centered on the dorsal premotor 
Discussion
We studied a large group of asymptomatic LRRK2-G2019S mutation carriers to 
identify potential preclinical cerebral reorganisation during a motor imagery task 
requiring internal selection of motor representations (de Lange et al., 2006, Helmich 
et al., 2007). This task was selected because it captures a core dysfunction in 
clinical stages of PD (Brown and Marsden, 1988, Helmich et al., 2009). There are 
three main results. First, LRRK2-G2019S mutation carriers and non-carriers were 
equally sensitive to the extent and biomechanical constraints of the imagined 
movements, in relation to the current posture of the participants’ hands. This result 
confirms that this motor imagery task relies on internal selection of motor represen-
tations (de Lange et al., 2008a). This result also indicates that the observed cerebral 
effects were not driven by between-groups differences in performance. Second, 
asymptomatic LRRK2-G2019S mutation carriers had reduced imagery-related 
activity in the right caudate nucleus. This result indicates that asymptomatic 
LRRK2-G2019S mutation carriers have a functional impairment in the striatum. 
Furthermore, in contrast to the structural alterations seen in the ventrolateral 
striatum of idiopathic PD patients and non-manifesting carriers of Parkin and PINK1 
mutations (Buhmann et al., 2005, Binkofski et al., 2007, Reetz et al., 2008), the 
striatal impairment in asymptomatic LRRK2 carriers arose in the caudate nucleus. 
Third, asymptomatic LRRK2-G2019S mutation carriers had increased imagery-re-
lated activity in the right PMd. Effective connectivity between this region and the 
right extrastriate body area increased in proportion to the caudate alteration. This 
suggests that long-range connectivity between the PMd and posterior sensory 
regions might compensate for striatal impairments, a mechanism recently observed 
in idiopathic PD patients (Helmich et al., 2007, van Nuenen et al., 2012). 
Altered caudate functionality in the premotor phase of LRRK2 
parkinsonism
The motor imagery task evoked largely overlapping cerebral responses across 
LRRK2 mutation carriers and non-mutation carriers, namely activity in parieto-fron-
tal regions previously associated with performance of this task (de Lange et al., 
2006, Helmich et al., 2007). This result indicates that the two groups used similar 
cerebral circuits for solving the motor imagery task. A notable exception was found 
for the head of the caudate nucleus, showing less activity in non-manifesting LRRK2 
mutation carriers. Given that the premotor phase of LRRK2 parkinsonism is also 
accompanied by nigrostriatal dopaminergic deficits (Khan et al., 2005a, 
Bruggemann et al., 2011), the imagery-related difference observed in the caudate 
might constitute a functional correlate of that dopaminergic deficit. Yet, this 
observation does not fit with the known consequences of dopaminergic denervation 
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activity, and with an inverse relation to task-related activity in the caudate. Given the 
matched behavioral performance between groups, these observations suggest 
that increased PMd-EBA coupling can be interpreted as compensating the reduced 
caudate activity observed in LRRK2 carriers. This finding extends and qualifies 
previous reports on the relevance of compensation for a (latent) nigrostriatal 
dopaminergic dysfunction during motor execution in symptomatic PD patients 
(Samuel et al., 1997, Haslinger et al., 2001) and non-manifesting mutation carriers 
(Buhmann et al., 2005, van Nuenen et al., 2009b). 
Conclusion
We have characterized cerebral alterations and potential compensatory mechanisms 
in asymptomatic LRRK2-G2019S mutation carriers. We show that this mutation 
leads to movement-related alterations in the caudate nucleus, a feature that 
distinguishes LRRK2 carriers from the endophenotype of other known genetic 
subtypes. LRRK2 carriers also show potentially compensatory activity implemented 
through long-range connectivity between the dorsal premotor cortex and posterior 
sensory regions, similar to what has been recently observed in idiopathic PD. These 
findings might capture mechanisms compensating progressive neurodegeneration 
at the pre-motor stage of PD. Alternatively, these findings might reflect congenital/
developmental abnormalities associated with LRRK2, only superficially related to 
clinical PD by virtue of a common compensatory mechanism deployed across 
different cerebral phenotypes. A prospective study, following these LRRK2-G2019S 
mutation carriers, could test the clinical significance of the current findings and 
their relevance as early markers of PD. 
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cortex (van Nuenen et al., 2009b). In fact, close comparison between the current 
findings, Buhmann et al 2005, and van Nuenen et al 2009 suggests that different 
portions of the premotor cortex are recruited during performance of motor-related 
tasks in carriers of recessive mutations (Parkin, PINK1) or dominant mutations 
(LRRK2). For instance, the internal selection of right thumb movements, studied by 
Buhmann et al (2005), evoked stronger responses in two frontal clusters of Parkin 
carriers. One cluster was centered on the mesial frontal cortex (right rCMA, rostral 
SMA, extending into the adjacent PMd). Another cluster was covering the left PMd, 
with two local maxima at -39, 6, 42, and -24, -12, 51. Even ignoring the obvious 
difference in the hemispheric location of the effects found in Buhmann et al (2005) 
and in the present study, the local maxima of the PMd cluster of Buhmann et al 
(2005) area 21 and 11 mm apart from the local maximum reported in this study (34, 
-14,46). The study of van Nuenen et al (2009), comparing the effects of internal 
selection of finger to thumb movements evoked in Parkin and PINK1 mutation 
carriers, reports a premotor effect (20, 6, 64) even further away to the effect found 
in the present study. These data indicate that the premotor effect found in the 
present study occurs at a different location than those found in Parkin and PINK1 
carriers. Taken together with the anatomical differences in striatal impairments 
observed between carriers of recessive mutations (Parkin, PINK1) and dominant 
mutations (LRKK2), these findings suggest that different genetic sources of 
nigrostriatal dopaminergic dysfunction lead to increased activity in different fronto-
striatal circuits. However, given that the motor tasks used in these studies (i.e. 
Buhmann et al, 2005; van Nuenen et al. 2009; present study) also differ in 
procedures and effectors, it remains to be tested whether different portions of the 
dorsal premotor cortex, in different hemispheres, would be recruited when carriers 
with different mutations perform exactly the same task.
The increased caudal PMd activity found in LRRK2 carriers might reflect a reduced 
ability of this region to specify the motor commands required to mentally match the 
current hand configuration of the subject with the target hand configuration shown 
on the screen. In this scenario, the increased influence that the right EBA was found 
to exert on PMd in LRRK2 carriers might be interpreted as a compensatory 
mechanism for the PMd alteration. EBA is a cortical region originally defined in 
relation to the visual perception of body parts (Downing et al. 2001). More recent 
work has also highlighted its involvement in planning voluntary manual actions 
(Astafiev et al. 2004; Kuhn et al. 2011), namely specifying the goal posture of a 
planned action (Zimmerman et al. 2011). The increased coupling between EBA and 
PMd in LRRK2 carriers could reflect increased reliance on visual predictions of the 
action outcome during the specification of the motor plan evoked by the imagery 
task. Furthermore, the increased coupling between EBA and PMd in LRRK2 carriers 
scaled as a function of task demands (hand orientation), after correcting for PMd 
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CHAPTER 6 ANTICIPATORY CODING OF GRIP FORCE
Abstract 
The dorsal premotor cortex (PMd) uses prior sensory information for motor 
preparation. Here we used a conditioning-and-map approach in 11 healthy male 
humans (mean age 27 years) to further clarify the role of PMd in anticipatory motor 
control. We transiently disrupted neuronal processing in PMd, using either 
continuous theta burst stimulation (cTBS) at 80% (inhibitory cTBS) or 30% (sham 
cTBS) of active motor threshold. The conditioning effects of cTBS on preparatory 
brain activity were assessed with functional MRI, while participants lifted a light or 
heavy weight in response to a go-cue (S2). An additional pre-cue (S1) correctly 
predicted the weight in 75% of the trials. Participants were asked to use this prior 
information to prepare for the lift. In the sham condition, grip force showed a 
consistent undershoot, if the S1 incorrectly prompted the preparation of a light lift. 
Likewise, an S1 that falsely announced a heavy weight produced a consistent 
overshoot in grip force. In trials with incorrect S1, preparatory activity in left PMd 
during the S1-S2 delay period predicted grip force undershoot but not overshoot. 
Real cTBS selectively abolished this undershoot in grip force. Further, preparatory 
S1-S2 activity in left PMd no longer predicted the individual undershoot after real 
cTBS. Our results provide converging evidence for a causal involvement of PMd in 
anticipatory down- but not up-scaling of grip force, suggesting an inhibitory role of 
PMd in anticipatory grip force control during object lifting.
Introduction
Prior sensory information is readily implemented in the preparation and anticipatory 
guidance of our actions. For instance, people match the applied force to the expected 
weight of an object when grasping and lifting an object (Johansson and Westling, 
1988, Flanagan et al., 2001, Cole and Rotella, 2002). Previous research suggests that 
the dorsal premotor cortex (PMd) codes predictive aspects of sensory information in 
the context of manual motor control. The PMd is involved in selecting hand movements 
based on sensorimotor mapping rules (Picard and Strick, 1996, Passingham et al., 
1998, Kurata et al., 2000, Toni et al., 2002, Amiez et al., 2006, van Eimeren et al., 
2006). In this process the left PMd plays a dominant role when action selection is 
based on an arbitrary (non-spatial) mapping rule (Schluter et al., 1998). Specifically, 
the PMd processes sensory information that is relevant to a pending action and uses 
it for movement preparation (Boussaoud, 2001, Astafiev et al., 2003, Hoshi and Tanji, 
2006, Schubotz, 2007, Grafton et al., 2008). 
This presumed role of the PMd has been substantiated by studies in which low- 
frequency repetitive transcranial magnetic stimulation (rTMS) was used to transiently 
suppress cortical excitability in the left PMd (Chouinard et al., 2005, Christensen et 
al., 2007, Nowak et al., 2009). Low-frequency rTMS of the left PMd disrupted the 
predictive scaling of forces based on arbitrary color cues in a grip-and-lift task 
(Chouinard et al., 2005, Nowak et al., 2009), and altered the impact of an incorrect 
predictive cue on subsequent visuomotor mapping (Ward et al., 2010). 
Motivated by this work, we combined rTMS and functional magnetic resonance 
imaging (fMRI) to further clarify the functional relevance of the left PMd in 
implementing prior sensory information into the scaling of grip force. We used 
continuous theta burst stimulation (cTBS) to mildly and transiently disrupt neural 
processing in the stimulated left rostral PMd (Huang et al., 2005). In addition, 
participants underwent fMRI to map the lasting effects of cTBS on preparatory brain 
activity. During fMRI, subjects performed a grip-and-lift task in which an arbitrary 
visual pre-cue (S1) correctly (75%) or incorrectly (25%) predicted whether subjects 
had to lift a heavy or light weight. A second visual cue (S2) which always correctly 
predicted the object weight triggered subjects to perform the grip-and-lift task. 
Subjects were asked to prepare for the task based on the information given by the 
S1 cue. When S1 and S2 cues were incongruent, subjects had to re-adjust the 
prepared grip according to the S2 information. 
The study was designed to test several hypotheses: 
(i) At the behavioural level, we reasoned that the prior knowledge about the weight 
provided by S1 would interfere with optimal anticipatory grip force control, if S1 and 
S2 were incongruent. We expected a relative overshoot or undershoot of grip force, 
when subjects wrongly prepared to lift a heavy or light weight, respectively.
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with their right dominant hand (for details see below). After participants were 
familiarized with the motor task, cortical excitability of the left primary motor hand 
area (M1HAND) was probed with single-pulse TMS of left M1HAND. We then applied 
either “real” or “sham” cTBS to the left rostral PMd. For “real” TBS (intervention 
(ii) We postulated that the regional BOLD signal in PMd should reflect anticipatory 
coding of predictive information given by the S1 pre-cue (Chouinard et al., 2005, 
Christensen et al., 2007, Schubotz, 2007, Ward et al., 2010). Specifically, we 
hypothesized that the level of sustained BOLD activity in PMd during the S1-S2 
period should indicate the relative strength of grip force anticipation triggered by 
the S1 cue and thus, should predict the magnitude of inappropriate grip force 
scaling in trials were S1 and S2 cues were different. 
(iii) Regarding the disruptive effects of cTBS, we predicted that real cTBS would 
impair the anticipatory force scaling in the stimulated left PMd, resulting in a 
reduction of relative grip force overshoot and undershoot in trials with different S1 
and S2 cues. Likewise, the preparatory activity of the stimulated PMd should no 
longer predict the grip force behavior after real cTBS of left PMd. Finally, we 
expected that the disruptive effect of cTBS on anticipatory force control in rostral 
PMd might be compensated by changes in preparatory activity in the rostral part of 
the supplementary motor area (SMA), which is also involved in conditional response 
selection based on arbitrary sensori-motor associations (Kurata et al., 2000). 
Materials & Methods
Participants
Eleven healthy male humans (age 27 ± 6.5 years; mean ± SD) without neurological 
or psychiatric history participated. Subjects were recruited from the student 
population of the University of Kiel and were naïve to the purpose of the study. 
Participants were consistently right-handed according to the Edinburgh handedness 
inventory.(Oldfield, 1971) The experimental procedures were approved by the local 
ethics committee of the Christian Albrechts University. Written informed consent 
was obtained prior to the study.
Experimental design
We used fMRI to assess the conditioning effects of inhibitory cTBS on regional 
neural activity during motor preparation (Figure 1). Each participant underwent two 
experimental sessions in a counterbalanced order. The experimental sessions were 
identical apart from the cTBS protocol, which used either a biologically real or a 
very low, sham intensity of stimulation. At least seven days separated the two 
sessions to exclude carry-over effects of TBS conditioning.
Figure 1A illustrates the order of the experimental procedures. At the beginning of 
each experimental session, participants were intensively trained on the experimental 
grip-and-lift task, first outside and then inside the MR scanner, for approximately 20 
minutes. The experimental task required participants to grasp and lift a manipulandum 
Figure 1   Experimental design. 
(A) Time line of the experimental procedures. See methods section for further details. 
TMS/MEP = Measurements of motor evoked potentials (MEP) with single-pulse 
transcranial magnetic stimulation (TMS) of left primary motor hand area. cTBS = 
continuous theta burst stimulation. fMRI = functional magnetic resonance imaging. 
(B) Visually guided grip-and-lift force task. During fMRI, subjects were presented with 
a S1 pre-cue (red color) and a S2 go-cue (green color) with a variable delay between 
S1 and S2. The cues were projected on the screen for 1 s, thereafter an orange or grey 
cross was projected during a jittered period of 2 s to 8 s. The shape of the stimulus 
indicated the weight to be lifted. A circle or a square predicted a light (100g) or a heavy 
(250g) weight. In 75% of the trials the preparatory S1-cue correctly predicted the S2 
cue. Depending on the combination of S1 and S2 cues, there were two trial types with 
correct pre-cue (HH = heavy-heavy and LL= light-light) and two trial types with 
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(100 g), while a red square prompted subjects to prepare for grasping and lifting a 
heavy weight (250 g) (Figure 1B). An orange cross appeared in the center of the 
visual field after the S1 cue. Participants were asked to fixate the cross and prepare 
for the grasp-and-lift task. The cross was presented for 2 to 8 s, and stimulus 
duration was pseudorandomly varied from trial to trial, resulting in a variable 
preparatory S1-S2 period. 
At the end of the preparatory period, a symbolic target cue was centrally presented 
for 1s. Again, there were two S2 cues: a green circle instructed participants to grasp 
and lift the light weight, whereas a green square prompted subjects to grasp and 
lift the heavy weight (Figure 1B). Participants were asked to lift the manipulandum 
2 to 4 cm up and then put the manipulandum back on the platform. After the S2 
cue, a grey fixation cross was presented in the centre of the screen for a variable 
period which was jittered between 2 to 8 s in steps of 1 s. 
Participants were instructed to actively prepare for lifting the weight that was 
indicated by the S1 pre-cue and to grip and lift the device as fast and as accurately 
as possible in response to the S2 target cue. In 75% of the trials the preparatory 
S1-cue correctly predicted the S2 cue. Participants were explicitly informed about 
the predictive value of the S1 cue. Participants were informed that S1 would correctly 
predict the forthcoming weight in the majority of trials, and were instructed to lift the 
weight swiftly and as accurately as possible also in incorrectly pre-cued trials.
The experimental task resulted in four experimental conditions of interest. There 
were two conditions in which the S1 pre-cue and S2 target cue had the same 
shape. In these trials, the S1 pre-cue correctly predicted the weight that had to be 
lifted. Participants prepared for a heavy lift and then lifted the heavy weight (referred 
to as “HH” condition) or they prepared for a light lift and lifted the light weight 
(referred to as “LL” condition). In the remaining two conditions, the S1 and S2 
pre-cue differed in shape and thus, the S1 cue was incorrect. Here the S1 pre-cue 
either triggered the preparation for a light lift, but the S2 target cue indicated a 
heavy lift (referred to as “LH” condition) or the S1 pre-cue indicated a heavy lift, but 
subjects were then instructed to lift the light weight (referred to as “HL” condition). 
There was also a fifth experimental condition which served as low-level control 
condition. In these “control trials”, a blue diamond was presented as S1 and S2 cue 
in the center of the screen (Figure 1B). These cues were of no behavioral relevance. 
Participants had only to lay still and watch these cues without preparing for or 
performing any grip or lift. 
Functional magnetic resonance imaging
The fMRI measurements were split in two consecutive runs. Each fMRI run included 
40 grasp-and-lift trials (10 trials per experimental condition) and 15 control trials 
which were intermingled in a pseudorandom order. A single run lasted for 11 min. 
condition), stimulus intensity was set at 80% of active motor threshold (AMT), 
whereas intensity was reduced to 30% of individual AMT during “sham” TBS (control 
condition). Otherwise, the cTBS protocols were identical. 
After cTBS conditioning, participants rested for five minutes without moving their 
hands or feet. We introduced this resting period because previous studies showed 
that short periods of voluntary motor activity shortly before or after cTBS can 
modulate the conditioning effects of cTBS on cortical excitability.(Huang et al., 
2005, Gentner et al., 2008) After the five-minute resting period, single-pulse TMS 
was again applied to left M1HAND and MEPs were recorded from right FDI muscle to 
capture acute TBS-induced changes in corticospinal excitability (post-cTBS1 
measurement). Participants were then taken to the MR scanner and fMRI started 
approximately 15 min after the end of cTBS. Participants performed a grip-and-lift 
task with their right hand during fMRI. The experimental session was completed by 
measuring cortical excitability with single-pulse TMS over the left M1HAND (post-cTBS2 
measurement) in the TMS laboratory. The post-cTBS2 measurement started 
approximately 55 min after the end of TBS.  
Pre-cued grasp-and-lift task
During fMRI participants carried out a grasp-and-lift task which required precision 
grips with the right dominant hand (Figure 1B). An MRI-compatible custom-made 
force transducer (Dasch Instruments, Kiel, Germany) was used for the grasp-and-lift 
task. The transducer had two flat vertical grip surfaces (40 x 40 mm) spaced 28 mm 
apart which measured the isometric pinch force exerted between the pads of the 
thumb and index finger (spring excursion < 0.5 mm) and the load force. The grip 
surfaces were covered with thin felt.
Participants lay supine in the MR scanner with the left arm extended in a comfortable 
posture. The right arm was extended comfortably so that the right hand rested with 
a semi-prone posture on a custom-made platform that supported the force 
transducer. The force transducer was placed between the fingertip of the right 
thumb and index finger and could therefore be gripped and lifted without any 
elbow- or shoulder-joint movement. The lateral edges of the force transducer fitted 
smoothly in grooves of two vertically orientated aluminum bars, so that the device 
could easily move up and down without tilting. A weight of 100 or 250 g was fixed 
with a string to the lower end of the transducer. The weights could be changed 
between trials without the participant being aware of the change in weight. 
We employed an event-related fMRI paradigm. A single trial lasted on average 12 s 
and started with the presentation of a symbolic preparatory S1 cue which was 
presented in the center of a screen 15 cm above subjects’ visual field for 1 s. One 
of two S1 pre-cues was pseudorandomly presented from trial to trial (Figure 1B). A 
red circle instructed participants to prepare for grasping and lifting a light weight 
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100–250 µV peak-to-peak amplitude. MTs were determined by gradually decreasing 
and increasing the stimulus intensity in steps of 1% of maximum stimulator output. 
MEPs were recorded with surface electromyography (EMG). Ag–AgCl disc surface 
electrodes were attached over the right FDI muscle using a belly-tendon montage. 
Changes in  corticospinal excitability were assessed over the left M1HAND with 
single-pusle TMS using a stimulus intensity which elicited MEPs with approximately 
1 mV peak-to-peak amplitude in the right  FDI muscle. The stimulus intensity was 
determined at baseline in the real and sham TBS sessions and then kept constant 
across the entire experimental session. The reference electrode was placed at the 
wrist. EMG activity was continuously monitored using visual (oscilloscope) and 
auditory (speakers) feedback to ensure complete relaxation at rest and a constant 
level of EMG activity during tonic contraction. The raw EMG signals were amplified 
by 1000 (D360, Digitimer Ltd, Welwyn Garden City, Herts, UK), filtered between 20 
and 1000 Hz, and digitized at 5000 Hz per channel (CED Power1401, 16-bit-ADC; 
Cambridge Electronic Design, Cambridge, UK). The administration of TMS pulses 
as well as EMG data recording, storage, and analyses was performed with Signal 
software (Cambridge Electronic Design, Cambridge, UK). 
Continuous theta burst stimulation of left dorsal premotor cortex
We used cTBS for conditioning of left PMd because cTBS produces a lasting 
suppression of regional excitability in the stimulated cortex.(Huang et al., 2005) The 
cTBS protocol involved repeated administration of short high-frequency bursts. 
Each burst consisted of three pulses given at an inter-stimulus interval (ISI) of 20 ms 
(corresponding to a rate of 50 Hz). These high-frequency triple-pulse bursts were 
repeated every 200 ms. Theta burst stimulation was given to left PMd as a 
continuous train lasting for 40 s. The site for PMd stimulation was defined in relation 
to the “motor hot spot” with the coil being placed 2 cm anterior and 1 cm medial to 
the left M1HAND. This coil positioning procedure used the functionally localized 
M1HAND as anchor point and was adopted from Schluter et al. (Schluter et al., 1998) 
who used this coil positioning procedure to interfere with processing in left PMd 
during the selection of visually cued movements. In addition, this coil location 
closely corresponds to the probabilistic location of the rostral PMd (Picard and 
Strick, 2001). The intensity of real cTBS was set at 80% of the individual AMT 
(cTBS80%), for sham cTBS we used an intensity of 30% of the individual AMT 
(cTBS30%). The latter intensity was predicted to be ineffective in terms of inducing 
action potentials in the PMd. We opted for low-intensity cTBS rather than using a 
sham coil because we wished to induce somatosensory stimulation of the scalp 
during sham cTBS (Helmich et al., 2006).
There was always an examiner (BvN or CK) in the MR-room who changed the 
weights (100 and 250 g) from trial to trial. A cue which was only visible to the 
examiner indicated which weight was to be lifted in the next trial. 
MRI was performed on a 3.0 T Philips Achieva MR scanner with an eight-channel 
array head coil (Philips, Best, The Netherlands). Participants wore headphones for 
noise protection, and foam pads restricted head motion. We used a T2*-weighted 
gradient echoplanar imaging (EPI) sequence with an  echo time of 35 ms. The field 
of view covered the whole brain (230 x 230 mm) and a pixel size 2.9 x 2.9 mm. Each 
EPI volume was obtained within 3000 ms (repetition time) and comprised 36 axial 
slices with a voxel size of 2.9 x 2.9 x 3.0 mm and interslice gaps of 0.3 mm. We also 
obtained a whole-brain structural MRI dataset using a three-dimensional 
T1-weighted FLASH sequence (repetition time 7.7 ms, axial field of view: 230 mm, 
160 contiguous slices, voxel size 1 x 1 x 1 mm).
Measurement of corticospinal excitability with TMS of left M1HAND
Motor cortical excitability was assessed with single-pulse TMS over the left M1HAND 
using a biphasic pulse configuration and a figure-of-eight shaped ‘MC-B70’ coil 
with an outer diameter of 70 mm connected to a MagPro-100 stimulator (MagVenture, 
Farum, Denmark). TMS was applied while participants were comfortably seated in 
an armchair with the head stabilized by a neck rest. Both arms were supported by 
a cushion to facilitate complete relaxation of the arm and hand muscles. Subjects 
were instructed to relax but to keep their eyes open and fixate a wall two meters in 
front of them. 
The coil was positioned tangentially to the skull over the left M1HAND with the handle 
pointing backwards and laterally at an angle of approximately 45° to the sagittal 
plane. At this coil orientation, the second phase of the biphasic TMS pulse induces 
an electrical current in the brain tissue with a posterior-lateral to anterior-medial 
direction roughly perpendicular to the central sulcus which is optimal for evoking a 
motor response in the contralateral hand (Mills et al., 1992). 
We defined the scalp site where a single TMS pulse at slightly suprathreshold 
intensity consistently yielded maximal Motor Evoked Potential (MEP) in the right 
contralateral first dorsal interosseus (FDI) muscle. This “motor hot spot” was used 
as stimulation site for all TMS measurements and used as anchor point to define 
the site for TBS of the left PMd. To individually adjust the stimulus intensity, we 
determined the resting and active MT. We first determined the resting MT in the 
relaxed FDI muscle which was defined as the minimum stimulus intensity that 
produced an MEP of more than 50 µV in five out of 10 consecutive trials. We then 
measured the active MT defined as the lowest stimulus intensity at which MEPs 
were elicited in five out of 10 consecutive trials during tonic contraction of the FDI 
muscle at about 10% of maximum force level using a criterion for the MEP of 
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work, applied grip force was influenced by the weight of the previous trial. When the 
previous trial required a heavy lift, subjects showed a relative overshoot in peak 
grip force when lifting a light weight. Conversely, there was a relative undershoot in 
peak grip force, when a heavy lift followed a light lift. Critically, this effect was not 
influenced by the type of TMS being significant after sham cTBS: F(10)=38.49; 
p<0.001 and after real cTBS F(10)=22.19; p=0.001. 
Greenhouse-Geisser (GG) correction for non-sphericity was applied if necessary. 
Conditional on significant F-values, ANOVAS were followed by post-hoc two-sided 
paired-sample t-tests. Statistical threshold was set at P ≤ 0.05. Group data is given 
as mean ± standard deviation if not specified otherwise.
Analysis of motor evoked potentials 
Peak-to-peak amplitudes (mV) of the MEP recorded from the right FDI muscle  were 
measured trial-by-trial and mean MEP amplitudes were calculated for each block of 
measurements (NuCursor software, Sobell Department of Motor Neuroscience and 
Movement Disorders, Institute of Neurology, Queen Square, London, UK). Repeated 
measures ANOVAS were used to test for lasting effects of cTBS over left PMd on 
excitability of ipsilateral left M1HAND. The ANOVA model included the factors type of 
intervention (2 levels: real cTBS80% vs. sham cTBS30%) and block of measurement (3 
levels: baseline, measurements starting 5 and 55 min after TBS conditioning). 
ANOVAS were followed by post-hoc two-sided paired-sample t-tests conditional of 
significant F-values. For all analyses a significance level of P < 0.05 was applied 
after non-sphericity (GG) corection. 
Analysis of the fMRI data
The fMRI data were processed and analyzed using statistical parametric mapping 
(SPM) software (Wellcome Trust Centre for Neuroimaging, London, UK; http://www.
fil.ion.ucl.ac.uk/spm). The first two scans of each session were discarded to allow 
for steady-state magnetization. The remaining images were realigned to the first 
image and spatially normalized to MNI stereotactic space using a standard EPI 
template as implemented in SPM.  The normalized images were spatially smoothed 
with a Gaussian kernel of 9 mm full-width at half-maximum.
At the individual level, we constructed a general linear model which comprised both 
experimental sessions and took into account the factorial design. The presentation 
of the S1 onset pre-cue, the variable interval between S1 and S2 (i.e. preparatory 
period), and the onset of the S2 pre-cue were modeled separately for each of the 
five trial types (i.e., HH, LL, LH, HL, and control trials) using delta functions 
convolved with a hemodynamic response function (HRF). Based on this model we 
computed t-statistical maps which expressed regional changes in BOLD signal for 
experimental contrasts of interest for each voxel in the brain.
Data analysis
Analysis of grip and lift force data
The non-metallic custom-made force transducer (Dasch Instruments, Kiel, 
Germany) was connected to the computer based SC/ZOOM data acquisition and 
analysis system (Department of Physiology, Umeå University, Sweden) via a fiber 
optic connector. Grip and lift forces were sampled at a rate of 200 Hz. 
We focused our analysis on the initial changes in grip- and load force until the first 
peak to assess initial preparatory scaling of grip force (Figure 3). Four force 
measures were determined for each trial: (i) peak grip force (GF), (ii) peak load 
force (LF), (iii) peak rate of grip force (GFR), and (iv) peak rate of load force (LFR). 
We also calculated the reaction time (RT), which was defined as the time between 
the onset of the S2 target cue and the onset of increase in GF. Mean values of each 
measure were calculated for each of the four experimental conditions of interest 
(i.e. HH, LL, LH and LH). 
In a first step, we explored the patterns of normal task performance without 
perturbation of left PMd using only the data recorded after sham TBS30%. We 
computed separate two-factorial repeated measures of analyses of variance 
(ANOVA) with the factor weight (2 levels: 100 g vs. 250 g) and S1 validity (2 levels: 
correct vs. incorrect S1 precue) using GF, LF, GFR, LFR, and RT as dependent 
variable. We also performed an additional three-factorial ANOVA which included 
the factor type of intervention (2 levels: real cTBS80% vs. sham cTBS30%) to assess the 
conditioning effects of real cTBS80% on grip force control.
We were particularly interested in the behavioural consequences of an incorrect 
pre-cue on grasping and lifting. To this end, we calculated the ratio between the GF 
in incorrectly pre-cued and correctly pre-cued trials for each weight (GFHL/GFLL 
and GFLH/GFHH). The same ratio was also calculated for the other grip and lift force 
measures (i.e., GFR, LF and LFR). Using these ratios as dependent variables, 
two-factorial ANOVAs tested whether the absolute weight (2 levels: 100 g vs. 250 g) 
or the type of intervention (2 levels: real cTBS80% vs. sham cTBS30%) influenced the 
effect of the incorrect pre-cue on task performance. 
Previous grip force studies have consistently shown that the somatosensory 
Information acquired by a recent lift influences the predicive scaling of forces for a 
subsequent lift(Johansson and Westling, 1988, Gordon et al., 1993, Chouinard et 
al., 2005). Therefore, we performed supplementary two-factorial ANOVAs with the 
factor weight (heavy vs. light weights) and compatibility with previous lift (same 
weight vs. different weight) for the real cTBS and sham cTBS session. 
Prompted by the reviewers comment, we performed an additional analysis which 
assessed the impact of the last trial on grip force control. In agreement with previous 
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Within the two ROIs statistical threshold was set to p<0.001 (uncorrected). The 
spherical ROIs (14 mm radius) were placed into the left PMd and left rostral PMd, 
centered on MNI stereotactic coordinates (x = -24, y = -3, z = 54 for PMd and x = 
-9, y = 9, z = 51 for SMA) that correspond to published activation peaks during a 
visuomotor response selection task (van Eimeren et al., 2006). 
For left rostral PMd and rostral SMA, correction for multiple comparison was only 
performed for all voxels within the ROI. For all remaining voxels, statistical results 
were corrected across the whole brain. 
All statistical parametric maps are superimposed onto a T2-weighted structural MRI 
template provided by MRIcro (http://www.cabiatl.com/mricro/mricro/index.html). 
The voxels of the activation maps are color-coded according to their Z values and 
for illustrative purposes thresholded at an uncorrected p value of p < 0.01.
Results
Changes in corticospinal excitability in left M1HAND 
Real cTBS80% induced a sustained decrease in mean MEP amplitude in the right FDI 
muscle, which was not found after sham cTBS30% (Figure 2). A differential effect of 
the two rTMS protocols on corticospinal excitability in ipsilateral M1HAND was 
confirmed by the ANOVA, showing an interaction between type of intervention and 
block of measurement (F(2,20) = 9.62, p = 0.001). Post-hoc paired t-test revealed 
significant decrease of the MEP amplitude 5 min (t(10) = 5.123, p<0.001) and 55 
min after the end of real cTBS80% (t(10) = 4.64, p = 0.001), but no consistent changes 
after sham cTBS30%. 
There were no differences in resting MT, active MT or mean MEP amplitude at 
baseline between the two experimental sessions. This lasting decrease in 
corticospinal excitability in ipsilateral M1HAND was comparable to the inhibitory after 
effects that have been reported in previous 1Hz rTMS studies(Gerschlager et al., 
2001, Chouinard et al., 2003, Suppa et al., 2008). This inhibitory effect of real 
cTBS80% on M1HAND excitability did not correlate with the cTBS-induced changes in 
grip force undershoot, nor did it correlate with cTBS-induced changes in weight-
specific preparatory activity. This may be due to the fact that corticospinal excitability 
was assessed at rest, whereas the behavioral and fMRI measures were obtained 
during an active motor context during a pre-cued grip-and-lift task. 
Grip force control
All participants found the tasks easy to perform. Error rate was very low with less 
than 2 error trials per fMRI session and are not considered further. The validity of 
the pre-cue had consistent effects on task performance. Compared to correct 
Second level analysis tested for experimental modulations of the regional BOLD 
signal during the preparatory S1-S2 period. The data for the second stage of 
analysis comprised pooled parameter estimates for each contrast of interest across 
all subjects in a random effects analysis. Contrast images for each subject were 
entered into a one sample t-test for each contrast of interest to identify brain regions 
which increased their neuronal activity (as indexed by the BOLD signal) in the 
preparatory period between the S1 precue and the S2 target cue. Another t-test 
was computed to identify brain regions where the real cTBS80% protocol increased 
or decreased regional preparatory activity relative to the sham TBS30% condition. 
We also used a one-sample t-test for main-effects of brain activity during the 
different conditions. A paired t-test was calculated to test for weight specific brain 
activities during the preparatory phase for preparing to lift a heavy or light weight. 
The mean difference in grip force between the correctly  and incorrectly pre-cued 
trials for each weight were included in the analysis as covariate of interest to test 
whether inter-individual variations in preparatory brain activity during the S1-S2 
period correlated with inter-individual differences in the behavioural impact of the 
incorrect  pre-cue on task performance. 
In addition to rostral PMd, it has been shown that the rostral part of the SMA is also 
involved in conditional response selection based on arbitrary sensori-motor 
associations.(Sakai et al., 1999, Kurata et al., 2000) This raises the possibility that 
activity in rostral SMA might compensate for the disruptive effects of real cTBS80% 
on anticipatory force control in the stimulated left rostral PMd. Therefore, we used 
simple regression analysis to test whether the effects of real cTBS80% on anticipatory 
grip force control were less pronounced in subjects in whom real cTBS80% changed 
preparatory S1-S2 activity in rostral SMA. 
All t-tests carried out within SPM were one tailed and included all voxels within the 
brain. The height threshold for the resulting statistical parametric maps (t-score 
maps) was set at an uncorrected p-value of p< 0.01. All SPMs were transformed to 
the unit normal Z-distribution to create a statistical parametric map (SPM). P-values 
were corrected at the cluster level applying an uncorrected extent threshold of P < 
0.01. A custer that failed to meet the significance criterion but consisted of more 
than 50 contiguous voxels is reported as statistical trend if the peak voxel in the 
cluster exceeded an uncorrected P < 0.001. 
Since cTBS targeted the left rostral PMd and our experiment was specifically 
designed to explore the role of left PMd in the implementation of advance sensory 
information in movement preparation, the left rostral PMd was defined as a priori 
region of interest (ROI). The rostral SMA was defined as second ROI since we 
expected the rostral SMA to compensate for the lesion effect induced by real 
cTBS80% of left PMd.
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pre-cues, incorrect pre-cues resulted in longer mean reaction times (F(1,10)=14.9; 
p=0.003). Neither the absolute weight that had to be lifted nor the intensity of cTBS 
influenced mean RT. There were no significant interactions among the experimental 
factors that influenced mean RT.
Table 1 summarizes the group data for the grip force measures of interest. The 
weight that had to be lifted in a given trial had a consistent effect on all four force 
measures with higher force and force rate levels when subjects grasped and lifted 
the heavy weight (GF, GFR, LF,LFR; p < 0.001). The measurements during the 
control session in which we applied sham TBS at very low intensity revealed that 
the validity of the S1 pre-cue affected the force generation. Incorrect pre-cues 
produced opposite effects on force measures during heavy or light lifts: gripping 
and lifting a light weight was associated with a higher GF, GFR and LFR in incorrectly 
pre-cued trials (HL) than correctly pre-cued (LL) grip-and-lift trials (Figure 3; right 
Figure 2   Conditioning effects of cTBS to left PMd on corticospinal excitability 
in left M1HAND. 
Group data of relative changes in mean peak-to-peak amplitude of the motor 
evoked potentials (MEPs) normalized to the mean amplitude before the 
intervention. The filled squares give the MEP amplitudes after real cTBS80% of left 
PMd. The open diamonds represent the MEP amplitudes after sham cTBS30% of 
left PMd. The first post-cTBS measurement was  performed 5 minutes after the 
end of cTBS prior to fMRI. The second post-cTBS measurement was carried out 
after the end of the fMRI session (i.e., approximately 55 min after the end of 


















































































































































































































































































































































































































































































































































CHAPTER 6 ANTICIPATORY CODING OF GRIP FORCE
The same pattern emerged when comparing the ratios between incorrectly and 
correctly pre-cued trials (i.e., comparing the HL:LL ratio and LH:HH ratio). 
Paired-t-tests revealed highly significant differences between the two ratios for 
GFsham, GFRsham and LFRsham (p < 0.001). Individual HL:LL ratios were mainly above 
1 reflecting the overshoot triggered by the incorrect “HEAVY” pre-cue. Conversely, 
individual LH:HH ratios were consistently below 1 reflecting the undershoot induced 
by the incorrect “LIGHT” pre-cue. With respect to the relative magnitude, the 
undershoot as indexed by the LH:HH ratio (Figure 4; black bars) was less 
pronounced compared to the overshoot as indexed by the HL:LL ratio (see figure 4; 
white bars).  Paired-t-tests revealed highly significant differences between the two 
ratios for GFsham, GFRsham and LFRsham (p < 0.001).
panel). In other words, the force profiles showed relative overshoot in force 
production when subjects had anticipated a heavy weight but had to lift a light 
weight in the HL condition. Conversely, participants consistently applied lower GF, 
GFR and LFR (i.e., undershoot) when gripping and lifting a heavy weight after the 
S1 pre-cue had wrongly announced a light weight (Figure 3; left panel). Hence, 
force profiles displayed a relative undershoot when subjects wrongly anticipated to 
lift a light weight in the LH condition. A repeated-measures ANOVA confirmed the 
relative undershoot (LH trials) and overshoot (HL trials) in force output. There was a 
significant interaction between the validity of the S1 pre-cue and the actual weight 
that had to be lifted for peak grip force (GFsham; F(1,10) = 21.9; p = 0.001), peak grip 
force rate (GFRsham; F(1,10) = 26.7; p < 0.001) and peak lift force rate (LFRsham; 
F(1,10) = 5.8; p = 0.037). 
Figure 3   Impact of the validity of the pre-cue on the grip force curves. 
Mean gripforce (GF), gripforce rates (GF rate), loadforce (LF) and loadforce 
rates (LF rate) for the four different trial types of a representative subject. Normal 
lines indicate the correctly precued trials; the dotted lines represent the mean 
data of the incorrectly precued trials. The left panel depicts the mean data of 
trials requiring subjects to lift a heavy weight, while the right panel shows the 
mean data of trials requiring a light lift. Trial types according to S1-S2 sequence: 
HH = heavy-heavy, LL= light-light, LH = light-heavy, HL =heavy-light).
  
Figure 4   Effect of the validity of the pre-cue on grip and lift force. 
The white columns give the mean overshoot in force production caused by an 
incorrect S1 pre-cue indicating a heavy weight. The overshoot corresponds to the 
ratio between HL and HH trials. The black columns give the mean undershoot in 
force production caused by an incorrect S1 pre-cue indicating a light weight. The 
undershoot corresponds to the ratio between LH and LL trials. Trial types according 
to S1-S2 sequence: HH = heavy-heavy, LL= light-light, LH = light-heavy, HL 
=heavy-light). Error bars indicate standard deviation.  GF = grip force; LF = lift 
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Figure 5 plots the relative overshoot (HL:LL ratio) and undershoot (LH:HH ratio) of 
mean GF separately for the sessions in which real cTBS80% or sham cTBS30% was 
given to left PMd. While the relative overshoot was comparable between the two 
experimental sessions, there was a difference in the relative undershoot. Real 
cTBS80% of left PMd abolished the relative undershoot in LH trials when the pre-cue 
had incorrectly announced a light weight (t(10)=2.51, p = 0.031). In contrast, the 
relative overshoot in HL trials was not changed by real cTBS80% when an incorrect 
pre-cue had wrongly announced a heavy weight (p > 0.3). The individual changes 
in the magnitude of undershoot in LH trials did not correlate with the individual 
changes in corticospinal excitability after real cTBS80% (r=-0.12; p=0.72).
We tested whether the magnitude of the effect of S1-S2 discrepancy, as reported in 
Fig. 4, on force responses is entirely accountable for by S1, or whether the S1-S2 
discrepancy contributes to the execution of the force response planned by the 
same S1 weight cue. Paired-t-tests revealed highly significant differences (p < 
0.001) by directly comparing the gripforces (GF, GFR, LF and LFR) form HL vs HH 
and LH vs LL, indicating that the force response was not entirely planned based on 
the information provided by S1. The data rather indicate that the predictive 
information provided by S1 interfered with the information provided by S2, causing 
a response conflict.
A two-factorial repeated-measures ANOVA with the factor weight (heavy vs. light 
weight) and compatibility with previous lift (same weight vs. different weight) was 
performed to test whether the weight of the previous lift influenced predictive grip 
force control. In agreement with previous work (Johansson and Westling, 1988, 
Gordon et al., 1993, Chouinard et al., 2005), the ANOVA showed that grip force was 
influenced by the weight of the previous trial. When the previous trial required a 
heavy lift, subjects showed a relative overshoot in grip force when lifting a light 
weight. Conversely, subjects showed a relative undershoot in grip force force, when 
a heavy lift followed a light lift.
Critically, this effect was not influenced by the type of TMS being significant after 
sham cTBS: F(10)=38.49; p<0.001 as well as after real cTBS F(10)=22.19; p=0.001). 
Post-hoc paired T-tests revealed for the sham cTBS session a significant decrease 
in GF for heavy weights when the previous lift was a light weight (mean±SD 
11.89±4.0 N for previous heavy weight  and 11.28±3.9 N for previous light weight; 
t(10)=3.49; p=0.006) and a significant increase in GF for light weights when the 
previous lift was a heavy weight (mean±SD 5.39±3.0 N for previous light weight 
and 6.0±3.0 N for previous heavy weight; t(10)=5.35; p<0.006). Post-hoc paired 
T-tests revealed for the real cTBS session a significant decrease in GF for heavy 
weights when the previous lift was a light weight (mean±SD 11.62±3.5 N for 
previous heavy weight  and 10.82±3.5 N for previous light eight; t(10)=3.38; 
p=0.007) and a significant increase in GF for light weights when the previous lift 
was a heavy weight (mean±SD 4.73±2.0 N for previous light weight  and 5.8±2.6 
N for previous heavy weight; t(10)=3.62; p<0.005). 
Effect of premotor cTBS on anticipatory grip force control
We also tested whether real cTBS80% changed the pattern of task performance as 
opposed to performance after sham cTBS at 30% of AMT. A two-factorial repeated-
measures ANOVA including the factors force ratio (2 levels; HL/LL and  LH/HH) and 
type of intervention (2 levels, cTBS80% and sham cTBS30%) revealed a significant 
interaction between ratio and intervention only for GF (F(1,10) = 4.79; p = 0.05), but 
not for the other three variables. 
Figure 5   Effect of real cTBS80% of left PMd on maximal grip force. 
The white columns give the mean overshoot in force production (i.e., the ratio 
between HL and HH trials) caused by an incorrect S1 pre-cue indicating a heavy 
weight. The black columns give the mean undershoot in force production (i.e., 
the ratio between LH and LL trials) caused by an incorrect S1 pre-cue indicating 
a light weight. Compared to sham cTBS30%, real cTBS80% abolished the undershoot 
in maximal grip force caused by an incorrect “light-weight” cue. The asterisk 
denotes a significant difference of the pair-wise comparison at p <0.05. Error 
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Distinct clusters in left and right PMd, left supramarginal gyrus, as well as left and 
right medial intraparietal sulcus (IPS) showed significant greater activation when 
participants prepared for lifting the heavy weight as opposed to preparing for lifting 
the light weight (Figure 6B). The relative increase in preparatory activity for the 
heavy weight was significant in the left PMd (peak at x, y, z = -27, -15, 60; Z = 3.04, 
pSVC = 0.001). No cluster in the brain showed increased preparatory activity for the 
light-weight relative to the heavy-weight cue, even when applying a liberal threshold 
of p<0.01 (uncorrected). 
Preparatory activity in left PMd predicts undershoot in grip force
We hypothesized that in the absence of real cTBS80%, the level of preparatory activity 
in the left PMd would predict the behavioural impact of the incorrect S1 pre-cue on 
force generation. To test this hypothesis, we performed a second-level regression 
analysis based on the preparatory activity during the control fMRI session (i.e., after 
sham cTBS30%). In each subject, we calculated the mean LH:HH ratio of peak grip 
force during the control session which indicates the relative undershoot of grip 
force when lifting the heavy weight after having prepared to lift the light weight. 
Using the LH:HH ratio as covariate of interest, we found that the magnitude of 
preparatory activity (of light weights) in left rostral PMd correlated with the relative 
undershoot in maximal grip force in the LH condition (peak correlation at x, y, z = 
-30, -3, 54; Z=3.73, PSVC = 0.025). The greater the preparatory activity in left PMd, 
the greater was the relative undershoot in peak grip force when lifting the heavy 
weight after preparing to lift the light weight (Figure 7A). 
We performed the same type of regression analysis using the individual HL:LL ratio 
of peak grip force. The HL:LL ratio reflects the relative overshoot in grip force when 
lifting the light weight after having prepared to lift the heavy weight. In this analysis, 
inter-individual variations of preparatory activity in the left PMd did not correlate 
with inter-individual differences in the amount of overshoot. In contrast, preparatory 
S1-S2 activity in the caudal SMA showed a statistical trend towards a positive 
correlation with the individual overshoot in the HL condition (peak correlation at x, 
y, z = -9, -18, 54; Z = 3.92, Puncorrected < 0.001). The greater the preparatory activity 
in left caudal SMA, the greater the overshoot  in peak grip force when lifting the light 
weight after having prepared for lifting the heavy weight. This statistical relationship 
did not survive whole brain correction for multiple comparisons.
Preparatory brain activity after inhibitory theta burst stimulation 
of left PMd
The level of preparatory neuronal activity in left PMd was not altered by the real 
cTBS80% protocol compared to control cTBS30%. However, real cTBS80% of left PMd 
abolished the relationship between the preparatory activity in the stimulated left 
Preparatory brain activity triggered by the pre-cue
Analysis of the fMRI data acquired in the control session (i.e. after sham cTBS30%) 
revealed sustained increases in the preparatory period between the S1 pre-cue 
and S2 target cue in a large cluster covering a bilateral set of dorsal and mesial 
premotor areas. Increased BOLD signal levels were found in the SMA, caudal 
cingulate motor area, left and right PMd (Figure 6A). Regional peak activation in left 
PMd was located in the caudal portion of PMd (at x, y, z = -27, -21, 60; Z = 3.83), 
The rostral PMd (at x, y, z = -12, -9, 54; Z = 2.92; Psvc=0.002) and the rostral SMA 
(at x, y, z = -9, -21, 48; Z = 3.91; psvc<0.001). The subthalamic region was also 
activated bilaterally when participants prepared for the grip-and-lift task (Figure 6A).
Figure 6   Regional increases in BOLD signal during preparation (S1-S2 interval).  
(A) Main effect of preparation regardless of the weight indicated by the S1 pre-cue. 
The sagittal, coronal and axial slices show the regions that showed a increase in 
BOLD signal during the preparation of a lift (heavy and light). (B) Relative increases 
in BOLD signal during the preparation for lifting a heavy weight relative to preparing 
for lifting a light weight. The statistical parametric maps are based on the fMRI data 
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PMd and the behavioural effect of incorrect pre-cueing on force generation (Figure 
7B). In the control session with low-intensity cTBS30%, inter-individual variations of 
preparatory activity in left PMd predicted the behavioural effect of an incorrect 
“LIGHT” pre-cue on the undershoot in grip force (r = 0.85; P = 0.001), whereas 
preparatory activity in the stimulated left rostral PMd no longer predicted individual 
variations in the relative undershoot in LH trials after real cTBS80% (r = 0.24; P = 0.48). 
We examined whether inter-individual variations in the effects of real cTBS80% on 
anticipatory grip force control (i.e., the reduction in grip force undershoot in LH 
trials) were associated with inter-individual variations in cTBS80% induced changes 
in preparatory S1-S2 activity. Specifically, we were interested to test whether the 
inter-individual differences in cTBS80%-induced change of GF undershoot (i.e., 
change in LH:HH ratio) were correlated  with cTBS80%-induced changes in weight-
specific preparatory activation (i.e., preparatory S1-S2 activity for light lifts relative 
to heavy lifts). Given its  involvement in conditional response selection based on 
arbitrary sensory cues (Sakai et al., 1999, Kurata et al., 2000), we reasoned that real 
cTBS80% of left rostral PMd might trigger a compensatory increase in preparatory 
activity for light-weight lifts in rostral SMA and that this compensatory recruitment 
might vary across subjects. 
Confirming our hypothesis, a cluster in left rostral SMA (peak correlation at x, y, z = 
-6, 18, 54; Z = 3.32, PSVC < 0.001 and x, y, z = -15, 12, 57; Z = 2.99; PSVC = 0.001) 
showed a linear relationship between the cTBS effect on weight-specific preparatory 
activity and undershoot in LH trials (r=0.868; p=0.001; Figure 8): In subjects showing a 
relative increase in preparatory S1-S2 activity for light lifts (relative to heavy lifts) 
after real cTBS80%, real cTBS80% did not affect the undershoot in response to an 
incorrect S1 pre-cue (Figure 8). Conversely, real cTBS80% induced a clear reduction 
in grip force undershoot in those subjects showing no increase in preparatory 
S1-S2 activity for light lifts (relative to heavy lifts) (Figure 8). Additional clusters 
showing the same linear relationship were located in the left globus pallidus internus 
(peak at stereotactic coordinates x, y, z = -12, 3, 6 ; Z = 3.78 Punc < 0.001) and right 
medial prefrontal cortex (peak at x, y, z = 9, 57, 33; Z = 3.95; Punc < 0.001).
We also tested for a linear relationship between the individual decreases in MEP 
amplitude after real cTBS80% and preparatory activity during the task. The inter-indi-
vidual variation in MEP suppression did not correlate with individual changes in 
BOLD signal in the left rostral PMd during the preparatory period (r = 0.036; P = 
0.917).
Figure 7   Linear relationship between regional activation during motor 
preparation and the relative undershoot in maximal grip force in 
trails where an incorrect S1 pre-cue announced a light weight after 
(A) sham cTBS30% or (B) real cTBS80% of left PMd.  
(A) In the control session without effective cTBS, preparatory activity during the 
S1-S2 period predicted the individual undershoot in maximal grip force. The higher 
the preparatory activity in the left PMd, the larger was the undershoot in trials with 
an incorrect S1 pre-cue indicating a light weight. (B) This linear relationship was 
abolished after real cTBS80% of left PMd. The left panels show axial slices of the 
statistical parametric map for the linear relationship between preparatory activity 
and force undershoot. The corresponding scatter plots for the peak voxel in left 
PMd are presented on the right (x, y, z = -30, -3. 54). The parameter estimates of 
preparatory BOLD signal changes are plotted along the y-axis. The maximal grip 
force ratios (LH / LL trials) are displayed along the x-axis. The grey color marks the 
area with negative LH/HH force ratio (i.e., undershoot). The regression line gives 
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Discussion 
The experiments yielded three main findings. First, cTBS80% of left PMd selectively 
impairs anticipatory down-scaling, abolishing the grip force undershoot but not 
overshoot in trials with incorrect S1. Second, in the absence of cTBS80%, individual 
variations in preparatory activity of left PMd as triggered by a “light weight” cue 
predicted the relative grip force undershoot in LH trials. Third, this association 
between preparatory activity in left PMd and individual variations in grip force 
undershoot was cancelled by cTBS80% of left PMd. Taken together, these experiments 
offer the first demonstration that human left PMd contributes to anticipatory 
down-scaling of grip force based on arbitrary visual cues. 
Anticipatory grip force control based on arbitrary visual cues
Grip-and-lift tasks involving small objects have been used intensively to study the 
role of prediction on sensorimotor control (Flanagan et al., 2006, Johansson and 
Flanagan, 2009). Here, we used a novel S1-S2 paradigm in which predictive grip 
force control was informed by prior visual information based on arbitrary cues. In 
contrast to previous work (Chouinard et al., 2005), anticipatory force scaling was 
challenged by introducing a conflict between two “predictive” visual cues, an 
incorrect S1 pre-cue and a correct S2 go-cue, rather than by causing a conflict 
between an incorrect visual cue and somatosensory feedback during the task 
signaling the prediction error. Because the S2 go-cue was always correct, task 
performance always created somatosensory feedback that was concordant with 
the predictive visual information provided by this cue. However, including a S1 cue 
did not prevent the subjects to take the previous lift into account for the scaling of 
gripforce, therefore we propose that there are two scaling mechanisms which are 
reflected in the behavioural data (proprioceptive and visual), but cTBS80%  only 
influenced the visually cued interference and not the proprioceptive interference. 
These results are in line with previous data showing that the prioceptive information 
gained during the previous can be disturbed by inhibiting the primary cortex and 
that the visuomotor information is stored in the PMd(Chouinard et al., 2005). 
Although the S2 go-cue always provided the correct information about object 
weight, the incorrect S1 cue still interfered with anticipatory force control causing an 
undershoot (in case of an incorrect “light weight” pre-cue) or an overshoot (in case 
of an incorrect “heavy weight” pre-cue). This finding indicates that subjects actually 
used the S1 pre-cue for motor preparation. It further shows that the correct 
predictive information provided by the S2 go-cue was not sufficient to rapidly 
discard the inappropriate preparatory set evoked by the incorrect S1 stimulus. 
The longer reaction times after an incorrect S1 stimulus indicates that grip initiation 
was delayed in order to allow for partial reprogramming of grip force (Loh et al., 
Figure 8   Relationship between cTBS-induced change in force undershoot 
and weight-specific preparatory activity in left rostral SMA.  
Subjects in whom fMRI revealed a relative increase in preparatory S1-S2 activity 
for light lifts (relative to heavy lifts) after real cTBS80%, showed no or little change 
in grip force undershoot (LH / HH ratio) after real cTBS80%. Conversely, real 
cTBS80% induced a clear reduction in grip force undershoot in those subjects 
who showed an increase in preparatory S1-S2 activity for light lifts (relative to 
heavy lifts) after real cTBS80%. The axial slice (upper panel) illustrates the cluster 
in left rostral SMA showing a linear relation between cTBS-induced change in 
force undershoot and weight-specific preparatory activity. The corresponding 
scatter plot for the peak voxel in left rostral SMA is illustrated in the lower panel 
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pre-cues, anticipatory grip force control had to integrate the diverging visual 
information provided by the S1 and S2 cue. Our task enabled us to assess the 
specific involvement of PMd in anticipatory up- and down-scaling of grip force 
based on arbitrary visual cues. Extending previous work (Chouinard et al., 2005, 
Nowak et al., 2009), we show that a transient disruption of the PMd selectively 
impaired down-scaling of force if a visual mode of anticipatory control is reinforced 
by the paradigm. 
The preparatory S1-S2 period did not only require to prepare for the grip and lift, but 
also to withhold the grip until the appearance of the S2 go-cue. Application of the 
GABA antagonist bicuculline in monkeys to the PMd reduces the ability to withhold 
reaching movements of the contralateral limb in a visually guided reaching task 
(Sawaguchi et al., 1996). This raises the possibility that in the present study, regional 
PMd activity during the S1-S2 period was not only related to motor preparation but 
also to preventing a premature grip. This inhibitory activity should be larger in trials 
in which subjects prepared for a heavy lift. In fact, we found a higher level of S1-S2 
activity in left PMd when subjects prepared for lifting a heavy weight as opposed to 
a light weight. We hypothesize that in left PMd, inhibitory activity preventing a 
premature motor response prevailed in the S1-S2 period following a “heavy-weight” 
pre-cue, whereas preparatory activity coding the anticipated force dominated the 
S1-S2 period following a “light-weight” pre-cue. This would explain why S1-S2 
activity in PMd only predicted the relative force undershoot in LH-trials with an 
incorrect “light-weight” pre-cue, but not overshoot in HL-trials with an incorrect 
“heavy-weight” pre-cue. 
A recent electrophysiological study in two monkeys supports the notion that 
inhibitory processes in PMd might prevail during motor preparation (Kaufman et al., 
2010). Extracellular recordings were obtained from chronically implanted multi-
electrode arrays in contralateral PMd while monkeys performed a visuospatially 
instructed delayed reach task. Recordings revealed a significant rise in overall firing 
rate of inhibitory interneurons, but not pyramidal cells during the delay period. This 
raises the possibility that in our fMRI measurements, the BOLD signal increase in 
PMd during the S1-S2 period was mainly driven by a net increase in inhibitory 
activity.
We propose that one important role of the PMd is to prevent excessive motor activity 
during motor preparation and execution. Hence, when preparing for a heavy lift, 
PMd activity during the S1-S2 period is more concerned with preventing a premature 
grip. Conversely, the PMd is more engaged in preparatory down-scaling of the grip 
force level when preparing for a light lift. 
A similar effect, albeit not reaching significance, was also found for lift force control 
in the present study. Furthermore, several previous neuroimaging studies reported 
higher premotor activity, the less force had to be applied across a range of manual 
2010). Without a delay in reaction time, the undershoot (after an incorrect “light 
weight” pre-cue) and the overshoot (after an incorrect “heavy weight” pre-cue) 
might have been even higher. Interestingly, the relative overshoot caused by an 
incorrect “heavy weight” pre-cue in HL-trials was more pronounced in magnitude 
as opposed to the relative undershoot produced by incorrect “light weight” pre-cues 
in LH-trials. This might reflect a general bias of the motor system to apply too much 
rather than too little grip force in order to avoid dropping the object.
The variable delay between the S1 pre-cue and the S2 go-cue enabled us to 
dissociate preparatory activity in left PMd from event-related activity evoked by the 
visual cues, or by task performance itself. We reasoned that if left PMd codes the 
predictive information revealed by the S1 pre-cue, preparatory activity in left PMd 
should predict the behavioral consequences of an incorrect S1 pre-cue on force 
scaling. In fact, preparatory activity of left PMd predicted inter-individual variations 
in grip force undershoot following an incorrect “light weight” pre-cue. This was, 
however, not the case when an incorrect “heavy weight” pre-cue caused an 
overshoot in force scaling. Here it was the SMA rather than the PMd showing a 
correlation between preparatory activity and inter-individual variations in grip force 
overshoot in HL-trials. The results suggest that the left PMd is primarily concerned 
with predictive down-scaling of grip force, while other premotor areas such as the 
SMA might preferentially support predictive up-scaling of grip force in humans 
(Vaillancourt et al., 2007, Haller et al., 2009). 
Causal involvement of PMd in anticipatory force scaling
The transient dysfunction of left PMd (as induced by cTBS80%) impaired the ability to 
implement prior information given by the light-weight pre-cue into motor preparation. 
cTBS80% of left PMd abolished predictive grip force undershoot in trials with incorrect 
S1 without having any consistent effect on anticipatory up-scaling of grip force in 
response to a heavy-weight pre-cue. Further, cTBS80% abolished the relationship 
between preparatory PMd activity and individual variations in grip force undershoot. 
We infer that preparatory activity in PMd tunes the motor system towards low grip 
forces and thus prevents inappropriately high force levels.
Two previous rTMS studies showed that inhibitory rTMS applied over the left PMd 
impairs the ability to use arbitrary visual information for anticipatory force scaling in 
a grip-and-lift task (Chouinard et al., 2005, Nowak et al., 2009). Specifically, after 
1Hz-rTMS (Chouinard et al., 2005) or cTBS (Nowak et al., 2009), healthy subjects no 
longer used the weight information provided by the colour of the go-cue, but scaled 
their forces to the weight of the previous lift (Chouinard et al., 2005). In this study, 
the grip force task critically differed from the task used by Chouinard et al. (2005) 
and Nowak et al. (2009) in that the visual go-cue was always correct. This ensured 
that subjects used a visual mode of anticipatory force control. In trials with incorrect 
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response rules (Neubert et al., 2010). We therefore propose that in this study, a 
relative increase in preparatory activity of rostral SMA effectively compensated for 
the lesion effect induced in left PMd. This finding speaks against a strict functional 
segregation between lateral and medial premotor areas in predictive motor control. 
It suggests a gradual functional differentiation which enables the motor system to 
maintain functional integrity in the presence of a focal lesion by re-distributing 
neural activity between medial and lateral premotor areas. 
Our results further show that the ability to recruit the rostral SMA varied from subject 
to subject, resulting in a variable behavioural deficit. This observation highlights the 
potential of a combined neuroimaging-rTMS approach to identify individual differences 
in functional reorganisation at behavioural level. 
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tasks, including a power grip task (Ward and Frackowiak, 2003), index finger 
abduction(van Duinen et al., 2008), static precision grip (Kuhtz-Buschbeck et al., 
2001), and dynamic precision grip (Ehrsson et al., 2001). Therefore, it can be 
assumed that the involvement of PMd in down-scaling is not specific to the present 
paradigm, but generalises across all manual skills requiring a fine and flexible 
tuning of the motor output. 
In everyday life, we do not integrate two conflicting sources of predictive weight 
information when grasping and lifting an object. The ability to effectively rescale the 
motor output based on visual cues is more relevant to visually guided activities 
required by human-machine systems, for instance the manipulation of tools during 
minimally invasive surgery or performing a landing with an airplane.
In contrast to predictive force scaling based on arbitrary visual cues, cTBS80% over 
left PMd did not influence anticipatory force scaling based on the weight of the 
previous grip. Despite of the presence of a visual S1 pre-cue, the motor system still 
implemented the somatosensory information about the weight of the previous lift in 
anticipatory grip force control. This mechanism was not modified by premotor 
cTBS, suggesting that the stimulated left PMd does not play a crucial role in 
anticipatory grip force control based on the somatosensory information obtained 
during the previous lift. This notion is in good agreement with a previous TMS study 
(Chouinard et al. J Neurosci 2005) in which inhibitory 1Hz rTMS of left M1HAND but 
not 1Hz rTMS of PMd impaired predictive scaling of forces based on information 
acquired during a previous lift. Together, these findings suggest two complementary 
mechanisms of anticipatory grip force scaling based on arbitrary visual or 
somatosensory inputs with a selective involvement of the PMd in the former and the 
M1HAND in the latter.
Re-distribution of preparatory activity within premotor areas
The magnitude of the disruptive effect of cTBS80% over left PMd on predictive 
down-scaling of grip force correlated with a shift in preparatory S1-S2 activity in left 
SMA: cTBS80% did not affect predictive down-scaling, when SMA increased its 
preparatory activity for light-weight lifts (relative to heavy-weight lifts) after cTBS80%. 
Conversely, cTBS80% disrupted predictive down-scaling, when SMA was unchanged 
after cTBS80%. 
The putative role of the rostral SMA in motor control makes this region a plausible 
candidate for functional compensation: the rostral SMA is critical to conditional 
response selection based on learned rules (Sakai et al., 1999, Kurata et al., 2000, 
Donohue et al., 2008). It shows sustained activity during tasks requiring delayed 
rule-based responses and is engaged in producing appropriate and withholding 
inappropriate motor responses according to these rules (Mostofsky and Simmonds, 
2008), including the re-programming of actions based on changes in conditional 
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CHAPTER 7 COMPENSATORY ACTIVITY IN THE EXTRASTRIATE BODY AREA OF PARKINSON’S DISEASE PATIENTS
Abstract
Compensatory mechanisms are a crucial component of the cerebral changes 
triggered by neurodegenerative disorders. Identifying such compensatory 
mechanisms requires at least two complementary approaches: locating candidate 
areas using functional imaging; and showing that interference with these areas has 
behavioural consequences. Building on recent imaging evidence, we here use this 
approach to test whether a visual region in the occipito-temporal cortex - the 
extrastriate body area - compensates for altered dorsal premotor activity in 
Parkinson’s disease (PD) during motor-related processes. We separately inhibited 
the extrastriate body area and dorsal premotor cortex in 11 PD patients and 12 
healthy subjects, using continuous theta burst stimulation. Our goal was to test 
whether these areas are involved in motor compensatory processes. We used 
motor imagery to isolate a fundamental element of motor planning, namely subjects’ 
ability to incorporate the current state of their body into a motor plan (mental hand 
rotation). We quantified this ability through a posture congruency effect, i.e. the 
improvement in subjects’ performance when their current body posture is congruent 
to the imagined movement. Following inhibition of the right extrastriate body area, 
the posture congruency effect was lost in PD patients, but not in healthy subjects. 
In contrast, inhibition of the left dorsal premotor cortex reduced the posture 
congruency effect in healthy subjects, but not in PD patients. These findings 
suggest that the right extrastriate body area plays a compensatory role in PD by 
supporting a function that is no longer performed by the dorsal premotor cortex. 
Introduction
Neurodegenerative disorders are often associated with system-level compensatory 
phenomena, with behavioural impairments emerging from a cerebral balancing act 
between compensatory and degenerative processes: neurodegeneration starts 
several years before affected individuals start to display clinically visible symptoms, 
allowing for cerebral compensation to develop in unaffected brain areas (Braak et 
al., 2003, Palop et al., 2006). Characterizing cerebral compensatory phenomena is 
crucial for their potential therapeutic exploitation, and for understanding how 
different cerebral circuits can support the same function or yield the same output 
(Edelman and Gally, 2001). 
Parkinson’s disease (PD), a prototypical example of a neurodegenerative disorder, 
is characterized by degeneration of dopaminergic neurons in the substantia nigra 
pars compacta. This degeneration causes dopamine depletion and disrupts the 
function of both the basal ganglia and the connected neural circuits, e.g. the basal 
ganglia-thalamo-motor cortex circuit (Blandini et al., 2000). Disruption in this circuit 
eventually leads to motor deficits, clinically apparent as the classic symptoms of 
PD: akinesia, hypokinesia and bradykinesia (Berardelli et al., 2001). Observations 
in animal models of PD and in clinically unaffected humans at risk of developing PD 
(i.e. asymptomatic Parkin and PINK1 mutation carriers) have shown that, before the 
disease becomes symptomatic, compensatory mechanisms arise within the fron-
to-striatal circuit (Bezard et al., 2003, Buhmann et al., 2005, van Nuenen et al., 
2009). After clinical signs have become evident, compensatory mechanisms 
appear to engage circuits involving more posterior sensory regions (Sabatini et al., 
2000, Helmich et al., 2007). These changes might explain why PD motor deficits 
improve when external sensory cues are provided (Suteerawattananon et al., 2004, 
Azulay et al., 2006, Keus et al., 2009). Accordingly, we have recently shown that the 
right extrastriate body area (EBA), a visual region in the occipito-temporal cortex, 
showed stronger activity and connectivity with the left dorsal premotor cortex (PMd) 
when PD patients imagined moving their most-affected hand (Helmich et al., 2007). 
However, it remains difficult to prove that stronger EBA connectivity (as identified 
using functional imaging) is compensatory, rather than a collateral by-product of 
basal ganglia disinhibition. Further supportive evidence requires at least a second 
complementary approach: showing that interference with the candidate area 
identified by functional imaging has behavioural consequences.
We have used this approach to test the possibility that the EBA compensates for 
altered PMd activity in PD during motor-related processes. Specifically, we have 
used continuous Theta Burst Stimulation (Huang et al., 2005) to selectively inhibit 
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without moving their hands or feet. We introduced this resting period because 
previous studies have shown that short periods of voluntary motor activity shortly 
before or after cTBS can strongly modulate the conditioning effects of cTBS on 
cortical excitability (Huang et al., 2005, Gentner et al., 2008). Following this resting 
period, cortical excitability in left M1 was measured again to capture acute TBS- 
induced changes in corticospinal excitability. Thereafter, participants performed 
the motor imagery task again (384 trials). The experimental session was completed 
with a fourth measurement of cortical excitability with single-pulse TMS over the left M1. 
Motor imagery task
We asked participants to perform a hand laterality judgment task, i.e. a task that 
has been repeatedly shown to reliably evoke motor imagery (de Lange et al., 2006, 
Helmich et al., 2007). Participants were shown line drawings of one hand at a time, 
either left or right, with either the back or the palm of the hand in view. The left and 
either EBA or PMd to test their possible compensatory role in PD. We assessed the 
consequences of this interference on both corticospinal excitability and cerebral 
motor function. The latter was indexed through a validated motor imagery task that 
quantifies subjects’ ability to incorporate the current state of their body into a motor 
plan (de Lange et al., 2006, Helmich et al., 2007). This ability should be reduced if 
EBA or PMd play a compensatory role in PD. 
Materials and Methods
Subjects
Eleven PD patients (6 men, 52.0 ± 7.8 years, mean ± S.D.; table 1 for clinical 
 characteristics) and twelve healthy subjects (6 men, 61.3 ± 6.4 years; mean ± S.D.; 
t(21) = 2.912; p = 0.01) participated after giving informed consent according to 
institutional guidelines of the local ethics committee (CMO region Arnhem- 
Nijmegen, the Netherlands). Participants were consistently right-handed according 
to the Edinburgh handedness inventory (Oldfield, 1971). Before the experiment, the 
patients’ disease severity was assessed by one examiner (BFLvN) using the Hoehn 
and Yahr stages and the Unified Parkinson’s Disease Rating Scale (UPDRS; table 1). 
Patients were included if they had idiopathic PD, diagnosed according to the UK 
Brain Bank criteria by an experienced movement disorder specialist (BRB), with 
clearly right-lateralized PD symptoms. Exclusion criteria were: cognitive dysfunction 
(i.e. mini mental state examination <24), other neurological diseases (such as 
severe head trauma or stroke) and general exclusion criteria for TMS (such as 
epilepsy, pace-maker, implanted metal parts and cardiac arrhythmias). Patients 
were all studied twice with at least a one-week interval and off-medication with at 
least a 12 h withdrawal of medication (i.e. practically defined off-condition (Langston 
et al., 1992)). The whole experimental protocol involved 2 experimental sessions, 
with session order counterbalanced between participants. The experimental 
sessions were identical apart from the cTBS protocol which used either cTBS over 
the right EBA or the left PMd. At least seven days elapsed between the two sessions 
to exclude carry-over effects of TBS conditioning. Fig.1 (panel A) illustrates the 
order of the experimental procedures. At the beginning of each experimental 
session, participants were trained on the motor imagery task (192 trials and <10% 
of errors, see below for task description). Afterwards, cortical excitability of the left 
primary motor hand area (M1) was probed with single-pulse TMS of left M1, 
recording motor-evoked potentials (MEPs) from the right first dorsal interosseus 
(FDI) muscle. Following performance of a set of 384 motor imagery trials, cortical 
excitability in left M1 was measured again. Following application of cTBS to either 
the left PMd or the right EBA (40 seconds), participants rested for seven minutes 
Table 1  Clinical characteristics
Patient Gender Age (years) H&Y UPDRS-L UPDRS-R
1 W 54 1.5 1 12
2 M 46 1 0 3
3 M 69 2 1 7
4 W 50 1.5 1 7
5 M 41 1 0 5
6 M 46 1 3 10
7 M 65 1 1 6
8 W 52 1 0 7
9 W 52 2 1 9
10 M 54 1 0 5
11 W 53 2 4 13
Mean 6 men 52 1.4 1.1 7.6
S.D. 8 0.5 1.3 3.1
Eleven patients (6 men; age 52.0±7.8 years; mean±S.D.) with idiopathic Parkinson’s disease were 
tested in a practically defined off-state (i.e. more than 12 hours after having taken their last medication). 
All patients were consistent right-handers. Patients had markedly asymmetric symptoms lateralized to 
the right side of their body. UPDRS: Unified Parkinson’s Disease Rating Scale; H&Y: Hoehn and Yahr 
Rating Scale; M: man; W: woman.
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right hand drawings were identical mirror images. A hand drawing could be shown 
rotated from its upright position in either a counter-clockwise (CCW) or a clockwise 
(CW) orientation. For both orientations, four different rotations from 45° to 135° in 
steps of 30° were used, yielding eight different rotations. The stimuli were presented 
through a PC running Presentation software (Neurobehavioral systems, Albany, 
USA). They were projected onto a screen in front of the subjects. The subjects’ task 
was to report whether the hand drawing on display represented a left or a right 
hand by pressing one of the two buttons with the corresponding left or right foot. 
During the task, reaction times and error rates were measured. One experimental 
session consisted of 32 blocks. Each block consisted of 12 trials, which started with 
a fixation cross displayed for a variable interval (0.5-1.5 s), followed by the 
presentation of a hand drawing. After a response was provided (reaction time 
cut-off: 5 sec), the stimulus was replaced by the fixation cross for a jittered period 
of 0.5-1.5 seconds and then the next hand drawing was shown. On each trial, a 
different hand drawing was presented, pseudorandomly sampled from a set of 32. 
During the experiment, the posture of the subjects’ left and right hand was 
manipulated. At the beginning of each block, a text instructed the subjects to 
position their arms in one of four postures: (1) both hands with the palm up; (2) left 
hand palm up, right hand palm down; (3) left hand palm down, right hand palm up; 
(4) both hands palm down. The period during which this instruction was displayed 
had a fixed duration (5 sec) and was followed by a block of 12 trials. The posture 
effect was established by comparing the presented hand drawing and the actually 
instructed posture of the subject. The posture for a trial was coded as “matching” 
when the side of the hand (palm or back) and the laterality (left or right) of the hand 
drawing corresponded with the hand position of the subject. When the hand 
drawing and the hand position did not correspond, the posture for the trial was 
coded as “non-matching”. We also considered the influence of biomechanical 
constrains (BMC) on motor imagery performance. BMC were operationalized as 
the RT difference in mentally rotating a hand towards either an orientation lateral to 
the body axis (i.e. towards the extreme range of movement allowed by the arm 
joints) or towards an orientation medial to the body axis (i.e. towards a comfortable 
arm configuration). Lateral and medial orientations were coded as follows: CCW 
rotations (-135°, -105°, -75° and -45°) were averaged and recoded as a lateral 
orientation for left hands and a medial orientation for right hands; CW rotations (45°, 
75°, 105°, 135°) were averaged and recoded as a medial orientation for left hands 
and a lateral orientation for right hands. Participants were seated in front of the 
screen with their hands in a box (75 x 27 x 9.5 cm), so there was no visual feedback 
of the own hands. Before the start of the experiment, patients were trained until they 
could perform the task with an accuracy of at least 90% correct responses. 
Figure 1   Task setup.  
(A) Time line of the experimental procedures. MEP measurements were collected 
before and after performance of a motor imagery task. The task was performed 
before and after delivery of cTBS over PMd or EBA (on two different days). The 
MEP measurements taken before and after the first motor imagery task were 
combined into a single measure (“cTBS baseline”) for each experimental session. 
MEPs = motor evoked potentials; TMS = transcranial magnetic stimulation; 
cTBS= continuous Theta-Burst Stimulation; EBA=extrastriate body area; PMd= 
dorsal premotor cortex. (B) Motor imagery task. Participants had to judge whether 
the stimulus presented on a computer screen was a left or right hand, pressing 
one of two buttons with the corresponding left or right foot. Every 12 trials, subjects 
were instructed to assume a particular posture with their left and right hands. This 
manipulation of spatial congruency between the hand drawing and the current 
posture of the subject lead was coded as “matching” (left panel) when the side of 
the hand (palm or back) and the laterality (left or right) of the hand drawing 
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participants from the two groups performed the motor imagery task appropriately 
(before receiving cTBS), and whether they did so in a comparable manner. We 
analysed the influence of the factors GROUP (2 levels: CONTROL or PATIENT), 
LATERALITY (2 levels: RIGHT or LEFT), ORIENTATION (2 levels: LATERAL or 
MEDIAL), POSTURE (2 levels: MATCH or NONMATCH) and ROTATION (8 levels: 
from -135° to -45° and 45° to 135° in steps of 30°), by means of a five-way repeated 
measures ANOVA on RT collected during the baseline sessions. Second, we 
analysed how cTBS over EBA or PMd influenced overall reaction times and error 
rates, by assessing the effects of factors GROUP (2 levels: CONTROL or PATIENT), 
SESSION (3 levels: baseline, post-EBA session, post-PMd session) by means of 
two two-way repeated measures ANOVA’s on errors and RTs. Third, we tested 
separately the effect of biomechanical constraints (BMC) and hand posture (HP) 
on behavioural performance. Specifically, we tested the effect of factors GROUP (2 
levels: healthy subjects or patients), SESSION (3 levels: baseline, post-EBA session 
or post-PMd session) and POSTURE (match or non-match) or ORIENTATION 
(lateral or medial) on the RT using  two three-way repeated measures ANOVA’s. The 
Greenhouse–Geisser method was used to correct for non-sphericity. Alpha-level 
was set at p = 0.05.
Measurement and analysis of corticospinal excitability 
The physiological outcome measure of cTBS effects was corticospinal excitability, 
assessed with single-pulse TMS over the left M1 using a biphasic pulse configuration 
and a 70 mm diameter figure-of-eight shaped coil (Magstim Company Ltd., 
Whitland, Wales) connected to a Magstim Super Rapid stimulator (Magstim 
Company Ltd., Whitland, Wales). TMS was applied while participants were 
comfortably seated in an armchair. Both arms were supported by a cushion to 
facilitate complete relaxation of the arm and hand muscles. Subjects were instructed 
to relax but to keep their eyes open and fixate on a wall 1.5 meters in front of them. 
The coil was positioned tangentially to the skull over the left M1HAND with the handle 
pointing backwards and laterally at an angle of approximately 45° to the sagittal 
plane. At this coil orientation, the second phase of the biphasic TMS pulse induces 
an electrical current in the brain tissue with a posterior-lateral to anterior-medial 
direction roughly perpendicular to the 
central sulcus which is optimal for evoking a motor response in the contralateral 
hand (Mills et al., 1992). 
We defined the scalp site where a single TMS pulse at slightly suprathreshold 
intensity consistently yielded maximal Motor Evoked Potential (MEP) in the right 
contralateral FDI muscle. This “motor hot spot” was used as stimulation site for all 
TMS measurements and used as anchor point to define the site for TBS of the left 
Continuous theta burst stimulation of left PMd and right EBA
We used cTBS for conditioning of left PMd and right EBA because cTBS has been 
shown to produce a lasting suppression of regional excitability in the stimulated 
cortex.(Huang et al., 2005) The cTBS protocol involved repeated administration of 
short high-frequency bursts. Each burst consisted of three pulses given at an 
inter-stimulus interval (ISI) of 20 ms (corresponding to a rate of 50 Hz). These 
high-frequency triple-pulse bursts were repeated every 200 ms. Theta burst 
stimulation was given to left PMd as a continuous train lasting for 40 s. The intensity 
of cTBS was set at 80% of the individual AMT. In every subject, cTBS was delivered 
over the right EBA and over the left PMd in two different sessions with a minimal 
interval of seven days. The location in the first session was randomized, so in the 
first session half of the subjects and half of the patients had cTBS over the right EBA 
and the other subjects had cTBS over the left PMd. The site for left PMd stimulation 
was 2 cm anterior and 1 cm medial to the “motor hot spot” on the left motor cortex. 
The site for right EBA stimulation was determined on the basis of the following 
procedure. We performed a pilot in 5 subjects (4 men), in which the stereotactic 
coordinates of the right EBA, as obtained in Helmich et al. (Helmich et al., 2007) 
(MNI coordinates: [x y z] = [+46 -78 +6]) were mapped onto T1 structural scans of 
those subjects. Each individual right EBA location was then projected on the skull 
with a stereotactic image guidance system (Brainsight, Rogue Research, Montreal, 
Canada). This procedure revealed that the skull projection of the right EBA had a 
consistent location across the five subjects, namely 12 cm laterally and 7 cm 
posterior to the vertex (Cz). Accordingly, we used this skull-based coordinates to 
localize EBA in the participants tested in this study. For both simulation sites, the 
coil was positioned tangentially to the skull with the handle pointing backwards and 
laterally at an angle of approximately 45° to the sagittal plane (Urgesi et al., 2004, 
Urgesi et al., 2007).
Analysis of task performance
We considered two outcome measures of the effects of cTBS on PMd and EBA: 
one behavioural and one physiological outcome measure. The behavioural 
outcome was performance of the motor imagery task, and more specifically how 
motor features like biomechanical constraints and the current hand posture 
influenced reaction times. Behavioural data were analyzed using SPSS Statistics 
19.0. Incorrect responses (either wrong or no response) were excluded from further 
analysis. We considered reaction times (RT) of the correct responses (measured in 
ms) and number of errors (ERRORS, i.e. errors/total number of trials(%)). ERRORS 
and RT from both EBA and PMd pre-intervention sessions within each group were 
combined as a single baseline (paired-samples t-test on ERRORS and RT on these 
sessions did not reveal any significant difference). First, we tested whether 
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Results
Patients
The patients had markedly lateralized symptoms according the UPDRS (two- 
samples t-test: t(10)=9.8; p<0.001; table 1) and were in average 9.3 years younger 
than the healthy subjects (t(21)=2.9; p=0.01).
Behavioural performance at baseline 
Overall performance: Patients and healthy subjects performed the task accurately, 
with mean error rates and mean reaction times over all sessions that were 
comparable across groups (mean error rates ± S.E.M.: healthy subjects: 2.3±0.7%; 
patients: 3.3±1.1%; 2-samples t-test: t(21) = -0.407; p = 0.688; mean RT± S.E.M. 
healthy subjects: 1257±81 ms; patients: 1194±97 ms; 2-samples t-test: t = 0.505; 
p = 0.619).
Mental rotation performance: RTs changed as a function of stimulus rotation (main 
effect of ROTATION: F(7,19)=32.38; p<0.001) and this effect was comparable 
across groups (interaction GROUP X ROTATION: F(7,2)=0.40; p=0.636; Fig. 2; 
panel A). RTs increased also as a function of LATERALITY (F1,11)18.82; p=0.001), 
ORIENTATION (F(1,11) =42.71; p<0.001) and POSTURE (F1,11)=20.85; p=0.001). 
There were no significant interactions of GROUP with other factors (p>0.1). These 
findings are in line with previous studies and it implies that both patients and healthy 
subjects were engaged in motor imagery, taking the current position of their hand 
and the biomechanical constraints of their joints into account when solving the 
hand laterality judgement task (de Lange et al., 2006, Helmich et al., 2007).
Behavioural changes induced by cTBS
Overall performance: There were no significant between groups differences in error 
rates and RT before the cTBS intervention (baseline session). The mean error rate 
did not significantly change between sessions (main effect of SESSION: 
F(2,18)=4.29; p=0.32) and there were no significant between-sessions differences 
across groups (SESSION X GROUP interaction: F(2,15)=0.013; p=0.970). The 
mean RT changed between sessions (main effect of SESSION: F(2,19)=18.39; 
p<0.001), indicating a time-related effect that, importantly, did not differ between 
groups (GROUP X SESSION interaction: F(2,19)=0.43; p=0.653; Fig 2; panel B). 
Mental rotation performance: To assess whether cTBS altered movement-related 
processes, we considered how biomechanical constraints (BMC) and hand posture 
(HP) influenced cTBS effects on task performance. Given the presence of 
time-related effects across sessions (see previous paragraph), we focused these 
PMd. To individually adjust the stimulus intensity, we determined the resting and 
active MT. We first determined the resting MT in the relaxed FDI muscle which was 
defined as the minimum stimulus intensity that produced an MEP of more than 
50 µV in 5 out of 10 consecutive trials. We then measured the active MT defined as 
the lowest stimulus intensity at which MEPs were elicited in 5 out of 10 consecutive 
trials during tonic contraction of the FDI muscle at about 10% of maximum force 
level using a criterion for the MEP of 100–250 µV peak-to-peak amplitude. MTs were 
determined by gradually decreasing and increasing the stimulus intensity in steps 
of 1% of maximum stimulator output. 
MEPs were recorded with surface electromyography (EMG). Ag–AgCl disc surface 
electrodes were attached over the right FDI muscle using a belly-tendon montage. 
The grounding electrode was placed at the wrist. Electromyographic activity was 
continuously monitored using visual (oscilloscope) and auditory (speakers) EMG 
feedback to ensure either complete relaxation at rest or a constant level of EMG 
activity during tonic contraction. The raw EMG signals were filtered between 20 and 
1000 Hz, and digitized at 5000 Hz per channel (A/D converter; model Micro1401, 
Cambridge Electronic Design, Cambridge, UK). The administration of TMS pulses 
as well as EMG data recording, storage, and analyses was performed with Spike2 
software (Cambridge Electronic Design, Cambridge, UK). To measure corticospinal 
excitability we applied 20 pulses with a mean of 0.2 Hz (with random interstimulus 
intervals of 4, 5 or 6 seconds) and an intensity necessary to obtain a 1 mV MEP in 
the contra-lateral FDI. After baseline-recording this was repeated four times, before 
and after each motor imagery task (Fig 1; panel B).
Peak-to-peak amplitudes (mV) of the MEP recorded from the right FDI muscle were 
measured trial-by-trial and mean MEP amplitudes were calculated for each block of 
measurements (MATLAB  software, Mathworks, Natick, USA).  First, we conducted 
a paired-samples t-test for the MEPs for each group between the two pre-interven-
tion sessions. When there were no significant differences between the two pre-in-
tervention sessions we further combined them as one baseline mean for each 
group and each intervention. Repeated measures ANOVA was used to test for 
lasting effects of cTBS over left PMd or right EBA on excitability of ipsilateral left 
M1HAND. The ANOVA model included the factors GROUP (2 levels: HC or PD), 
INTERVENTION (2 levels: cTBSEBA or cTBSPMd) and BLOCK of MEASUREMENT (3 
levels: baseline, measurements starting 7 min after cTBS(cTBS1) or after last MI 
session (cTBS2)). ANOVA was followed by post-hoc two-sided paired-sample 
t-tests conditional of significant F-values. For all analyses a significance level of P 
< 0.05 was applied after non-sphericity (GG) correction. 
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analyses on differential RT effects sampled within the same experimental session. 
For each session, we considered the RT differences between lateral and medial 
hand orientations (BMC ΔRT) and the difference in RT between matching and 
non-matching hand postures (HP ΔRT). We found that cTBS over either EBA or PMd 
had opposite effects on the ability of patients or healthy subjects to incorporate 
their hand posture into imagined movements (GROUP x SESSION interaction on 
HP ΔRT: F(2,18)=7.52; p=0.005; Fig. 3). Paired-samples t-test revealed that in the 
PD group, EBA-cTBS significantly reduced the effect of hand posture on imagery 
performance in the PD group as compared to baseline (HP ΔRT: t(10)=2.55; 
p=0.029). In the control group, PMd-cTBS significantly reduced the effect of hand 
posture on imagery performance as compared to EBA-cTBS (HP ΔRT: t(11)=2.29; 
p=0.043; Fig 3).  This interaction was not driven by a speed-accuracy trade-off in 
the posture effects  (GROUP x SESSION x POSTURE interaction on error rate: F(2, 
20)=0.997; p=0.385).
Figure 2   Behavioural performance.  
(A) Response times (mean±S.E.M.) during the baseline sessions (marked as 
“pre” in table 1) as a function of group (healthy subjects or Parkinson disease 
patients) and stimulus rotation (as illustrated by the hand drawings). Response 
times changed as a function of stimulus rotation for both groups. (B) Response 
times (mean±S.E.M.) as a function of group (healthy subjects or Parkinson 
patients) and experimental session (baseline, after cTBS over EBA, and after 
cTBS over PMd). Response times decreased after either cTBS interventions, 
similarly for both groups.
  
Figure 3   Behavioural performance: effects of cTBS.  
Panel A: Differences in response times (RT; mean in ms±S.E.M.) between trials 
with non-matching and matching configurations between subjects’ own hands 
and hand drawings on display (posture congruency effect). Data are shown as a 
function of group and experimental session. cTBS over PMd reduced the posture 
congruency effect in the healthy control group. cTBS over EBA reduced the 
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paired-samples t-test revealed a significant decrease in MEPs for the PD group in 
the first post-PMd session compared to the baseline measurements, but not for the 
healthy healthy subjects (healthy subjects: p=0.195; PD patients: p=0.027; Fig. 4) 
and an increase in MEPs for the healthy control group after the motor imagery task 
after cTBS over PMd compared to the baseline measurements, but not for the PD 
patients (healthy subjects: p=0.028; PD patients: p=0.119; Fig. 4). There were no 
significant differences after cTBS over EBA for both groups.
Discussion
We assessed a possible compensatory role of the EBA during motor imagery in PD 
patients, as suggested by a previous fMRI study (Helmich et al., 2007), by testing 
whether inhibition of this area (using cTBS) influences behavioural performance in 
PD. This was done by using a validated task that quantifies subjects’ ability to 
consider their current body posture when imagining a movement (de Lange et al., 
2006, Helmich et al., 2007). There are two main results. First, after inhibition of the 
right EBA, PD patients were unable to benefit from knowledge of their hand posture 
There were no significant between-group differential effects of cTBS intervention 
when considering biomechanical constraints (GROUP X SESSION interaction on 
BMC ΔRT: F(2,12)=0.056; p=0.878). These findings were confirmed in additional 
analyses performed on the absolute RTs (values shown in Table 2), showing that 
cTBS over either EBA or PMd had opposite effects on the ability of patients or 
healthy subjects to incorporate their hand posture into imagined movements 
(GROUP x SESSION x POSTURE interaction on RT: F(2,20)=17.78; p<0.001). 
Paired-samples t-test revealed that in the PD group, EBA-cTBS dismished the effect 
of hand posture on imagery performance in the PD (HP (match vs non-match): 
t(10)=-1.16; p=0.272) as compared to PMd-cTBS (HP (match vs non-match): 
t(10)=-3.27; p=0.008) and baseline (HP (match vs non-match): t(10)=-3.60; 
p=0.005). In the control group, PMd-cTBS dismished  the effect of hand posture on 
imagery performance (HP (match vs non-match): t(11)=-1.65; p=0.127) as 
compared to EBA-cTBS (HP (match vs non-match): t(11)=-3.13; p=0.010) and 
baseline (HP (match vs non-match): t(11)=-3.97; p=0.002). Again, there were no 
significant between-group differential effects of cTBS intervention when considering 
biomechanical constraints (GROUP X SESSION x ORIENTATION interaction on RT: 
F(2,20)=0.056; p=0.878).
Finally, there were no significant between sessions effects (SESSION on BMC ΔRT: 
F(2,15)=3.06; p=0.087; SESSION on HP ΔRT: F(2,20)=2.53; p=0.107) or laterality 
effects (HAND on BMC ΔRT: F(1,10)=1.06; p=0.328; HAND on HP ΔRT: F(1,10)=0.12; 
p=0.773). There were no significant interactions of HAND with other factors (p>0.1 
for all interactions).
It is possible that the altered task performance observed after cTBS over EBA in the 
PD group could be driven by an impairment of recognizing whether the hand picture 
shows a palm or a back view, rather than a visuomotor impairment. We tested this 
possibility with a three-way repeated measument ANOVA with the factors Group 
(healthy subjects or patients), Session (baseline or EBA or PMd) and hand 
orientation (Back or Palm) on RTs. These three factors did not significantly interact 
(F(2,220) =0.74; p=0.463) indicating that cTBS over EBA does not differentially 
impair the recognition of palm or back-views of hands in the two groups of subjects.
Motor Evoked Potentials (MEP)
The two baseline MEP measurements before cTBS were not significantly different 
within each of the two groups. This indicates that performing the task did not 
influence corticospinal excitability of the left M1. In both groups (PD and healthy 
subjects), and for both sites of stimulation (EBA and PMd), cTBS lead to an initial 
reduction of corticospinal excitability that was followed by increased corticospinal 
excitability after motor imagery performance (F(2,17)=5.0; p=0.023). Post-hoc 
Figure 4   Motor Evoked Potentials (MEPs).  
Relative change in mean peak-to-peak amplitude of the motor evoked potentials 
(MEPs), normalized to MEP amplitude measured at baseline. The first post-cTBS 
measurement (cTBS1) was performed 7 minutes after the end of cTBS, and before 
the onset of the motor imagery task. The second post-cTBS measurement (cTBS2) 
was performed after the end of the motor imagery task. cTBS = continuous theta 
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during motor imagery, as indicated by absence of a posture congruency effect (de 
Lange et al., 2006). The same intervention had no effect in healthy subjects. This 
suggests that, unlike healthy subjects, PD patients depend upon EBA for providing 
the motor system with an estimate of the current state of the body in space (derived 
from somatosensory information, given that subjects could not see their hands 
during the experiment). Healthy subjects did not require this compensatory activity 
from EBA or, alternatively, engaged other brain regions to compensate for the 
transient EBA alteration. Second, inhibition of the left PMd reduced the posture 
congruency effect in healthy subjects, but not in PD patients. We infer that, in PD, 
the PMd is functionally disconnected from the cerebral network incorporating the 
current state of the body in space into a motor plan. The right EBA apparently 
compensates for this PMd alteration, and this was supported by our finding that 
overall imagery performance was comparable between patients and healthy subjects. 
 
A compensatory role for the extrastriate body area in PD 
Inhibiting the right EBA prevented PD patients, but not healthy subjects, from 
integrating current estimates of the body state into a motor plan. This effect was not 
a consequence of EBA-driven changes in corticospinal excitability in either group. 
Yet, the present findings clearly indicate that the EBA can play a role in motor 
control, adding causal evidence to previous suggestions (Astafiev et al., 2004, 
Kuhn et al., 2011). More precisely, we show that PD patients use the EBA to estimate 
the current state of the body in space, a necessary requirement for specifying a 
motor plan suitable to achieve a desired end state (Shadmehr and Krakauer, 2008). 
It remains unclear how the EBA of PD patients can support this function. One 
possibility is that the EBA estimates the difference between desired and current 
body posture, integrating visual and somatosensory information (Zimmermann et 
al., 2011). In our study, subjects had no visual information about the current 
orientation of their hands, so PD patients would use the EBA for processing 
somatosensory information about body parts. However, it is unclear whether the 
EBA receives somatosensory information. Another possibility is that the EBA effects 
shown in this study reflect remote alterations conveyed from the EBA into parietal 
and premotor regions known to be involved in estimating the spatial configuration 
of the body (de Lange et al., 2006, Helmich et al., 2007). In this scenario, 
compensatory effects of EBA would arise from enhanced connectivity, rather than 
enhanced local activity. 
Dorsal premotor functionality in PD
Inhibiting the left PMd prevented healthy subjects, but not PD patients, from 
integrating current estimates of the body state into a motor plan. We draw three 
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This study builds on recent findings (Helmich et al., 2007), yet the two studies report 
different effects. However, these studies differs in a number of procedures, and 
those inconsistencies are likely related to different sensitivities of the outcome 
measures to different factors influencing performance of the imagery task. Helmich 
et al. (2007) focused on the effects of biomechanical constraints on metabolic 
indexes of cortical activity and connectivity. In contrast, the present study was 
designed for isolating behavioral effects related to the current body posture. 
Subjects changed their hand posture every 12 trials. This procedure reduced the 
chances of habituation of the posture congruency effect, and generated differential 
reaction time effects between posture-matched and un-matched conditions that 
were un-affected by time-related effects across experimental sessions. By the 
same token, this measure does not allow us to specify whether the present findings 
result from increased reaction times in the posture-matched condition or from 
decreased reaction times in the posture-unmatched condition. 
Another outstanding issue concerns the interference procedure, and in particular 
the largely unknown physiological effects of cTBS on diseased brains. Continuous 
TBS produces inhibitory effects when applied over different cortical areas (Franca 
et al., 2006, Huang et al., 2009, Volman et al., 2011). In this study, MEPs decreased 
immediately after cTBS over PMd in both the PD group (statistically) and in healthy 
subjects (numerically). Similarly, a recent study demonstrated that cTBS given to 
the right PMd of healthy subjects did not change the size of MEPs recorded from 
either left or right abductor pollicis brevis muscle (Stefan et al., 2008). In this study, 
MEPs increased in both healthy healthy subjects (statistically) and PD patients 
(numerically) after cTBS was followed by ~25 min of motor imagery. This effect fits 
with the well-known state-dependency of cTBS effects. For instance, one minute of 
voluntary contraction of a muscle, during or after cTBS, changes the size and 
direction of the TBS after-effects (Huang et al., 2008). This study suggests that 
motor imagery evokes similar cTBS after-effects as voluntary contractions, in line 
with the neurophysiological overlap between motor imagery and movement 
execution (Jeannerod and Frak, 1999, Cisek and Kalaska, 2004).
Conclusion
We have shown that patients with PD use a visual cortical area, the extrastriate 
body area, to influence the motor imagery network that encodes the current state 
of the body in space during the generation of a motor plan. This compensatory 
effect might be related to altered PMd functionality in PD, and it might be 
implemented through changes in long-range connectivity between EBA and PMd 
(Helmich et al., 2007). These findings provide causal evidence for the compensatory 
logically sensitive to cTBS (as indicated by an MEP reduction), but that intervention 
did not influence motor imagery performance. This finding suggests that the known 
hyperactivity of premotor areas in PD (Sabatini et al., 2000, Wu and Hallett, 2005) 
is more likely to be dysfunctional than compensatory in nature. Second, unilateral 
inhibition of the left PMd in healthy subjects is sufficient to alter their ability to 
incorporate the current state of their body into a motor plan, a strong confirmation 
of the known hemispheric dominance of this frontal region for supporting motor 
imagery (Haaland et al., 2004, de Lange et al., 2006, de Lange et al., 2008). Third, 
healthy subjects could not recruit compensatory circuits to supplement PMd 
alterations, as observed in PD patients. This observation suggests that the 
EBA-based compensatory mechanism found in PD might require time to develop. 
It is also possible to speculate that the compensatory role of the EBA becomes 
effective only once the PMd is functionally disconnected from the posterior parietal 
regions supporting the incorporation of the current body posture into a motor plan 
(de Lange et al., 2006). 
Interpretational issues
Matched performance between patient and control groups is an important 
pre-condition for isolating compensatory mechanisms (Price and Friston, 2002). In 
this study, both performance and cTBS effects on cortical excitability were matched 
across groups at baseline. There was a significant difference in age between 
groups, and it is possible that control subjects were more sensitive to cTBS 
stimulation over PMd than PD patients. Elderly subjects might have higher cerebral 
activation to compensate for age-related decline in functionality (Ramsoy et al., 
2011). However, it is unclear how the age difference alone could account for the 
double dissociation between behavioural consequences of cTBS on EBA and PMd 
across groups. 
It might be argued that motor imagery is a loosely defined phenomenon that could 
be solved using a variety of strategies and cerebral mechanisms. In fact, the char-
acteristics of the imagery task used in this study allow for specific inferences. 
Reaction times increased with increasing stimulus rotation for both hands, indicating 
that the participants used mental rotation to solve the task, in line with previous 
findings in healthy subjects (Parsons, 1987, 1994, de Lange et al., 2006) and PD 
patients (Dominey et al., 1995, Helmich et al., 2007). Reaction times were also 
sensitive to orientation of the stimulus with respect to the body axis, indicating that 
the participants imagined a movement with the same biomechanical constraints as 
their own hand. Moreover, reaction times were sensitive to the congruency between 
the orientation of the hand shown on the screen and the current posture of the 
subject’s (unseen) hand, indicating that the computations occurring during motor 
imagery incorporated the current state of the body.
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SUMMARY, OUTLOOK AND FUTURE PERSPECTIVES
Summary and outlook
This chapter discusses the main findings of this thesis, which aimed to provide 
different examples of cerebral reorganization in healthy controls and in subjects 
with premotor parkinsonism. We used a multimodal imaging approach, combining 
functional Magnetic Resonance Imaging (fMRI) and transcranial magnetic 
stimulation (TMS). Changes were observed both at the behavioral level (e.g. 
changes in grip force rate or reaction times) and locally in specific brain regions 
(e.g. altered task-related activity in the or extrastriate body area). In the next 
paragraphs, I will provide a summary and discussion of these findings. I will 
conclude this chapter with some perspectives for future research in this field.
Premotor parkinsonism
Next to the influence of environmental factors and aging, there is a strong genetic 
component to the pathogenesis of PD as described in chapter 2. In the last decade, 
several monogenetic forms of parkinsonism have been discovered, both recessive 
and dominant in nature. The recognition of asymptomatic carriers of mutations in 
these genes makes it possible to do research in these subjects, who are assumed 
to be in a premotor stage of the disease. Knowledge derived from these studies will 
give us a better understanding of the pathogenesis of PD, in both the premotor and 
motor phase of the disease. It is known that mutations in the Parkin (PARK2) and 
PINK1 (PARK6) genes can cause recessively inherited PD, as is discussed in more 
detail in chapter 3. The presence of a single Parkin or PINK1 mutation should 
theoretically not cause PD, but turns out to be associated with a mild but detectable 
dopaminergic nigrostriatal dysfunction (as can be detected using nuclear imaging 
of the dopaminergic system). Moreover, carrying such a single mutation in a 
recessive Parkinson gene conveys a mildly increased risk to develop PD, typically 
later in life. Therefore, neuroimaging of non-manifesting individuals with a single 
mutant Parkin or PINK1 allele opens up a window for the in vivo investigation of the 
premotor and very early phases of PD. Specifically, we outline that fMRI can be 
used to identify potential compensatory mechanisms that might help to delay 
development of clinically manifest disease. 
Premotor compensatory processes in PD
The first evidence for motor redistribution at a systems level in non-manifesting 
carriers of a heterozygous mutation in the Parkin gene was provided by fMRI 
(Buhmann et al., 2005). With internally cued movements, Parkin mutation carriers 
displayed a stronger activation of the right rostral cingulate motor area (rCMA) and 
left dorsal premotor cortex (PMd) compared with externally cued movement 
(Buhmann et al., 2005). They also showed stronger functional coupling between 
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In chapter 5, we extended these findings to a unique, large group of non-manifest-
ing LRRK2 mutation carriers. This study differed from the previous fMRI study 
(chapter 4) in two crucial ways: first, we used a well-established motor imagery 
paradigm which excluded the possibility that the altered cerebral activity was due 
to altered sensory feedback in the non-manifesting mutation carriers (Gierthmuhlen 
et al., 2010). Secondly, we focused on non-manifesting carriers of a mutation in the 
LRRK2 gene, which causes dominantly inherited PD and is the most frequent 
genetic cause of PD, particularly in those of Ashkenazi Jewish origin (Farrer, 2006). 
Importantly, the risk of developing overt PD is much higher (up to 80% at age of 70 
years (Healy et al., 2008)) in these LRRK2 mutation carriers, as compared to the 
previously studied non-manifesting carriers of a single mutation in a recessive gene 
(Parkin or PINK1 gene) (Clark et al., 2006, Park et al., 2006). Therefore, these 
dominant mutation carriers offer a much more powerful model of studying the 
functional phenotype at a brain network level, and offers further opportunities to 
study whether this adaptive plasticity is similar to the pattern observed previously 
in the mutation carriers in recessive genes. 
Several groups have actually explored these possibilities. For example, previous 
studies using transcranial sonography of the substantia nigra in manifesting and 
non-manifesting LRRK2 carriers showed substantia nigra signal changes, which 
were not substantially different from idiopathic PD (Bruggemann et al., 2011), 
suggesting the presence of intermediate nigrostriatal pathology that apparently 
appears on in the course of parkinsonism. Additionally, voxel based morphometry 
in 30 asymptomatic mutation carriers of four different genes associated with PD 
showed an increased grey matter volume mainly in the putamen in asymptomatic 
Parkin, PINK1 and ATP13A2 mutation carriers, and conversely an increased grey 
matter volume of the right caudate in the LRRK2 carriers (Reetz et al., 2010). 
In chapter 5, we addressed the question whether the latent nigrostriatal dysfunction 
caused by a mutation in the LRRK2 G2019S gene gives rise to cortical reorganization 
in the premotor phase, and whether this can be explained by anatomical differences 
in the human striatum. To this end, asymptomatic first-degree relatives of 
symptomatic patients with the LRRK2 G2019S mutation underwent high-resolution 
structural and functional MRI. During fMRI, the subjects performed a well-defined 
motor imagery task that involved mental rotation of hand pictures presented to the 
subjects, forcing participants to decide whether the projection displayed a left or 
right hand. A further manipulation involved a change in the subject’s own hand 
position during the experiment, because subjects use this position as a reference 
for mental rotation. We chose this approach since with use of this specific motor 
imagery paradigm cortical reorganization was previously shown in the right extrastriate 
the rCMA and posterior putamen during internal movement selection. Because 
mutation and non-mutation carriers performed the task equally well, these activity 
changes were attributed to an adaptive redistribution that helps to maintain motor 
function in the context of a latent nigrostriatal dysfunction. Chapter 4 extended this 
previous study. In the first fMRI study (Buhmann et al., 2005), the onset of each 
movement was externally paced at a low rate. Hence, movements were not 
sequentially performed but separated by periods of rest. The focus of that study 
was on motor circuits subserving the internal selection of each movement as 
opposed to external movement selection. In our study (chapter 4), participants 
quickly performed a brief “chunk” of three movements as indicated by external 
spatial cues. This task mainly probed neuronal circuits subserving the control of 
movement sequences rather than internal movement selection.
By using a “real” sequential task, we hypothesized that the study as described in 
chapter 4 would reveal a different regional pattern of motor reorganization relative 
to the first study in non-manifesting heterozygous Parkin mutation carriers. These 
regional “discrepancies” would confirm the hypothesis that there is no regionally 
fixed pattern of motor areas (i.e. no “default” pattern of motor reorganization). 
Furthermore, we studied adaptive redistribution of cortical activity within a 
pre-existing motor network in non-manifesting carriers of a single mutant allele in 
the Parkin or PINK1 gene. This enabled us to examine whether the patterns of 
compensatory recruitment of areas that subserve complex motor sequences were 
specifically linked to mutations in a specific gene. Given the closely related 
dysfunctional effects of mutations in both proteins in a drosophila model (Clark et 
al., 2006, Park et al., 2006), our prediction was that the functional phenotype at a 
brain network level would be similar for both groups. We indeed showed that when 
non-manifesting heterozygous carriers of a Parkin or PINK1 mutation perform a 
simple motor sequence task, both groups recruit areas that are not utilized by 
healthy controls without such a mutation, namely the pre-SMA and right rostral 
PMd. No convincing differences were found between the two groups of mutation 
carriers. These findings might also be a functional correlate of the increase in grey 
matter volume in the basal ganglia that was found in a comparable group of non-
manifesting carriers of a Parkin or PINK1 mutation using morphometric MRI 
(Binkofski et al., 2007). Taken together, these functional and structural MRI data 
suggest that non-manifesting heterozygous mutation carriers of a Parkin or PINK1 
gene produce a very similar functional and structural endophenotype. These 
findings imply that single heterozygous mutations in these two different genes have 
a similar impact on the human motor system, and suggest the human brain adapts 
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and individual variations in grip force undershoot was cancelled by cTBS of the left 
PMd. Taken together, these results provide converging evidence for a causal 
involvement of PMd in anticipatory down- but not up-scaling of grip force, 
suggesting an inhibitory role of PMd in anticipatory grip force control during object 
lifting.
Interference of cortical function using cTBS in  
Parkinson’s disease
Chapter 6 thus demonstrated that it is indeed possible to capture behavioural and 
functional changes after inhibiting a specific cortical region with cTBS. We were 
intrigued by a previous fMRI study that suggested that the EBA might have a 
compensatory role in PD patients during the generation of a motor plan (Helmich et 
al., 2007), which was later confirmed by us in non-manifesting LRRK2-carriers 
(chapter 5). Therefore, we conducted a new experiment where we inhibited this 
region with cTBS, in order to test whether this area is indeed involved in motor 
compensatory processes (chapter 7). The consequences of this intervention were 
assessed with a validated task, which was the same as used in chapter 5 and 
which quantifies the subjects’ ability to consider their current body posture when 
imagining a movement (de Lange et al., 2006, Helmich et al., 2007). There were two 
main results. First, inhibition of the right EBA made PD patients lose the performance 
benefits associated with having a body posture congruent to the imagined 
movement (posture congruency effect (de Lange et al., 2006)). The same 
intervention did not have any effect in a group of healthy subjects, indicating that in 
healthy subjects either EBA is not involved in providing the motor system with an 
estimate of the current state of the body in space, or that other brain regions can 
compensate for the transient EBA disruption. Second, inhibition of the left PMd 
reduced the posture congruency effect in healthy subjects, but not in PD patients. 
We infer that in clinically manifest PD, the PMd can no longer be recruited for this 
specific task and the right EBA compensates for this. In conclusion, the EBA 
influences the motor imagery network in PD patients that encodes the current state 
of the body in space during the generation of a motor plan.
Dorsal premotor functionality in healthy controls and 
Parkinson’s disease 
Inhibition of the left PMd with cTBS prevented healthy subjects, but not PD patients, 
from integrating current estimates of the body state into a motor plan during a motor 
imagery task. Three inferences can be drawn from these observations. First, the left 
PMd of PD patients was indifferent to cTBS during motor-related processes, an 
indication that the known hyperactivity of premotor areas in PD (Sabatini et al., 
2000, Wu and Hallett, 2005, Eckert et al., 2006) is more likely to be dysfunctional 
body area (EBA) and left dorsal PMd of patients with clinically overt PD (specifically, 
during mental rotation of the affected hand in right-sided affected PD patients) 
(Helmich et al., 2007). The new study presented in chapter 5 yielded three main 
findings. First, LRRK2-carriers and non-carriers were equally sensitive to the extent 
and biomechanical constraints of the imagined movements, and to the current 
posture of their own hands. This result validates the relevance of the motor imagery 
task: all subjects were effectively engaged in internally selecting motor representa-
tions, and any observed cerebral effects could not have been driven by 
between-groups differences in performance. Second, non-manifesting 
LRRK2-carriers had reduced imagery-related activity in the right caudate nucleus. 
This result indicates that non-manifesting LRRK2-carriers already have some form 
of functional impairment in the striatum. Furthermore, in contrast to the ventrolateral 
striatal alterations seen in idiopathic PD patients and in premotor carriers of Parkin 
and PINK1 (Binkofski et al., 2007, Reetz et al., 2008), the striatal impairment of non-
manifesting LRRK2-carriers arose in the caudate nucleus. Third, non-manifesting 
LRRK2-carriers had increased imagery-related activity in the right PMd, and 
increased effective connectivity between this region and the right EBA. This result 
suggests that the PMd might support compensatory activity through long-range 
connectivity with posterior sensory regions.
Interference of cortical function using cTBS in healthy controls
The next step after the identification of several premotor regions that play an 
important compensatory role in premotor parkinsonism, was to demonstrate the 
compensatory role of these regions by means of functional interferences. This was 
done with TMS, hypothesizing that inhibition of these regions would lead to 
measurable impairments in task performance. To determine that such functional 
interferences can indeed be mapped, we used a conditioning-and-map approach 
in 11 healthy men. This also allowed us to further clarify the role of PMd in anticipatory 
motor control (chapter 6), since it is known that the PMd uses prior sensory 
information for motor preparation (Picard and Strick, 1996, Passingham et al., 1998, 
Kurata et al., 2000, Toni et al., 2002, Amiez et al., 2006, van Eimeren et al., 2006). 
We transiently disrupted neuronal processing in left PMd, using continuous theta 
burst stimulation (cTBS; see figure 1.4). The conditioning effects of cTBS on 
preparatory brain activity were assessed with fMRI while participants performed a 
‘grip-and-lift’ task. The experiments firstly showed that cTBS of left PMd selectively 
impairs anticipatory downscaling, abolishing the grip force undershoot but not 
overshoot in trials with incorrect precue. Secondly, in the absence of cTBS, 
individual variations in preparatory activity of left PMd as triggered by a “light 
weight” cue predicted the relative grip force undershoot for incorrectly precued 
heavy-lift trials. Thirdly, this association between preparatory activity in the left PMd 
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Future perspectives
Functional neuroimaging studies, as reported in chapters 3 to 5, have given the 
first insights in the cerebral structures that are involved in premotor compensation 
strategies of the human brain in order to overcome the latent nigrostriatal 
dopaminergic dysfunction. The premotor regions seem to play a key role in these 
compensatory processes, which are more likely task-dependent rather than 
gene-dependent (chapter 4). An intriguing question is whether these increases in 
task-related activity in premotor areas persist, increase or attenuate in mutation 
carriers who are on the brink of developing clinical (motor) signs of parkinsonism. 
There are at least two competing explanations for the extra recruitment of premotor 
areas in these non-manifesting mutation carriers. It may be that among the mutation 
carriers, who have an increased risk for developing PD, the observed premotor 
changes reflect early premotor cortical alterations, i.e. an early manifestation of 
subtle alterations within the motor network. This intriguing possibility can only be 
confirmed through long-term follow-up of these subjects. Another possibility is that 
the motor network in these mutation carriers is simply different and as such 
unrelated to future development of PD. The cortical changes observed in these 
mutation carriers might therefore reflect, at least in part, an endophenotypic marker 
and not an early biomarker of PD. Longitudinal studies with repeated functional 
imaging are now needed to assess whether the observed cortical changes are 
predictive of PD during the premotor phase and if they are, whether these increase 
or attenuate when subjects develop clinical signs of PD.
When these longitudinal studies indeed show that the reorganization pattern in 
premotor areas is correlated with early PD and is not merely an endophenotypic 
marker, then fMRI protocols such as the ones described in this thesis might serve 
future diagnostic purposes. If we are able to identify subjects at risk for PD, fMRI 
can be used to determine the activity of regions involved in compensatory 
processes in the premotor phase. Moreover, quantification of activity within these 
regional activities during standardized tasks could provide metrics for stratifying 
the disease state. Such an approach is needed when starting to think about how to 
design and interpret future trials with, for example, disease modifying drugs or 
other treatments.
On top of this potential “diagnostic” use and the new insights in the pathophysio-
logy of PD, our results cautiously point to new treatment options for PD, for instance 
with TMS. In chapters 6 and 7, we used a relatively new rTMS protocol (cTBS) 
(Huang et al., 2005) to inhibit cortical areas and map the behavioral consequences 
of the intervention. With this method we showed that the cortical areas found 
rather than compensatory in nature. Second, unilateral inhibition of the left PMd in 
healthy subjects is sufficient to alter their ability to incorporate the current state of 
their body into a motor plan, a strong confirmation of the known hemispheric 
dominance of this frontal region for supporting motor imagery (Hlustik et al., 2002, 
Haaland et al., 2004, de Lange et al., 2006). Third, healthy subjects could not recruit 
compensatory circuits to supplement PMd disruption as observed in PD patients. 
This suggests that the EBA-based compensatory mechanism found in PD might 
require time to develop, or that the compensatory role of the EBA becomes effective 
only once the PMd is functionally disconnected from the posterior parietal regions 
that support the incorporation of the current body posture into a motor plan (de 
Lange et al., 2006).  Conversely, in the premotor phase of the disease, as studied 
in non-manifesting PARK-gene mutation carriers, we found an increased reliance 
on the PMd during simple motor tasks suggesting compensatory over-activity in 
order to overcome the (mild) nigrostriatal dopaminergic dysfunction. 
Previous neuroimaging studies in PD have consistently shown impaired movement-
related activation in distinct frontal motor areas in patients tested off their 
dopaminergic medication (Playford et al., 1992, Jahanshahi et al., 1995, Samuel et 
al., 1997, Buhmann et al., 2003, Mentis et al., 2003). For instance, the rostral SMA 
or right dorsolateral prefrontal cortex showed deficient activation during internal 
selection of movement onset (Jahanshahi et al., 1995) or the type of movement 
(Playford et al., 1992) in unmedicated PD patients. This relative hypoactivity in 
frontal motor areas could be partially reversed by dopaminergic therapy (Jenkins et 
al., 1992, Haslinger et al., 2001, Buhmann et al., 2003). In contrast to symptomatic 
PD patients, non-manifesting mutation carriers showed no relative decreases in 
frontal motor areas. It is possible that in these studies, the nigrostriatal dopamine 
depletion in these asymptomatic mutation carriers was below the threshold causing 
impaired movement-related activation of frontal motor areas. Alternatively, a normal 
or compensatory increased level of activation may be maintained by adaptive 
mechanisms that facilitate movement-related activity in frontal motor areas and 
effectively compensate for deficient cortical activation via the cortico-basal gan-
glia-thalamocortical motor loop. Whatever the cause, our findings lend further 
support to the notion that the clinical manifestation of parkinsonism ultimately 
results from a failure of compensatory mechanisms to maintain a sufficient level of 
movement-related activity in premotor areas (Bezard et al., 2003). 
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previously are indeed compensatory and engaged in generating a motor plan in 
PD. Future research should explore whether “boosting” these compensatory areas 
with rTMS protocols leads to improvement of motor and perhaps even cognitive 
symptoms of PD. We can expect to encounter a few problems on the way. The 
effects of rTMS are not focal to a particular cortical area, but spread to distant sites. 
Even at the site of stimulation, TMS as it is currently used activates a mixture of 
neural populations that use different neurotransmitters and that have different 
actions. In addition, the effects of rTMS are variable and depend on the prior history 
of brain activity, the pathological state of the networks stimulated, and any drugs 
that patients might be taking (Huang et al., 2008). These caveats are, however, not 
all negative. The spread of after-effects might be a useful way to target deep 
structures that are not directly accessible to TMS. Also, a mixture of neural effects 
in a functional circuit occurring both within and at a distance from the area of 
stimulation could produce a better effect than stimulation of just a small 
homogeneous population of neurons. A major problem is that most of the work in 
healthy subjects suggests that the duration of after-effects is short. Repeated daily 
sessions may lead to longer-lasting effects (Baumer et al., 2003) but, again, the 
effects will probably only be minor. So is it reasonable to assume that any sustained 
therapeutic benefit can be achieved? Finally, should we limit the parameters that 
are used in patient studies to those that have been deemed safe in healthy 
individuals? Similar to drug trials, we might need to test a wider range of stimulation 
parameters (‘dose finding’) if the benefit to risk ratio is sufficiently high.
192 193
8
CHAPTER 8 SUMMARY, OUTLOOK AND FUTURE PERSPECTIVES
Jenkins IH, Fernandez W, Playford ED, Lees AJ, Frackowiak RS, Passingham RE, Brooks DJ (1992) Impaired 
activation of the supplementary motor area in Parkinson’s disease is reversed when akinesia is treated 
with apomorphine. Ann Neurol 32:749-757.
Kurata K, Tsuji T, Naraki S, Seino M, Abe Y (2000) Activation of the dorsal premotor cortex and pre-supple-
mentary motor area of humans during an auditory conditional motor task. J Neurophysiol 84:1667-1672.
Mentis MJ, Dhawan V, Feigin A, Delalot D, Zgaljardic D, Edwards C, Eidelberg D (2003) Early stage 
Parkinson’s disease patients and normal volunteers: comparative mechanisms of sequence learning. 
Hum Brain Mapp 20:246-258.
Park J, Lee SB, Lee S, Kim Y, Song S, Kim S, Bae E, Kim J, Shong M, Kim JM, Chung J (2006) Mitochondrial 
dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441:1157-1161.
Passingham RE, Toni I, Schluter N, Rushworth MF (1998) How do visual instructions influence the motor 
system? Novartis Found Symp 218:129-141; discussion 141-126.
Picard N, Strick PL (1996) Motor areas of the medial wall: a review of their location and functional activation. 
Cereb Cortex 6:342-353.
Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiak RS, Brooks DJ (1992) Impaired mesial frontal 
and putamen activation in Parkinson’s disease: a positron emission tomography study. Ann Neurol 
32:151-161.
Reetz K, Gaser C, Klein C, Hagenah J, Buchel C, Gottschalk S, Pramstaller PP, Siebner HR, Binkofski F 
(2008) Structural findings in the basal ganglia in genetically determined and idiopathic Parkinson’s 
disease. Mov Disord.
Reetz K, Tadic V, Kasten M, Bruggemann N, Schmidt A, Hagenah J, Pramstaller PP, Ramirez A, Behrens MI, 
Siebner HR, Klein C, Binkofski F (2010) Structural imaging in the presymptomatic stage of genetically 
determined parkinsonism. Neurobiol Dis 39:402-408.
Sabatini U, Boulanouar K, Fabre N, Martin F, Carel C, Colonnese C, Bozzao L, Berry I, Montastruc JL, 
Chollet F, Rascol O (2000) Cortical motor reorganization in akinetic patients with Parkinson’s disease: 
a functional MRI study. Brain 123 ( Pt 2):394-403.
Samuel M, Ceballos-Baumann AO, Blin J, Uema T, Boecker H, Passingham RE, Brooks DJ (1997) Evidence 
for lateral premotor and parietal overactivity in Parkinson’s disease during sequential and bimanual 
movements. A PET study. Brain 120 ( Pt 6):963-976.
Toni I, Rowe J, Stephan KE, Passingham RE (2002) Changes of cortico-striatal effective connectivity during 
visuomotor learning. Cereb Cortex 12:1040-1047.
van Eimeren T, Wolbers T, Munchau A, Buchel C, Weiller C, Siebner HR (2006) Implementation of visuospatial 
cues in response selection. Neuroimage 29:286-294.







In dit hoofdstuk worden de belangrijkste bevindingen van dit proefschrift besproken, 
welke als doel had verschillende voorbeelden van cerebrale reorganisatie bij 
gezonde proefpersonen en bij personen met premotorisch parkinsonisme aan te 
tonen. We gebruikten hiervoor een multimodale aanpak, die bestond uit een 
combinatie van functionele Magnetic Resonance Imaging (fMRI) en transcraniële 
magnetische stimulatie (TMS). Veranderingen werden zowel op gedragsniveau 
(bijvoorbeeld wijzigingen in grijpkracht of reactietijd) als lokaal in specifieke 
gebieden van de hersenen (zoals veranderde taakgerelateerde activiteit in de 
dorsale premotorische cortex) waargenomen. In de volgende paragrafen zal ik een 
samenvatting geven van deze bevindingen, evenals een discussie tegen de 
achtergrond van de bestaande literatuur. Ik sluit dit hoofdstuk af met een aantal 
suggesties voor toekomstig onderzoek op dit gebied.
 
Premotorisch parkinsonisme
Naast de invloed van omgevingsfactoren en veroudering, is er een belangrijke 
genetische bijdrage aan de pathofysiologie  van de ziekte van Parkinson zoals 
beschreven in hoofdstuk 2. In de afgelopen tien jaar zijn verschillende mono- 
genetische vormen van parkinsonisme ontdekt, met zowel recessieve als dominante 
overervingsvormen. De herkenning van asymptomatische dragers met een mutatie in 
één van deze genen maakt het mogelijk om onderzoek te doen in deze personen, 
die zich mogelijk in de premotorische fase van de ziekte van Parkinson bevinden. 
De kennis die verkregen wordt uit deze studies geeft ons een beter begrip ten 
aanzien van de pathogenese van de ziekte van Parkinson, zowel in de premotorische 
als in de motorische fase van deze ziekte. Het is bekend dat mutaties in het Parkin 
(PARK2) gen of het PINK1 (PARK6) gen een erfelijk parkinsonisme kan veroorzaken 
met een recessief overervingspatroon, hetgeen in meer detail besproken wordt in 
hoofdstuk 3. De aanwezigheid van één Parkin of PINK1 mutatie zou theoretisch 
niet leiden tot parkinsonisme, maar blijkt geassocieerd te worden met een milde, 
maar detecteerbare dopaminerge nigrostriatale dysfunctie (zoals kan worden 
aangetoond met behulp van nucleaire beeldvorming van het dopaminerge 
systeem). Bovendien, een enkele mutatie in een recessief Parkinson gen brengt 
een licht verhoogd risico met zich mee voor het ontwikkelen van parkinsonisme, 
meestal op latere leeftijd. 
Beeldvormend onderzoek bij personen met één mutant Parkin of PINK1 allel maar 
zonder klinische kenmerken passend bij de ziekte van Parkinson, vormt een toegang 
tot in vivo onderzoek naar de premotorische en zeer vroege fase van de ziekte van 
Parkinson. Functionele MRI kan gebruikt worden om mogelijke cerebrale compensatie-
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We hebben aangetoond dat wanneer asymptomatische heterozygote dragers van 
een Parkin of PINK1 mutatie een eenvoudige motorische sequentiële taak uitvoeren, 
beide groepen bepaalde cerebrale gebieden meer activeren dan de gezonde 
controlegroep zonder een dergelijke mutatie. Hierbij gaat het om de supplementaire 
motorische cortex (pre-SMA) en de rostrale PMd aan de rechterzijde. Er werden 
geen overtuigende verschillen gevonden tussen de twee groepen mutatiedragers. 
Deze bevindingen zijn wellicht ook een functioneel correlaat van de toename van 
het volume van de grijze stof in de basale ganglia, dat gevonden werd in een 
vergelijkbare groep asymptomatische dragers van een Parkin of PINK1 mutatie met 
behulp van morfometrische MRI (Binkofski et al., 2007). Al deze functionele en 
structurele MRI-gegevens wijzen erop dat asymptomatische heterozygote 
mutatiedragers van een Parkin of PINK1 gen zeer vergelijkbare functionele en 
structurele endofenotypen bezitten. Deze bevindingen impliceren dat heterozygote 
mutaties in deze twee verschillende genen een vergelijkbare impact hebben op het 
motore systeem. Daarnaast suggereren deze bevindingen dat het humane brein 
zich aanpast in een ‘generieke’ manier wanneer er sprake is van een  mild 
presynaptisch dopaminerge laesie, ondanks verschillen in specifieke etiologie. 
 
In hoofdstuk 5 hebben we bovenstaande bevindingen ook onderzocht in een 
unieke, grote groep asymptomatische LRRK2 mutatiedragers. Deze studie 
verschilde van de vorige fMRI studie (hoofdstuk 4) in twee opzichten. Ten eerste 
hebben we een veelgebruikt “motorische verbeelding” paradigma toegepast dat 
de mogelijkheid dat de veranderde cerebrale activiteit te wijten is aan veranderde 
sensorische feedback in de asymptomatische mutatie dragers uitsluit (Gierthmuhlen 
et al., 2010). Bij motorische verbeelding stellen proefpersonen zich voor een 
beweging te maken zonder deze daadwerkelijk uit te voeren. Eerder onderzoek 
heeft aangetoond dat tijdens motorische verbeelding (grotendeels) dezelfde 
hersengebieden geactiveerd worden als tijdens echte bewegingen. Het voordeel 
van motorische verbeelding is dat het relatief gemakkelijk in de scanner te 
onderzoeken is. Proefpersonen kregen een plaatje te zien van een hand en moesten 
vervolgens aangeven of het een linker- of rechterhand was. Om deze vraag te 
kunnen beantwoorden, draaiden de personen in gedachten hun eigen hand in de 
oriëntatie van het plaatje. Dit proces heet “mentale rotatie” en is een manier om 
motorische verbeelding te onderzoeken. Ten tweede hebben we ons gericht op 
asymptomatische dragers van een mutatie in het LRRK2 gen, dat een dominant 
erfelijk parkinsonisme veroorzaakt en de meest voorkomende genetische oorzaak 
van parkinsonisme is, in het bijzonder in mensen van Ashkenazi Joodse origine 
(Farrer, 2006). Belangrijk hierbij is dat de kans op klinische symptomen van 
parkinsonisme veel hoger is (tot 80% op de leeftijd van 70 jaar (Healy et al., 2008)) 
bij personen met een mutatie in het LRRK2 gen in vergelijking met asymptoma-
mechanismen te identificeren, die de ontwikkeling van klinische symptomen van de 
ziekte vertragen.
Premotorische compensatie in de ziekte van Parkinson
Het eerste bewijs voor cerebrale reorganisatie in asymptomatische dragers van 
een heterozygote mutatie in het Parkin gen werd aangetoond met behulp van fMRI 
(Buhmann et al., 2005). Tijdens het uitvoeren van intern geselecteerde vingerbewe-
gingen vertoonden asymptomatische dragers van een Parkin mutatie een sterkere 
activiteit in het rostrale cingulate gebied (rCMA) en de linker dorsale premotore 
cortex (PMd) in vergelijking met extern (d.m.v. een aanwijzing) geactiveerde 
bewegingen. Deze groep toonde ook een sterkere functionele koppeling tussen de 
rCMA en het achterste deel van het putamen tijdens intern geselecteerde 
bewegingen. Omdat mutatiedragers en personen zonder mutatie de taak even 
goed uitvoerden is deze veranderde activiteit toegeschreven aan een motorische 
reorganisatie die leidt  tot een normale functie bij mutatiedragers ondanks de latente 
nigrostratiale disfunctie. Hoofdstuk 4 is een uitbreiding van deze eerdere studie. In 
de eerste fMRI studie (Buhmann et al., 2005) was het begin van iedere beweging 
extern aangegeven met een relatief laag tempo. Zo werden de bewegingen niet 
snel opeenvolgend uitgevoerd, maar van elkaar gescheiden door perioden van 
rust. Deze studie was gericht op de motore circuits die zorgdragen voor de interne 
selectie van elke beweging, in tegenstelling tot externe selectie van een beweging. 
In onze studie, moesten de proefpersonen zo snel mogelijk drie bewegingen achter 
elkaar uitvoeren; de volgorde werd vooraf aangegeven door externe spatiële 
aanwijzingen. Deze taak was vooral gericht op neuronale circuits die de controle 
van de extern aangestuurde sequenties beïnvloeden.
Door het gebruik van een “echte” sequentiële taak, was onze hypothese dat de 
studie zoals beschreven in hoofdstuk 4 een ander regionaal patroon van motore 
reorganisatie zou laten zien ten opzichte van het eerste onderzoek in asymptoma-
tische heterozygote Parkin mutatiedragers. Het aantonen van deze regionale 
‘verschillen’ zou bevestigen dat er geen standaard patroon van motore reorganisatie is. 
Daarnaast hebben we de adaptieve herverdeling van corticale activiteit in een 
bestaand motorisch netwerk bestudeerd in asymptomatische dragers van een 
mutant allel in het Parkin of PINK1 gen. 
Dit stelde ons in staat om te onderzoeken of de patronen van cerebrale compensatie 
worden gekoppeld aan mutaties in een specifiek gen. Gezien de nauwverwante 
disfunctionele effecten van de mutaties in beide eiwitten, zoals aangetoond in een 
Drosophila model (Clark et al., 2006, Park et al., 2006), was onze voorspelling dat 
het functionele fenotype op cerebraal niveau gelijk zou zijn voor beide groepen. 
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goed en op dezelfde manier de taak oplossen en dus dat de waargenomen 
cerebrale effecten niet kunnen worden verklaard door verschillen in de prestaties 
tussen de twee groepen. Ten tweede toonden LRRK2 dragers een verlaagde 
activiteit in de rechter nucleus caudatus tijdens toenemende rotatiehoeken van de 
gepresenteerde handen in vergelijking met de controlegroep. Dit bevestigt dat er 
tijdens de premotore fase van LRRK2 parkinsonisme reeds cerebrale veranderingen 
gaande zijn. In tegenstelling tot de veranderingen in het  putamen  die beschreven 
zijn bij de idiopathische ziekte van Parkinson en bij de premotore dragers van een 
Parkin of PINK1 mutatie (Binkofski et al., 2007, Reetz et al., 2008), lijken de striatale 
veranderingen bij de premotore LRRK2 mutatiedragers te beginnen in de nucleus 
caudatus.  
Ten derde lieten LRRK2 mutatiedragers in vergelijking met de controlegroep een 
toegenomen activiteit in de rechter PMd zien tijdens toenemende rotatiehoeken van 
de gepresenteerde handen, alsmede een verhoogde effectieve connectiviteit tussen 
deze regio en de rechter EBA. Dit resultaat suggereert dat de PMd kan compenseren 
door middel van een toegenomen connectiviteit met de posterieure regio’s.
 
Interferentie van corticale functie met behulp van cTBS bij 
gezonde controles
Het doel van het tweede deel van dit proefschrift was om de compenserende rol 
van deze eerder gevonden regio’s aan te tonen door actief te interfereren met de 
corticale activiteit. Hiervoor gebruikten we TMS. Onze hypothese was dat inhibitie 
van deze regio’s kan leiden tot meetbare veranderingen in de uitvoering van een 
(motore) taak. Hiermee konden we ook meer duidelijkheid krijgen over de rol van 
de PMd in de motoriek (hoofdstuk 6). We hebben hiertoe de linker PMd (tijdelijk) 
geïnhibeerd met continue theta burst-stimulatie (cTBS, figuur 1.4). De gecondition-
eerde effecten van cTBS op de hersenactiviteit die gebruikt wordt tijdens het 
voorbereiden van een beweging werden gemeten met fMRI, terwijl de deelnemers 
een ‘grip-and-lift’ taak uitvoerden. Uit deze experimenten bleek dat we inderdaad 
in staat waren gedragsmatige veranderingen teweeg te brengen door de PMd te 
inhiberen. De resultaten beschreven in dit hoofdstuk bieden meer bewijs voor een 
oorzakelijk betrokkenheid van de PMd in anticiperende ‘downscaling’ van 
grijpkracht, hetgeen wijst op een remmende rol van de PMd in anticipatie op 
grijpkracht in gezonde controles tijdens het optillen van objecten.
 
Interferentie van corticale functie met behulp van cTBS de ziekte 
van Parkinson
Hoofdstuk 6 heeft aangetoond dat het inderdaad mogelijk is om gedragsverand-
eringen en functionele veranderingen vast te leggen na inhibitie van een specifieke 
corticale regio met cTBS. We waren geïntrigeerd door een vorige fMRI studie, die 
tische dragers van een mutatie in één van de recessieve genen (Parkin of PINK1 
gen) (Clark et al., 2006, Park et al., 2006). Daarom zijn deze LRRK2 mutatiedragers 
een veel krachtiger model voor het bestuderen van het functionele fenotype op 
motorisch netwerk niveau. Daarnaast biedt deze groep de mogelijkheid om te 
onderzoeken of het patroon van deze motore reorganisatie vergelijkbaar is met het 
patroon dat eerder waargenomen werd in de Parkin- en PINK1-gen mutatiedragers. 
Verschillende onderzoeksgroepen hebben deze mogelijkheden al verkend. 
Bijvoorbeeld is in eerdere studies met behulp van transcraniële echografie van de 
substantia nigra bij asymptomatische LRRK2 mutatiedragers een veranderd signaal 
van de substantia nigra aangetoond, die niet wezenlijk verschilde van de 
veranderingen die met dit onderzoek gevonden worden bij patiënten met de 
idiopathische ziekte van Parkinson (Bruggemann et al., 2011). Dit suggereert de 
aanwezigheid van een intermediaire nigrostriatale pathologie die blijkbaar naar 
voren komt in het beloop van de ziekte. Daarnaast liet “voxel based morphometry” 
(VBM) in 30 asymptomatische mutatiedragers van vier verschillende genen 
geassocieerd met parkinsonisme een toegenomen grijze stof volume zien (vooral 
in het putamen bij asymptomatische Parkin, PINK1 en ATP13A2 mutatiedragers) en 
een verhoogde toegenomen grijze stof volume van de nucleus caudatus in de 
LRRK2 mutatiedragers (Reetz et al., 2010).
 
In hoofdstuk 5, hebben we de vraag gesteld of de latente nigrostriatale disfunctie 
veroorzaakt door een G2019S-mutatie in het LRRK2 gen aanleiding geeft tot 
corticale reorganisatie in de premotorische fase van de ziekte, en of dit kan worden 
verklaard door anatomische verschillen in het striatum. Hiertoe hebben asymptom-
atische eerstegraads familieleden van symptomatische patiënten met de LRRK2 
mutatie een hoge resolutie structurele en functionele MRI ondergaan. Tijdens fMRI 
voerde de proefpersonen een motorische verbeeldingstaak uit.
In tegenstelling tot de eerdere studie met motorisch verbeelding (Helmich et al., 
2007) voegden we nu een nieuwe manipulatie toe aan het experiment. Dit betrof 
een verandering van de handpositie van de proefpersoon zelf. Dit deden we 
meerdere malen tijdens de taak, omdat de proefpersonen de positie van de hand 
als referentie voor mentale rotatie zullen gebruiken. We kozen voor deze benadering, 
omdat tijdens eerder onderzoek het gebruik van deze specifieke motorische ver-
beeldingstaak een corticale reorganisatie te zien was in de “extrastriatale body 
area” (EBA) en de linker dorsale premotore cortex (PMd) in patiënten met een 
duidelijke klinische ziekte van Parkinson (Helmich et al., 2007). 
De nieuwe studie zoals gepresenteerd in hoofdstuk 5 leverde drie belangrijke 
bevindingen op. 
Ten eerste zagen we geen gedragsmatige verschillen tussen de LRRK2 mutatie-
dragers en niet-dragers tijdens de taak. Dit bevestigt dat alle proefpersonen even 
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om de geïnhibeerde PMd te compenseren zoals gezien werd bij de patiënten met 
de ziekte van Parkinson. Dit wijst erop dat de EBA bij de ziekte van Parkinson 
waarschijnlijk tijd nodig heeft om de compenserende rol te ontwikkelen of dat de 
compenserende rol van de EBA pas effectief wordt als de PMd functioneel 
losgekoppeld is van de achterste pariëtale gebieden van waaruit de huidige li-
chaamshouding geïncorporeerd wordt in het motorisch plan (de Lange et al., 
2006). Echter in de premotorische fase van de ziekte zoals bestudeerd in dragers 
van mutaties in Parkinsongenen, vonden we een verhoogde activiteit in de PMd 
tijdens eenvoudige motorische taken, wat pleit voor een compenserende 
overactiviteit om de (milde) nigrostriatale dopaminerge disfunctie te overwinnen. 
 
Eerdere neuroimaging studies bij de ziekte van Parkinson hebben consequent 
verstoorde bewegings-gerelateerde activatie laten zien van verschillende frontale 
motore gebieden bij patiënten die zonder dopaminerge medicatie getest werden 
(Playford et al., 1992, Jahanshahi et al., 1995, Samuel et al., 1997, Buhmann et al., 
2003, Mentis et al., 2003). Zo lieten bijvoorbeeld de SMA en de rechter dorsolaterale 
prefrontale cortex een verstoorde activiteit zien tijdens intern geselecteerde 
bewegingen in onbehandelde Parkinsonpatiënten (Playford et al., 1992, Jahanshahi 
et al., 1995). Deze relatieve verminderde activiteit in de frontale motorische gebieden 
kan gedeeltelijk worden teruggedraaid door dopaminerge therapie (Jenkins et al., 
1992, Haslinger et al., 2001, Buhmann et al., 2003). In tegenstelling tot symptomatische 
patiënten met de ziekte van Parkinson toonden asymptomatische mutatiedragers 
geen relatieve afname van activiteit in de frontale motorische gebieden. Het is 
mogelijk dat in deze studies de nigrostriatale dopaminerge depletie in de asymp-
tomatische mutatiedragers lager was dan de drempel die leidt tot aantasting van 
beweging die afhankelijk is van activering van frontale motorische gebieden. Als 
alternatieve gedachte kan een normale of compenserende verhoogde activiteit 
worden gehandhaafd door adaptieve mechanismen die bewegingsgerelateerde 
activiteit in de frontale motore gebieden faciliteren en zo effectief compenseren voor 
de verstoorde corticale activatie via het cortico-basale kernen-thalamo-corticale 
circuit. Wat het precieze mechanisme ook is, onze bevindingen ondersteunen de 
hypothese dat de klinische manifestatie van parkinsonisme, wat betreft het moment 
van optreden, uiteindelijk het gevolg is van het falen van compenserende 
mechanismen in de frontale motore gebieden (Bezard et al., 2003).
Toekomstperspectieven
Functionele neuroimaging studies, zoals beschreven in de hoofdstukken 2 tot en 
met 5, hebben de eerste inzichten gegeven in de cerebrale structuren die betrokken 
zijn bij compensatiestrategieën in de premotorische fase van de ziekte van 
Parkinson. De premotorische gebieden lijken een belangrijke rol te spelen in deze 
suggereerde dat de EBA een compenserende rol zou kunnen hebben bij patiënten 
met de ziekte van Parkinson tijdens het genereren van een motorisch plan (Helmich 
et al., 2007), wat later door ons bevestigd werd in LRRK2 mutatie dragers (hoofdstuk 
5). Met deze studies in gedachten hebben we een nieuw experiment opgezet 
waarin we dit gebied met behulp van cTBS geïnhibeerd hebben, om te testen of dit 
gebied inderdaad betrokken is bij compensatieprocessen (hoofdstuk 7). De 
gevolgen van deze interventie werden gemeten met een gevalideerde taak: de ver-
beeldingstaak zoals gebruikt in hoofdstuk 5. 
Hoofdstuk 7 gaf twee belangrijke resultaten. Ten eerste zorgde inhibitie van de 
EBA ervoor dat patiënten met de ziekte van Parkinson geen voordeel meer hadden 
als de eigen handpositie in dezelfde positie lag als de gepresenteerde hand. 
Dezelfde interventie had geen effect in de controlegroep, wat suggereert dat bij 
gezonde controles de EBA niet betrokken is bij de generatie van een motorisch 
plan, of dat andere gebieden compenseren voor de tijdelijke inhibitie van de EBA. 
Een tweede bevinding was dat inhibitie van de PMd ervoor zorgde dat gezonde 
controles geen voordeel meer konden halen uit hun eigen handpositie in 
tegensteling tot de groep Parkinson patiënten. We concludeerden dat Parkinson 
patiënten de PMd niet meer kunnen inzetten voor deze taak en dat deze disfunctie 
van de PMd gecompenseerd wordt door de EBA. Op basis van hoofdstuk 5 kan 
voorzichtig verondersteld worden dat deze rekrutering van meer posterieure 
gebieden als de EBA door een geleidelijk falende PMd zich al in de premotorische 
fase aftekent.
De functie van de premotore cortex in gezonde controles en de 
ziekte van Parkinson
Inhibitie van de linker PMd met cTBS voorkomt in gezonde proefpersonen maar niet 
in Parkinson patiënten dat de huidige lichaamshouding geïntegreerd wordt in een 
motorisch plan tijdens de verbeeldingstaak. 
Hieruit kunnen drie conclusies worden getrokken. Ten eerste is de linker PMd van 
Parkinsonpatiënten ongevoelig gebleken voor cTBS zoals gemeten met de ver-
beeldingstaak. Dit wijst op het feit dat de bekende overactiviteit van premotore 
gebieden bij de ziekte van Parkinson (Sabatini et al., 2000, Wu and Hallett, 2005, 
Eckert et al., 2006) waarschijnlijk berust op een disfunctie van deze gebieden in 
plaats van betrokkenheid bij compensatoire activiteit. Ten tweede is inhibitie van 
alleen de linker PMd bij gezonde proefpersonen voldoende om een verandering 
aan te brengen die ervoor zorgt dat de eigen lichaamshouding niet meer of minder 
wordt meegenomen in het motorisch plan, hetgeen een bevestiging is van de 
bekende hemisferale linkszijdige dominantie van deze frontale regio tijdens de ver-
beeldingstaak (Hlustik et al., 2002, Haaland et al., 2004, de Lange et al., 2006). Ten 
derde waren gezonde proefpersonen niet in staat om andere circuits in te schakelen 
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van een relatief nieuw rTMS protocol (cTBS) (Huang et al., 2005) om corticale 
gebieden te inhiberen en de gedragsmatige gevolgen van deze interventie in kaart 
te brengen. Met deze methode hebben we laten zien dat de corticale gebieden die 
eerder gevonden zijn inderdaad betrokken lijken te zijn bij compensatie en bij het 
genereren van een motorisch plan in de ziekte van Parkinson. Toekomstig 
onderzoek moet laten zien of “het stimuleren van” deze compenserende gebieden 
met rTMS-protocollen leidt tot verbetering van de motore (en misschien zelfs 
cognitieve) symptomen van de ziekte van Parkinson. We kunnen hierbij een aantal 
problemen tegenkomen. Zo zijn de effecten van rTMS niet focaal (m.a.w. beperkt tot 
het vooraf bepaalde corticaal doelgebied), maar kunnen naar verder en/of dieper 
gelegen gebieden verspreiden. Ook op de plaats van stimulatie activeert TMS, 
zoals het momenteel gebruikt wordt, meerdere neurale populaties die verschillende 
neurotransmitters gebruiken en verschillende functies uitoefenen. Bovendien zijn 
de effecten van rTMS variabel en afhankelijk van de hersenactiviteit voorafgaand 
aan de stimulatie, de pathologische toestand van gestimuleerde netwerken en de 
gebruikte medicijnen (Huang et al., 2008). Deze kanttekeningen zijn echter niet 
allemaal negatief. De verspreiding van na-effecten naar diepere structuren kan ook 
gebruikt worden om juist deze diepere structuren als doelgebieden te laten dienen. 
Het grootste nadeel van TMS blijft de korte duur van de na-effecten. Herhaalde 
dagelijkse sessies kunnen leiden tot effecten die langer aanhouden (Baumer et al., 
2003), maar de effecten blijven relatief klein. De vraag blijft dan ook of het wel 
realistisch is dat we therapeutische effecten kunnen bewerkstelligen met TMS. En 
moeten we de stimulatieparameters gebruiken die veilig blijken in gezonde 
controles of moeten deze veranderd worden voor patiënten? Net zoals bij medica-
tie-trials, zullen we moeten gaan testen welke stimulatieparameters het meest 
effectief blijken maar toch veilig zijn (“dose-finding”). 
compenserende processen. Een intrigerende vraag is of deze toegenomen taak-
gerelateerde activiteit in de premotorische gebieden blijft bestaan, toeneemt of 
vermindert in mutatiedragers die zich op de rand van de ontwikkeling van klinische 
(motore) tekenen van de ziekte van Parkinson bevinden. Er zijn tenminste twee 
verschillende verklaringen voor de extra rekrutering van premotorische gebieden 
bij deze asymptomatische mutatiedragers. Ten eerste zou het zo kunnen zijn dat bij 
de mutatiedragers, die een verhoogd risico hebben voor het ontwikkelen van de 
ziekte van Parkinson, de waargenomen veranderingen samenhangen met vroege 
premotorische corticale veranderingen. Dat wil zeggen dat dit een vroege 
manifestatie is van subtiele veranderingen in het motorisch netwerk. Deze 
hypothese kan alleen worden bevestigd door middel van een lange-termijn 
follow-up van deze proefpersonen totdat ze symptomatisch worden. Ten tweede 
bestaat er de mogelijkheid dat het motorisch netwerk in deze mutatiedragers 
anders is en dus los staat van het ontwikkelen van de ziekte van Parkinson. De 
corticale veranderingen die waargenomen worden in deze mutatiedragers zouden 
dus, althans voor een deel, een endofenotypische marker kunnen zijn en niet een 
vroege biomarker van de ziekte van Parkinson. Longitudinale studies met 
functionele beeldvorming op meerdere momenten in de tijd zijn nu nodig om te 
beoordelen of de waargenomen corticale veranderingen voorspellend kunnen zijn 
tijdens de premotorische fase en als ze dat zijn, of deze toenemen of juist afnemen 
wanneer deze personen klinische verschijnselen van de ziekte van Parkinson 
ontwikkelen.
Wanneer uit deze longitudinale studies inderdaad blijkt dat de reorganisatiepa-
tronen in de premotorische gebieden zijn gecorreleerd met de vroege ziekte van 
Parkinson en niet alleen endofenotypische markers zijn, dan kunnen de fMRI-pro-
tocollen zoals die beschreven zijn in dit proefschrift in de toekomst als diagnostische 
hulpmiddel dienen. Als we personen met een verhoogd risico op de ziekte van 
Parkinson kunnen identificeren, kan fMRI worden gebruikt om de activiteit van de 
betrokken compenserende gebieden in de premotorische fase te bepalen. 
Bovendien zou kwantificering van activiteit binnen deze gebieden tijdens gestan-
daardiseerde taken de mogelijkheid bieden om te kunnen stratificeren voor 
voorspelde duur tot klinische manifestatie. Een dergelijke aanpak is nodig wanneer 
we beginnen na te denken over hoe we toekomstige studies kunnen ontwerpen en 
moeten interpreteren met bijvoorbeeld ziektemodificerende medicijnen of andere 
behandelingen.
 
Bovenop het potentiele “diagnostische” gebruik en de nieuwe inzichten in de 
pathofysiologie van de ziekte van Parkinson, wijzen onze resultaten (met enige 
voorzichtigheid) op nieuwe behandelingsopties voor de ziekte van Parkinson, 
bijvoorbeeld met TMS. In de hoofdstukken 6 en 7, hebben we gebruik gemaakt 
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Allereerst gaat mijn grote dank uit naar alle Parkinson patiënten en alle andere 
proefpersonen die aan dit proefschrift hebben meegewerkt. Daarnaast ben ik veel 
dank verschuldigd aan mijn directe begeleiders en in het bijzonder prof. dr. Bas 
Bloem en prof. dr. Hartwig Siebner, zonder wie dit proefschrift er absoluut niet zou 
zijn geweest.
Prof. dr. Bloem, beste Bas, ongeveer 10 jaar geleden kwam ik als co-assistent jouw 
kamer binnen gelopen met de vraag of ik wat onderzoek voor je kon doen. Je 
besloot me letterlijk een kwijlstuk te laten schrijven! Dit was het begin van een zeer 
fijne samenwerking met dit proefschrift als resultaat, waarin geen spoortje kwijl te 
vinden is! Jij bent de motor achter dit proefschift. Jouw grenzeloze enthousiasme 
heeft mij er de afgelopen jaren doorheen getrokken. Bewonderenswaardig om te 
zien hoe iemand zoveel passie ergens in kan stoppen, het werkt zeer motiverend. 
Het meest heb ik nog genoten van de vele voetbaldiscussies, je verkeerde voetbal-
clubkeuze zij je vergeven!
Prof. dr. Siebner, dear Hartwig, together with Bas my scientific father! Thanks for the 
hospitality in Kiel in the hospital, but also at your home during the delicious diners. 
It was a great year that I will never forget. Besides the scientific memories, I will 
always remember you and your son wearing my orange clothes during the World 
Championships of 2006…
Prof. dr. Toni, dear Ivan, you are the accelerator of the last part of the thesis. 
Especially thanks for the resuscitation of the TMS paper and for the critical vision 
and the fast response-rate on the LRRK2 paper.   
Dr. van de Warrenburg, beste Bart, je bent wat later bij de club gekomen, maar je 
input is er niet minder om geweest. Jouw inzet heeft er mede voor gezorgd dat dit 
boekje nog in 2012 afgekomen is. Daarnaast is het altijd fijn als je een co-promotor 
hebt met een MG, bedankt!
Prof. dr. Padberg, ontzettend bedankt voor de tijd en mogelijkheden die u mij 
gegeven hebt voor dit onderzoek tijdens mijn opleiding. Ook dank aan stafleden, 
(oud)-AIOS en onderzoekers van de afdeling neurologie voor de prettige 
samenwerking tijdens de afgelopen jaren. 
Thanks to the Donders Centre and especially the “Intention and Action” group for 
accepting me as a “ghost clinician”.  
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Mijn paranimfen, twee vrienden sinds 1997. 
Ramon, maatje, hopelijk komt deze dag er voor jou ook snel aan. Ik vind het heel 
bijzonder dat je deze dag mijn paranimf wilt zijn. Veel is er gebeurd de laatste jaren 
en hopelijk gaat er nog veel meer gebeuren. Of het nou een (klein) biertje is, een 
hapje eten, een weekendje weg, spelen met de kids, een weekje skiën, het is altijd 
gezellig, zolang het maar niet over voetbal gaat… Laten we zo doorgaan!
Bart, collega Brabants Bartje! Een hele eer dat jij het water in wil schenken vandaag. 
Vanaf het eerste uur van de studie bij elkaar. Ik had het nooit voor mogelijk kunnen 
houden dat we zo dicht bij elkaar zouden eindigen met hetzelfde vak. Vrienden voor 
het leven!
Lieve schoonfamilie, bij jullie voel ik me altijd welkom. Bijzonder vind ik jullie steeds 
terugkerende interesse in dit boekje. Fijn dat jullie deze dag naast me staan! 
Mijn zusje, Eefje. (Dit hoef je me niet na te doen hoor!) Het is altijd thuiskomen bij 
jou, Jochem en de kids, en dat is een heerlijk gevoel. Ik hoop nog vele gezellige 
momenten samen te mogen delen, natuurlijk ook met jullie twee kanjers Simon en 
David. 
Papa en mama! Dit boek is voor jullie. Jullie hebben mij geleerd door te zetten en 
af te maken waar je aan begint. Jullie hebben me een heerlijke onbezonnen jeugd 
gegeven en mij neergezet waar ik nu sta. Alle dank ben ik aan jullie verschuldigd! 
Ik ben trots op jullie, ik hoop mijn kinderen hetzelfde mee te kunnen geven als wat 
jullie mij en Eefje hebben gegeven.
Lieve schat, Willemijn, het begon als een slecht doktersromannetje, maar nu jaren 
later zijn we een heus gezin. Onze tijd is eindelijk gekomen! Je bent er altijd voor 
me, en dat voelt heerlijk. Met jou en onze kinderen wil ik oud worden! Ik hou van je!
Joep en Nina, papa is gek op jullie!
In het bijzonder veel dank aan Rick Helmich vanwege alle uren die we samen achter 
de computer hebben doorgebracht voor de fMRI analyses. Nog mooier waren de 
dagen in Tel Aviv waar we uitblonken in het verenigen van het nuttige met het 
aangename! Also many thanks to Avner, our Israeli friend! Thanks for your hospitality 
and for all the work you did and still do for us. En Joyce, goed dat je mijn stokje in 
Kiel overgenomen hebt. Ik hoop daar snel het eindresultaat van te zien!
Noud Buenen bedankt voor de vele uren in het (te) kleine TMS lab. Het duurde 
even, maar dan heb je ook wat!
Special thanks to the collegaes from Kiel. I will never forget the coffee smell of the 
lab. Thanks to prof. dr. Deuschl for your hospitality, I really enjoyed my stay in Kiel. 
Especially thanks to Til, Martin, Michael, Oliver and Christoph: sorry for making the 
lab orange now and than. And remember: there is only one King Pin! 
Leden van de manuscriptcommissie. Prof. dr. G. Fernandez, Prof. dr. ir. M. van Putten 
en Prof. dr. H. Berendse, hartelijk dank voor de nauwkeurige beoordeling van het 
manuscript voor dit proefschrift en de goedkeuring ervan.
Een hele grote groep mensen hebben indirect een bijdrage geleverd aan dit 
proefschrift. 
De neurologen van het Slingeland Ziekenhuis Doetinchem wil ik bedanken voor de 
tijd die ik daar heb mogen werken en de ruimte die jullie mij daarnaast gegeven 
hebben om mijn proefschrift af te maken. Het ligt niet aan jullie, een Brabander gaat 
nou eenmaal graag terug…
Mijn collega’s in Eindhoven: Monique, Leo, Maarten, Koos, Ad, Janko, Gerald en 
Rob: bedankt voor de ruimte die jullie me de laatste maanden gegeven hebben om 
eerst mijn proefschrift af te maken. Nu ik dit heb afgerond kan en zal ik me gaan 
richten op de oncologie!
Natuurlijk mijn studententijd, deze had ik nooit willen missen en heeft een mooie 
Bordeaux-rode kleur in mijn hart achtergelaten! Bedankt (oud) leden van het M.H.D. 
Ferus Ebrius.
In het bijzonder nog Bas, Edwin en Robert Jan, dank voor de mooie avonden en 
weekenden gevuld met gesprekken over niets, maar zeker ook over onze studie en 
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Figure 1.1   
A. Photograph of a MRI scanner, the main magnetic field is 3 Tesla. Subjects lay 
supine in the scanner. Task stimuli are programmed on a computer in the control 
room, and presented onto the screen via a beamer. Subjects can respond in 
different ways (e.g. button press with hands or feet, or eye-movements with an 
eye-tracker). B. An image of the brain with areas of statistically significant areas 
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Figure 1   Continued.
Panel B (van Nuenen et al., 2009a): A two-dimensional drawing of the palm of 
the right hand was continuously presented in the centre of the visual field 
throughout the fMRI session. During the REST periods, the line drawing of the 
hand was continuously presented but without dots. Participants were instructed 
to remain still and fixate the hand with their eyes. During each block of TASK, 
participants performed three motor sequences. Each sequence consisted of 
three thumb-to-finger opposition movements. At the onset of each movement 
trial, the index, middle, ring or little finger was labeled with a red dot on a two-
dimensional drawing of the palm of the right hand. The position and order of the 
red dot specified the motor sequence that had to be performed within a given 
trial. Participants sequentially tapped with the tip of their right thumb onto the tip 
of the indicated fingers after the instruction cue had disappeared from the 
screen. Participants were asked to move at a convenient speed and to perform 
the task as accurately as possible. There were 10 blocks of TASK and 10 blocks 
of REST.
B
Figure 2   Regional increases in task-related BOLD signal changes in  
non-manifesting carriers of a Parkin or PINK1 mutation. Statistical 
parametric maps.
Sagittal, coronal, and axial slices highlighting those voxels in the left primary motor 
cortex, adjacent PMd and the right pre-SMA that showed a relative increase in 
BOLD signal during the sequential finger movements in the fast mutation carriers 
relative to the fast controls (upper row in A) and in the left caudal putamen and 
right pre-SMA that showed a relative increase in BOLD signal during the sequential 
finger movements in the slow mutation carriers relative to slow controls (lower 
row in A). All the statistical parametric maps are superimposed on to a T2- 
weighted structural MRI template provided by MRIcro (http://www.sph.sc.edu/
comd/rorden/mricro.html). The voxels of the activation maps are colour-coded 
according to their Z-values. For illustrative purposes, the maps are thresholded 
at an uncorrected p-value of p < 0.01. Parameter estimates of task-related BOLD 
signal changes. The column plots (B) give the mean Beta-values (as estimated 
by the general linear model) for the task-related change in BOLD signal during 
the sequential finger movement task for each of the four groups (blue columns 
= mutation carriers; yellow columns = non- mutation carriers). The Beta values 
are given in arbitrary units (A.U.) and refer to the voxel showing a peak difference 
between mutation carriers and non-carriers. Error bars equal the 95% confidence 
interval of the mean.
A B
232 233
COLOR FIGURES COLOR FIGURES
Chapter 4 Chapter 4
Figure 1   A. Experimental design.
The fMRI session consisted of ten alternating periods without movements (REST) 
or sequential movements. (TASK). Each block lasted for 24 s. There were 10 
blocks of TASK and 10 blocks of REST. A two-dimensional drawing of the palm 
of the right hand was continuously presented in the centre of the visual field 
throughout the fMRI session. During the REST periods, the line drawing of the 
hand was continuously presented but without dots. Participants were instructed 
to remain still and fixate the hand with their eyes. During each block of TASK, 
participants performed three motor sequences. Each sequence consisted of 
three thumb-to-finger opposition movements. At the onset of each movement 
trial, the index, middle, ring or little finger was labelled with a red dot on a two-
dimensional drawing of the palm of the right hand. The position and order of the 
red dot specified the motor sequence that had to be performed within a given 
trial. When the instruction cue disappeared from the screen, participants 
sequentially tapped with the tip of their right thumb onto the tip of the indicated 
fingers. They were asked to move at a convenient speed and to perform the task 
as accurately as possible. 
A
Figure 1   B. Main effect of the motor task.
The axial slices show the motor regions that showed a task-related increase in 
BOLD signal during the sequential finger movement task. The statistical 
parametric maps are superimposed on to a T2-weighted structural MRI template 
provided by MRIcro (http://www.sph.sc.edu/comd/rorden/mricro.html). The 
voxels of the activation maps are colour-coded according to their Z-values and 
thresholded at p<0.05 using the FWE method as implemented in SPM2.
B
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Figure 2   Regional increases in task-related BOLD signal changes in non-
manifesting carriers of a Parkin or PINK1 mutation. 
(A). Statistical parametric maps. Sagittal, coronal, and axial slices highlighting 
those voxels in the pre-SMA and adjacent PMd that showed a relative increase 
in BOLD signal during the sequential finger movement task in mutation carriers 
relative to controls without a mutation. The statistical parametric maps are 
superimposed on to a T2-weighted structural MRI template provided by MRIcro 
(http://www.sph.sc.edu/comd/rorden/ mricro.html). The voxels of the activation 
maps are colour-coded according to their Z-values. For illustrative purposes, the 
maps are thresholded at an uncorrected p-value of p<0.01. 
A
B
Figure 3   Relative increases in task-related BOLD signal changes in  
non-manifesting carriers of a PINK1 mutation compared with non-
manifesting carriers of a Parkin mutation. 
Axial slices showing voxels in dorsal frontoparietal cortex with significant 
increase in BOLD signal during the sequential finger movement task in PINK1 
mutation carriers relative to Parkin mutation carriers. The statistical parametric 
maps are superimposed on to a T2-weighted structural MRI images provided by 
MRIcro (http://www.sph.sc.edu/comd/rorden/mricro.html). The voxels of the 
activation maps are colour-coded according to their Z-values. For illustrative 
purposes, the maps are thresholded at an uncorrected p-value of p<0.01.  
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Figure 3   Cerebral effects. 
A: Between-groups differences in imagery-related brain activity. Anatomical 
distribution of voxels that showed a differential change in BOLD signal as a function 
of stimulus rotation (i.e. imagery-related) between non-mutation carriers (NMC) and 
non-manifesting LRRK2 mutation carriers (MC). On the left, axial slice showing 
reduced imagery-related BOLD signal in the caudate nuclei; On the right, axial slice 
showing increased imagery-related BOLD signal in the dorsal premotor cortex (PMd). 
Statistical parametric maps (SPMs) of imagery-related between-groups differences 
(Z-scores, in red-yellow) superimposed onto a T2-weighted structural MRI template (in 
grey). For illustrative purposes, SPMs are thresholded at an uncorrected p value of 
p<0.01 with a cluster extent threshold of > 50. B: Between-groups differences in 
imagery-related effective connectivity. The coronal slice on the right describes the 
anatomical distribution of voxels in the extrastriate body area (EBA) with differential 
increase in imagery-related coupling with the right PMd (left axial slice) between 
non-mutation carriers and non-manifesting LRRK2 mutation carriers. The SPM(Z) of 
between-groups differences  in PMd-EBA imagery-related connectivity (in red-yellow) 
is superimposed onto a T2-weighted structural MRI template (in grey). C: Between- 
groups differences in the relation between imagery-related activity in the right 
caudate and PMd-EBA connectivity. Scatterplot of parameter estimates (ß-values) 
of imagery-related activity in the right caudate (x = 18, y = 2, z = 18) against coupling 
strength between the right PMd (x =  34, y = -12, z = 46) and the right EBA (x = 40, 
y = -78, z = 4) for non-mutation carriers (left panel) and for non-manifesting LRRK2 




Figure 1   Experimental design. 
(A) Time line of the experimental procedures. See methods section for further details. 
TMS/MEP = Measurements of motor evoked potentials (MEP) with single-pulse 
transcranial magnetic stimulation (TMS) of left primary motor hand area. cTBS = 
continuous theta burst stimulation. fMRI = functional magnetic resonance imaging. 
(B) Visually guided grip-and-lift force task. During fMRI, subjects were presented with 
a S1 pre-cue (red color) and a S2 go-cue (green color) with a variable delay between 
S1 and S2. The cues were projected on the screen for 1 s, thereafter an orange or grey 
cross was projected during a jittered period of 2 s to 8 s. The shape of the stimulus 
indicated the weight to be lifted. A circle or a square predicted a light (100g) or a heavy 
(250g) weight. In 75% of the trials the preparatory S1-cue correctly predicted the S2 
cue. Depending on the combination of S1 and S2 cues, there were two trial types with 
correct pre-cue (HH = heavy-heavy and LL= light-light) and two trial types with 
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Figure 6   Regional increases in BOLD signal during preparation (S1-S2 interval).  
(A) Main effect of preparation regardless of the weight indicated by the S1 pre-cue. 
The sagittal, coronal and axial slices show the regions that showed a increase in 
BOLD signal during the preparation of a lift (heavy and light). (B) Relative increases 
in BOLD signal during the preparation for lifting a heavy weight relative to preparing 
for lifting a light weight. The statistical parametric maps are based on the fMRI data 




Figure 7   Linear relationship between regional activation during motor 
preparation and the relative undershoot in maximal grip force in 
trails where an incorrect S1 pre-cue announced a light weight after 
(A) sham cTBS30% or (B) real cTBS80% of left PMd.  
(A) In the control session without effective cTBS, preparatory activity during the 
S1-S2 period predicted the individual undershoot in maximal grip force. The higher 
the preparatory activity in the left PMd, the larger was the undershoot in trials with 
an incorrect S1 pre-cue indicating a light weight. (B) This linear relationship was 
abolished after real cTBS80% of left PMd. The left panels show axial slices of the 
statistical parametric map for the linear relationship between preparatory activity 
and force undershoot. The corresponding scatter plots for the peak voxel in left 
PMd are presented on the right (x, y, z = -30, -3. 54). The parameter estimates of 
preparatory BOLD signal changes are plotted along the y-axis. The maximal grip 
force ratios (LH / LL trials) are displayed along the x-axis. The grey color marks the 
area with negative LH/HH force ratio (i.e., undershoot). The regression line gives 







Figure 8   Relationship between cTBS-induced change in force undershoot 
and weight-specific preparatory activity in left rostral SMA.  
Subjects in whom fMRI revealed a relative increase in preparatory S1-S2 activity 
for light lifts (relative to heavy lifts) after real cTBS80%, showed no or little change 
in grip force undershoot (LH / HH ratio) after real cTBS80%. Conversely, real 
cTBS80% induced a clear reduction in grip force undershoot in those subjects 
who showed an increase in preparatory S1-S2 activity for light lifts (relative to 
heavy lifts) after real cTBS80%. The axial slice (upper panel) illustrates the cluster 
in left rostral SMA showing a linear relation between cTBS-induced change in 
force undershoot and weight-specific preparatory activity. The corresponding 
scatter plot for the peak voxel in left rostral SMA is illustrated in the lower panel 
(x, y, z = -6, 18, 54). The regression line gives the estimated linear relation.
  
